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ABSTRACT 
Fe(II) localized on DNA can reduce hydrogen peroxide (H2O2) to form hydroxyl 
radical, resulting in oxidative DNA damage. This oxidative DNA damage is an 
underlying leading cause of cardiovascular diseases, neurodegenerative diseases, and 
cancer. Sulfur and selenium antioxidants have been investigated for their prevention of 
metal-mediated oxidative DNA damage, and sulfur- and especially selenium-containing 
antioxidants prevent metal-mediated oxidative DNA damage, likely by radical 
scavenging and sacrificial oxidation via metal coordination. 
To determine how iron coordination results in DNA damage inhibition, Fe(II) 
complexes with imidazole-thione and –selone ligands were synthesized to examine their 
iron coordination modes (Chapter 2), electrochemistry (Chapter 2), and reactivity with 
H2O2 (Chapter 3). N,N’-dimethylimdiazole thione (dmit) and –selone (dmise) ligands 
were used since they resemble ergothioneine and selenoneine, thione and selone-
containing antioxidants naturally found in plants and animals. Dmit and dmise 
coordination to Fe(II) increases the zwitterionic character of these ligands, and binding 
occurs primarily through σ and π donation. Fe(II)-thione and selone complexes of the 
formulae Fe(L)2Cl2, [Fe(L)2(NCCH3)2]
2+
, and [Fe(L)4]
2+
 complexes (L = dmit or dmise)
have ligand-based oxidation potentials ranging from 0.36 - 0.69 V,  significantly higher 
than their observed Fe(III/II) oxidation potentials. Thus, the thione and selone ligands 
should undergo oxidation prior to Fe(II), possibly preventing iron-mediated oxidative 
DNA damage. 
iii 
The oxidation of Fe(dmit)2Cl2 and Fe(dmise)2Cl2 complexes by H2O2 was 
examined to determine potential antioxidant mechanisms (Chapter 3). Treatment of 
Fe(dmit/dmise)2Cl2 with H2O2 showed sacrificial oxidation of the thione and selone 
ligands; however, only dmise significantly protected Fe(II) from oxidation to Fe(III). If 
similar iron-thione and –selone complexes form in vivo, these complexes may similarly 
scavenge H2O2 to inhibit iron-mediated oxidative DNA damage. 
A comparative mechanistic study required synthesis and characterization of 
Zn(L)2Cl2 and [Zn(L)4]
2+
 complexes (L = dmit or dmise) as well as H2O2 oxidation
studies of Zn(dmit/dmise)2Cl2 complexes (Chapter 4). Dmit and dmise coordination to 
non-redox-active Zn(II) occurs thorough σ and π binding, similar to their Fe(II) analogs. 
However, the dmit and dmise ligand oxidation potentials decrease compared to unbound 
dmit and dmise, indicating stabilization of the chalcogenones, opposite the effect 
observed upon Fe(II) coordination. Treatment of Zn(dmit)2Cl2 with H2O2 showed dmit 
oxidation; however, dmit does not undergo complete oxidation, since dmit-OH species 
were observed by mass spectrometry. Unlike dmit, when Zn(dmise)2Cl2 was treated with 
H2O2 complete oxidation of dmise was observed, similar to that observed for its Fe(II) 
complex analog. These results indicate dmit oxidation is dependent upon the redox-
activity of the coordinated metal ion, whereas dmise oxidation is not metal dependent. 
Novel thione- and selone-containing imidazoles were synthesized and 
characterized with various substituents on the imidazole ring (Chapter 5). A novel 
synthetic approach was also implemented for the synthesis of thione derivatives to avoid 
the use of air-sensitive techniques. Addition of chlorine atoms in place of the imidazole 
iv 
ring hydrogen atoms in dmit increases its zwitterionic character compared to dmit; 
however, no similar difference in zwitterionic character is observed for its selenium 
analog compared to dmise. This difference suggests that the nucleophilicity of the Se 
compared to the S in these chloro-substituted imidazole thiones is significant, with a 
larger partially negative charge on the Se atom compared to its S analog even when not 
bound to a metal. Use of trityl as a thione sulfur protecting group is a novel synthetic 
route that allows facile synthesis of novel thione derivatives. Addition of a methyl-keto 
substituent on an imidazole nitrogen atom may increase metal binding affinity of the 
resulting thione due to an increase in zwitterionic character and a possible an increase in 
ligand denticity through the available S and O atoms compared to methimazole and dmit. 
Methimazole and its derivatives were also investigated for their ability to 
coordinate Fe(II) and Zn(II) (Chapter 6). Since methimazole and 2-mercaptoimidazole 
oxidize to their respective disulfides, the synthesis of Fe(II) and Zn(II) complexes with 
these oxidized ligands was also investigated. When bound to Fe(II) and Zn(II), 
methimazole and 2-mercaptoimdazole increase in zwitterionic character and bind solely 
through the S atom via σ and π donation. The oxidized thione and selones bind through 
their available nitrogen atom, forming seven-membered ring systems. These studies have 
enhanced our understanding of the possible antioxidant mechanisms of thiones and 
selones as well as provided proof that iron coordination is a major mechanism in 
prevention of metal-mediated DNA damage. 
v 
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CHAPTER ONE 
THIONE- AND SELONE-CONTAINING COMPOUNDS, THEIR LATE 
FIRST ROW TRANSITION METAL COORDINATION CHEMISTRY, 
AND THEIR BIOLOGICAL POTENTIAL 
 
1.1 Biological components of sulfur and selenium 
 Sulfur and selenium are essential elements and are incorporated into amino acids 
and enzymes.
1-7
 Sulfur has been very widely studied for its biological importance as well 
as its excess and deficiency.
8
 Although the recommended dietary allowance for selenium 
is low, 55-350 μg/day,9 selenium deficiency can lead to Keshan, Keshan-Beck, and 
numerous neurodegenerative diseases.
10
  An excess of selenium, however, can also have 
malnutritional effects such as garlic breath, selenosis, and selenium poisoning.
10
 Humans 
obtain their nutritional needs for sulfur and selenium from milk, cheeses, garlic, eggs, 
fruits, vegetables, Brazil nuts, grains, legumes, and meats.
7
 The main biological form of 
selenium in humans is selenocysteine, which is synthesized in the body from dietary 
selenium sources.
8,10,11
  
 Common sulfur and selenium compounds in biological systems include the amino 
acids cysteine, selenocysteine, methionine, and selenomethionine (Figure 1.1). 
Selenocysteine differs from cysteine by replacement of a single selenium atom in place of 
sulfur, and has similar chemical properties; however selenocysteine has a lower pKa and 
is a stronger nucleophile, making it much more reactive.
12
 Selenoproteins, including 
thioredoxin reductases and glutathione peroxidases (GPx), are involved in redox  
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Figure 1.1. Common biological sulfur and selenium compounds and antithyroid drugs. 
reactions, electron transfer, and the synthesis of thyroid hormones; however, many of the 
selenoproteins’ functions are not well elucidated.  Cysteine and selenocysteine are often 
found in proteins and enzymes bound to late-transition metal centers such as iron, copper, 
and zinc.
12
 
In contrast to the thiol and selenol functional groups of cysteine and 
selenocysteine, the amino acids ergothioneine and selenoneine (Figure 1.1) feature either 
a sulfur-carbon double bond (S=C, the thione functional group) or a selenium-carbon 
double bond (Se=C, the selone functional group). These thione- and selone-containing 
amino acids have the resonance forms shown in Figure 1.2, and belong to a class of 
pharmacologically active N,S ligands widely used in treating thyroid disorders.
13,14
  
Thione and selone compounds bind to metal ions through the sulfur or selenium atom as 
well as any unsubstituted NH groups of the imidazole ring. Imidazole thiones and selones 
have neutral and zwitterionic resonance forms; upon metal binding, spectroscopic data 
are consistent with stabilization of the zwitterionic resonance form with more negative 
charge on the sulfur or selenium atom,
13,14
 similar to thiolate and selenolate ligands. 
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Figure 1.2. Resonance structures of an example imidazole thione (E = S) and selone (E = Se) compound. 
 Thione-metal coordination has been widely examined, but reviews do not 
specifically discuss late-transition-metal complexes of these ligands. General 
coordination chemistry of thione ligands was reviewed more than ten years ago by 
Raper
15
 and Akrivos
16
, but significant advances have since been made in this field. 
Reviews of multidentate (scorpionate) thione ligands and their coordination chemistry 
were recently published by Spicer and Reglinski
17
 and Pettinari,
18
 but do not primarily 
focus on late transition metal coordination chemistry.  Selone-containing compounds are 
scarce, and their metal complexes are correspondingly rare, so this area has not been 
previously reviewed. This review focuses on describing the coordination chemistry of 
thione- and selone-containing compounds with the late-first-row-transition metals, 
especially studies that have been published in the past decade, and the biological 
implications of this chalcogenone-metal binding.  
 
1.2 Thione and selone compounds 
Recently, thione- and selone-containing compounds have been primarily 
examined for their antioxidant behavior and their metal coordination abilities
1,14,19,20
. 
Antioxidant behavior of thione and selone compounds arises from several different 
mechanisms, including reactive oxygen species (ROS) scavenging, GPx-like activity to 
scavenge hydrogen peroxide, and binding of ROS-generating metal ions.
1,21
 Because 
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ROS damage cells and can result in disease development, it is important to understand 
how naturally occurring thione- and selone-containing compounds, as well as thione- and 
selone-containing drugs, neutralize ROS and prevent oxidative damage that leads to 
disease. Since the antioxidant activity of these compounds is also linked to prevention of 
ROS formation by metal coordination, it is essential to understand how these compounds 
bind metals and how they might react in vivo.  
 
1.3 Thione and selone antioxidant drugs 
 The thione-containing amino acid ergothioneine is found in plants and animals (1-
3 mM
22,23
), including humans.  Ergothioneine is synthesized only in bacteria and various 
fungi, and it is thought that humans obtain ergothioneine in the diet.
24
 Although a specific 
transport system for ergothioneine has been identified in humans, no definite molecular 
pathway that involves ergothioneine has been reported.
24
 Franzoni, et al.
5
 demonstrated 
in vitro that ergothioneine scavenges peroxyl, hydroxyl, and peroxynitrite radicals more 
effectively than glutathione. In addition, several studies have determined that 
ergothioneine is a potent biological antioxidant, preventing many different types of 
oxidative damage, including lipid peroxidation oxidative DNA damage, and apoptosis, in 
cells or in animals.
25-31
 Metal coordination as an antioxidant mechanism has also been 
examined using density functional theory methods,
32
 and ergothioneine-copper 
coordination was found to prevent copper-mediated oxidative DNA and protein damage 
by inhibiting copper redox cycling.
33
  
Selenoneine, the selenium-containing analog of ergothioneine, has not been as 
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extensively studied due to its very recent discovery in the blood of bluefin tuna.
4
 Since 
then, selenoneine has been identified in humans in very low concentrations (5-10 nM
34
); 
similar to ergothioneine, selenoneine is taken up from the diet. It is thought that 
selenoneine may be metabolized through selenium methylation, and this metabolic 
product was identified from human urine by mass spectrometry.
35
 Selenoneine’s 
biological function is not known, but Yamishita, et al.
34
 reported that selenoneine is a 
more potent radical scavenger than ergothioneine, as determined by in vitro DPPH 
radical scavenging studies, and hence may play an important role in the redox cycle in 
animals.   
Many of the drugs used to treat hyperthyroidism have thione functional groups, 
the most common of which is methimazole (Figure 1.1).
36,37
 In addition to its anti-thyroid 
activity, methimazole prevents oxidative DNA damage by hydrogen peroxide 
scavenging.
38,39
 Other compounds that fall into this thione-containing class of 
hyperthyroid inhibitors are the thiourea drugs 6-n-propyl-2-thiouracil (PTU) and 6-
methyl-2-thiouracil (MTU; Figure 1.1), but these drugs have not been studied as potential 
antioxidants. Although these compounds are the most commonly employed drugs for 
treating hyperthyroidism, their detailed mechanism of action is still unproven.
26
 It has 
been proposed that these drugs may block thyroid hormone synthesis by coordinating to 
the iron center of thyroid peroxidase.
37
  
 
1.4 Imidazole thione compounds 
The heterocyclic N,N’-dimethylimidazole thione (dmit) and (N,N’- 
6 
 
dimethylimidazole selone (dmise) compounds (Figure 1.3) synthesized by Roy, et al.
37
 
resemble methimazole and are structurally similar to ergothioneine
24
 and selenoneine,
4
 
respectively.  Similar compounds 1,1’-(1,2-ethanediyl)-bis(3-methyl-imidazole-2-thione)  
 
Figure 1.3. Thione- and selone-containing ligands discussed in this chapter. 
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(ebit) and 1,1’-(1,2-ethanediyl)bis(3-methyl-imidazole-2-selone) (ebis; Figure 1.3) also 
have been synthesized by Jia, et al.
40
 to provide bidentate thione and selone ligands for 
metal coordination. These heterocyclic chalcogenones are strong σ- and π-donors, and 
similar compounds, such as the class of imidazoline-2-thione ligands (Figure 1.3), display 
a diversity of metal binding modes.
41
 
  Trithiocyanuric acid (2,4,6-trimercaptotriazine, ttcH3; Figure 1.3) and its 
trisodium salt have a wide range of applications: they can be used to precipitate heavy 
metals,
42-44
 and the acid shows anti-toxoplasmal activity more effective than the presently 
used drugs 5-fluorouracil and emimicin.
45
 The protonation state and solubility of 
trithiocyanuric acid depends strongly on pH. At pH values below 5, only the water-
insoluble ttcH3 exists, whereas increasingly soluble ttcH2
-
, ttcH
2-
, and ttc
3-
 anions are 
formed as the pH increases.  Unsurprisingly, the different protonation states of this 
compound greatly affect its metal binding abilities.
46
 Depending on the extent of ttcH3 
deprotonation, different metal coordination modes are possible, and transition metal 
complexes with various nuclearities can be formed.
46
  
 
1.5 Scorpionate-thione compounds 
 The so-called scorpionate compounds have become a hugely popular class of 
ligands in coordination chemistry since they mimic biological coordination sites.
17,47-53
 
This perceived analogy, coupled with their ease of synthesis and their remarkable 
versatility in transition-metal complexation, rapidly established them as a widely used 
class of ligands. One of the first examples, tris(pyrazolyl)borate, was described by 
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Trofimenko in 1966.
54
 These are tripodal, anionic ligands with an N3 donor set that caps 
one face of a coordination polyhedron. The ability to synthesize a wide range of 
substituted pyrazolyl ligands facilitates tuning of their steric, and to some degree, 
electronic properties.
18,55
  
The thione-containing hydrotris(methimazolyl)borate (Tm
R
), 
hydrobis(methimazolyl)borate (Bm
R
), hydrotris(thioxotriazolyl)borate (Tr
R,R’
), 
bis(thioimidazolyl)(pyrazolyl)borate (Bm
Me
pz), and  bis(mercaptoimidazolyl)borate 
(Bm
R
) ligands (Figure 1.3), like the pyrazolyl borates, have great potential for 
modification. The N-methyl group can be readily replaced by a range of alkyl (methyl, 
ethyl, tert-butyl, benzyl, and cyclohexyl) or aryl (phenyl, p-tolyl, o-tolyl, mesityl, 
cumenyl, 2-biphenyl, 2,6-xylyl, and 2,6-diisopropylphenyl) groups. In keeping with 
Trofimenko’s synthesis of the pyrazolyl borate ligands, Spicer and Armstrong17,56,57 
synthesized Tm
R
 and Bm
R
 by reaction of methimazole with sodium borohydride in a 
solvent-free system.
54
 Hydrogen evolves as the methimazole melts, forming sodium 
hydrotris(methimazolyl)-borate in 73-88% yields. Both lithium
58
 and potassium
59-61
 
borohydrides have also been used successfully in these syntheses. Coordination 
complexes of these soft scorpionate ligands have been used as structural enzyme models 
for nickel-containing hydrogenases 
62
 and zinc-containing alcohol dehydrogenases.
63,64
 
 
1.6 Thione compounds as ligands 
Thiones and selones readily bind transition metals such as Fe(II), Co(II/III), 
Ni(II), Cu(I/II), and Zn(II). Recently, there has been increased interest in the chemistry of 
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soft Lewis base donors such as thiolates, thioamides, selenolates, and selenoamides for 
use in catalysis
65
 and in bioinorganic chemistry for the study of copper metallothioneins, 
metallochaperones, and methinobactin.
66-68
 Metal-thione complexes also have been 
studied for a broad range of biological activities, including applications as antitumor, 
antibacterial, antifungal, and antiviral agents.
69-72
  
Many publications describe metal-thione complexes and, in a few cases, the 
structures and properties of these complexes have been compared to analogous metal-
selone complexes. Unsurprisingly given the polarizability of the sulfur donor atoms, 
thione complexes have been largely reported only for the late first-row d-block metal 
ions, typically only in lower oxidation states. 
  
1.7 Iron-thione complexes 
Iron-thione complexes have not been extensively studied, likely because Fe(II) is 
unstable to oxidation and, thus, these complexes must be synthesized using air-free 
conditions. Iron-thione complexes are of interest as model complexes to study sulfur-rich 
metal centers in proteins and to determine potential biological behavior of ergothioneine 
and thione-containing drugs. Sanina, et al.
73
 reported the synthesis of [Fe(1,2,4-triazole-
3-thione)2(NO)2]∙0.5H2O (Figure 1.4A) by combining 3-mercapto-1,2,4-triazole (Figure 
1.3) with [Na2Fe2(S2O3)2(NO)4]∙2H2O and Na2S2O3∙5H2O in a 10:1:2 molar ratio in 
aqueous alkaline solution. The heterocyclic thione ligands coordinate iron through the 
sulfur atom, rather than through the available nitrogen atoms, with Fe–S bond distances 
of 2.298(1) and 2.318(1) Å.
73
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The infrared spectrum of Fe(1,2,4-triazole-3-thione)2(NO)2∙0.5H2O has a single 
band at 702 cm
–1
 due to the iron-bound C=S that shifts to lower energy compared to the 
unbound 1,2,4-triazole-3-thione (750 or 745 cm
–1
).
73
 This shift upon complex formation 
indicates significant weakening of the C=S bond, and iron backbonding to the thione 
sulfur. Sanina, et al.
73
 reported that one of the sulfur atoms, S(1), is negatively charged 
and covalently binds to iron, whereas the other sulfur atom, S(2), is formally neutral and 
forms a donor–acceptor bond with iron. This description of the bonding is not supported 
by the single infrared C=S band and the very similar Fe-S bond lengths reported for this 
complex. 
 A similar complex was synthesized using 4-amino-3-methyl-1,2,4-triazole-5-
thione (amt; Figure 1.3) and iron(II)perchlorate to yield [Fe(amt)2(H2O)2][ClO4]2 (Figure 
1.4B).
73
 This iron compound decomposed during X-ray structural analysis as 
demonstrated by a ~30% decrease in the intensity of the standard reflections over the 
course of data collection.  As expected, the symmetrically equivalent Fe-S bond distances 
of 2.474(1) Å
73
 in this octahedral iron complex are significantly longer than the Fe-S 
bonds in the tetrahedral Fe(1,2,4-triazole-3-thione)2(NO)2∙0.5H2O. Crystals of 
[Fe(amt)2(H2O)2][ClO4]2, initially pale green and transparent, slowly become yellowish/ 
brown and cloudy within a few days of exposure to air, characteristic of Fe(II) to Fe(III) 
 
Figure 1.4. Crystal structures of A) Fe(1,2,4-triazole-3-thione)2(NO)2]∙0.5H2O,
73
 and B) 
Fe(amt)2(H2O)2][ClO4]2.
69
  Hydrogen atoms, solvent, and counterions are omitted for clarity. 
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oxidation.
69
  
 The monodentate iron-thione complexes Fe(dmit)2Cl2 (Figure 1.5A), 
[Fe(dmit)4][BF4]2, and [Fe(dmit)4][OTf]2 (Figure 1.5B), were synthesized by addition of 
dmit (Figure 1.3) to FeCl2∙H2O, Fe(BF4)2, or Fe(OTf)2, respectively.
74
 These distorted 
tetrahedral Fe(II) complexes bind though the sulfur atom of the monodentate thione 
ligand, with bond distances ranging from 2.3395(9) to 2.395(2) Å.  
When dmit is bound to iron(II), the infrared stretches for the S=C bonds shift very 
slightly to lower energies (3 to 5 cm
-1
) compared to unbound dmit (1181 cm
-1
; Table 1.1), 
indicating primarily σ and π bond donation. The 1H NMR spectra of these three 
complexes show a prevalent paramagnetic effects from the iron metal center. X-ray 
crystallography, IR spectroscopy and DFT calculations suggest an increase in aromaticity 
favoring the zwitterion structure with increased negative charge on the thione sulfur atom 
(Figure 2), promoting metal coordination. This effect has been observed previously with 
copper- and platinum-thione complexes.
13,14,19
  
The electrochemistry of the dmit ligand also changes when bound to iron, with the 
Epa shifting by 99 mV compared to unbound dmit (455 mV), indicating that the Fe(II)- 
 
Figure 1.5. Crystal structures of A) Fe(dmit)2Cl2,
74
 B) [Fe(dmit)4][BF4]2,
74
 and C) Tm
tBu
FeCl.
75
 Hydrogen 
atoms and counterions are omitted for clarity. 
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Table 1.1. Infrared bands for C=S and C=Se bond vibrations in thione and selone compounds. 
Metal Complex 
C=S/Se Infrared 
Band (cm
-1
) 
Change From 
Unbound Ligand 
(cm
-1
) 
Ref. 
Fe-Thiones 
   
Fe(dmit)2Cl2 1176 -5 74 
[Fe(dmit)4][BF4]2 1178 -3 74 
[Fe(dmit)4][OTf]2 1177 -4 74 
Fe-Selones 
   
Fe(dmise)2Cl2 1149 1 74 
[Fe(dmise)4][BF4]2 1155 7 74 
[Fe(dmise)4][OTf]2 1151 3 74 
Co-Thiones 
   
Tm
tBu
2Co2(μ-Tm
tBu
)2Cl2 1087 -30 78 
Co-Selones 
   
[Co(mbis)Cl2]n 1096 -32 82 
[Co(ebis)Cl2]n 1135 9 82 
Ni-Thiones 
   
Ni(mbit)Br2 1153 15 82 
Ni(ebit)Br2 1146 10 82 
Ni(S
R
N)Br2 1156 2 83 
Ni-Selones 
   
Ni(mbis)Br2 1133 5 82 
Ni(ebis)Br2 1128 2 82 
Cu-Thiones 
   
trans-Cu(dmit)2Cl 1173 -8 19 
trans-Cu(dmit)2Br 1173 -8 19 
trans-Cu(dmit)2I 1171 -10 19 
cis-Cu(dmit)2I 1171 -10 19 
[TpmCu(dmit)][BF4] 1174 -7 14 
[Tpm*Cu(dmit)][BF4] 1171 -10 14 
[Tpm
iPr
Cu(dmit)][BF4] 1180 -1 14 
Tp*Cu(dmit) 1175 -6 14 
[Cu(dmit)3][OTf] 1147 -34 20 
[Cu(dtucH2)(PPh3)Cl]n 1090 -45 103 
[Cu(dtucH2)(PPh3)Br]n 1105 -30 103 
[Cu(dtucH2)(PPh3)I]n 1125 -10 103 
Cu-Selones 
   
trans-Cu(dmise)2Cl 1149 1 19 
cis-Cu(dmise)2Br 1150 2 19 
 
13 
 
Table 1.1(cont.). Infrared bands for C=S and C=Se bond vibrations in thione and selone compounds. 
Metal Complex 
C=S/Se Infrared 
Band (cm
-1
) 
Change From 
Unbound Ligand 
(cm
-1
) 
Ref. 
cis-Cu(dmise)2I 1148 0 19 
Cu4(μ-dmise)4(μ-Br)2Br2 1150 2 19 
Cu4(μ-dmise)4(μ-I)2I2 1144 -4 19 
[TpmCu(dmise)][BF4] 1150 2 14 
[Tpm*Cu(dmise)][BF4] 1150 2 14 
[Tpm
iPr
Cu(dmise)][BF4] 1150 2 14 
Tp*Cu(dmise) 1146 -2 14 
[Cu(dmise)4][OTf] 1146 -2 20 
 
bound thione becomes more readily oxidizable.
74
 This increase in oxidation potential 
suggests that the bound dmit may protect Fe(II) from oxidation.   
Scorpionate-thione complexes with iron. Treatment of FeCl2 and LiTm
R
 at room 
temperature over four days yields the scorpionate-thione complexes Tm
R
FeCl (R = Me, 
t
Bu, Ph, and 2,6-
i
PrC6H3; Figure 1.3); the structure of the t-butyl derivative, Tm
tBu
FeCl, is 
shown in Figure 1.4C.
75
 These Fe(II) complexes adopt distorted tetrahedral geometry 
with Fe-S bond distances ranging from 2.366(1) to 2.3881(1) Å.
75
 As observed for the 
monodentate thione complexes, these chelating thione complexes are moderately air- and 
moisture-stable in the solid state but unstable in solution. 
The reported iron–thione complexes are only found as Fe(II) and adopt tetrahedral 
or octahedral geometry around the Fe(II) metal center.  They are easily synthesized, 
binding through the sulfur atom rather than an available nitrogen atom, as observed for 
Fe(1,2,4-triazole-3-thione)2(NO)2]∙0.5H2O.
73
 Fe(II)-thione complexes oxidize when 
exposed to oxygen, but these oxidized products have not been characterized. Because of 
iron’s importance in generating ROS such as hydroxyl radical, and the demonstrated 
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ability of biological thiones to prevent oxidative damage from these species, further 
studies of the relationship between iron-thione binding and reactivity of these complexes 
with ROS will help elucidate the mechanisms for thione antioxidant activity. 
  
1.8 Cobalt-thione complexes 
In the only report of a monodentate thione complex with cobalt, Castro, et al.
76
 
synthesized Co(C6H12N2S)2Cl2 with the heterocyclic thione 1-propylimidazolidine-2-
thione-S (Figure 1.6A). Similar to the Fe(dmit)Cl2 complex, the Co(II) center adopts 
distorted tetrahedral geometry with the two thione ligands bound through the S atoms and 
Co-S bond distances of 2.341(2) and 2.330(2) Å.
76
  
Scorpionate-thione complexes with cobalt. The scorpionate-thione ligand 
hydrotris(1-methylimidazol-2-ylthio)borate (HBmit3, Figure 1.3) was treated with CoF3 
to afford the cobalt complexes [Co(III)(HBmit3)2][HBmit3] (Figure 1.6B) and 
[Co(II)(HBmit3)2]∙4H2O.
77
 X-ray structural analysis indicated that these complexes have 
octahedral and tetrahedral geometries, respectively, with the cobalt bound to all three 
thione sulfur atoms. In [Co(III)(HBmit3)2][HBmit3], the Co-S distances range from 
2.293(6) to 2.321(5) Å, and in [Co(II)(HBmit3)2]∙4H2O, the Co-S bond distances are 
somewhat longer, ranging from 2.34(2) to 2.391(4) Å.
77
 As expected with the change in 
oxidation state, the geometry of the cobalt metal center also changes: Co(III) adopts the 
expected octahedral geometry, whereas Co(II) adopts tetrahedral geometry. Interestingly, 
coordination of the HBmit ligand does not favor a single cobalt oxidation state, the only 
example of a thione ligand to do so. 
15 
 
Similar to the synthesis of the Tm
R
 Fe(II) complexes, treatment of CoCl2 with 
LiTm
R
 (Figure 1.3) at room temperature over four days yielded the Tm
R
CoCl complexes 
(R = Me, 
t
Bu, Ph, and 2,6-
i
PrC6H3). The tetrahedral Tm
tBu
CoCl complex (Figure 1.6C) 
has Co-S bond distances of 2.312(1)  to 2.331(1) Å.
75
  The reaction of cobalt(II) chloride 
hexahydrate with N-tert-butyl-2-thioimidazole (Tm
tBu
) yields both [κ2-(TmtBu)2] CoCl2 
and Tm
tBu
2Co2(μ-Tm
tBu
)2Cl2∙CH3CN (Figure 1.6D) depending on the reaction time. In 
both complexes, each cobalt(II) center is four-coordinate with distorted tetrahedral 
geometry.
78
 Unexpectedly, two of the sulfur atoms of the Tm
tBu
 ligand in[κ2-
(Tm
tBu
)2]CoCl2 do not coordinate cobalt, but instead form a S–S bond with a typical bond 
distance of 2.050(4) Å, while the available nitrogen atoms on the imidazole coordinate 
Co(II). The infrared spectrum of this complex shows a weak absorption band at 472 cm
-1
, 
confirming disulfide bond formation, with no observable band at 1117 cm
-1
 for the C=S 
stretch of free thioimidazole.
78
 
 
Figure 1.6. Crystal structures of A) Co(C6H12N2S)2Cl2,
76
 B) [Co(III)(HBmit3)2][HBmit3],
77
 C) 
Tm
tBu
CoCl,
75
 and D) Tm
tBu
2Co2(μ-Tm
tBu
)2Cl2.
78
 Hydrogen atoms and counterions are omitted for clarity. 
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The Tm
tBu
2Co2(μ-Tm
tBu
)2Cl2 complex is a sulfur-bridged dimer where four Tm
tBu
 
ligands are coordinated to both Co(II) centers.75 Two of the tridentate thione ligands bind 
in a bidentate fashion through nitrogen as well as the sulfur atoms, with the other two 
thione ligands coordinate only through the sulfur atoms. The infrared spectrum of 
Tm
tBu
2Co2(μ-Tm
tBu
)2Cl2∙CH3CN exhibits a lower energy C=S stretching band at 1087 
cm
-1
 compared to the unbound ligand (1117 cm
-1
), indicative of cobalt backbonding to 
the sulfur atoms.
78
  
The majority of cobalt-thione complexes form with Co(II) in tetrahedral structures 
similar to Fe(II)-thione complexes, but thione ligands bind both Co(II) and Co(III) 
oxidation states, a feature not observed for iron complexes. In addition, the Tm
tBu
 ligand 
in [κ2-(TmtBu)]2CoCl2 does not bind through the sulfur atoms, but through the available 
nitrogen donors of the ligand, with concomitant formation of a diselenide bond from the 
thione sulfur atoms. No reactivity studies have been reported for these cobalt-thione 
complexes.  
 
1.9 Nickel-thione complexes 
 Ni-thiolate/thione chemistry is of significant interest because of its relevance to 
hydrogenase chemistry.
79-81
 In addition, since ergothioneine coordination chemistry is not 
well established, a recent study utilized a simpler version of this thione to investigate its 
nickel binding.
79
 Mononuclear Ni(II) dithione complexes with the bidentate ligands mbit 
or ebit (Figure 1.3) were synthesized by thione addition to Ni(PPh3)Br2 under nitrogen for 
10 h to yield Ni(mbit)Br2 or Ni(ebit)Br2 (Figure 1.7A).
82
 Both Ni(II)-thione complexes 
17 
 
are air- and moisture-stable and adopt distorted tetrahedral geometry with symmetrically 
equivalent Ni-S bond distances of 2.283(1) and 2.286(2) Å, respectively.  Ni(mbit)Br2 
and Ni(ebit)Br2 infrared spectra show C=S stretches at 1153 and 1146 cm
-1
, respectively, 
stretches that are shifted to higher energy compared to the unbound ligands (1138 and 
1136 cm
-1
, respectively), indicating primarily donor bond formation.
82
  
The tetrakis(1-tert-butyl-imidazole-2-thione) nickel complex [Ni(Hmim
tBu
)4][I]2 
(Figure 1.7B) is readily synthesized by treating Hmim
tBu 
 (Figure 1.3) with NiI2 in 
acetonitrile.
83
 The Ni(II) adopts square planar geometry, coordinated to four thione 
ligands with symmetrically equivalent Ni-S bond distances of 2.220(2) and 2.236(3) Å. 
Two iodide ions bridge the deprotonated nitrogen atoms from separate Hmim
tBu
 ligands. 
When the coordinated Hmim
tBu
 ligands are deprotonated by KH in the presence of a 
second equivalent of NiI2, the dinuclear complex Ni2(mim
tBu
)4 is formed. Each of the four 
mim
tBu
 ligands bridge the two Ni centers through N and S atoms, forming N2S2 Ni(II)  
 
Figure 1.7. Crystal structures of A) Ni(ebit)Br2,
82
 B) [Ni(Hmim
tBu
)4][I]2,
79
 and C) Ni(S
R
N)Br2 (S
R
N = 1-
pyridyl-(3-(2,6-diisopropylphenylimidazole)-2-thione)).
83
 Hydrogen atoms and counterions are omitted for 
clarity. 
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coordination with symmetrically equivalent Ni-S bond distances of 2.218(1) Å and 
2.238(1) Å,
79
 similar to Ni-S distances from the monomeric [Ni(Hmim
tBu
)4][I]2. 
Mixed thione/nitrogen and thione/oxygen donor ligands have also been used to 
synthesize Ni(II) complexes. Reaction of Ni(DME)Br2 (DME = dimethoxyethane) with  
1-pyridyl-(3-tert-butylimidazole-2-thione) or 1-pyridyl-(3-(2,6-
diisopropylphenylimidazole)-2-thione) yields Ni(S
R
N)Br2 complexes.
83
 The structure of 
Ni(S
R
N)Br2 (S
R
N = 1-pyridyl-(3-(2,6-diisopropylphenylimidazole)-2-thione) is shown in 
Figure 1.7C.  Both complexes adopt tetrahedral geometry, with a Ni-S bond distance of 
2.282(3) Å. The infrared C=S stretching frequencies for both complexes (1156 cm
-1
) 
show little change compared to the unbound ligand (1154 cm
-1
), indicating primarily 
donor Ni-S interactions.
83
  
A separate crystallographic study used the 1-hydroxy-3-methylpyridine-2(1H)-
thione ligand (3-Me-HPT, Figure 1.3), a compound widely investigated for its antifungal 
and antibacterial properties
84
 as well as its potential as a ligand for metalloenzyme  
 
Figure 1.8. Crystal structures of A) Ni(3-Me-HPT)2,
86
 B) Ni(Bm
Me
)2,
62
 and C) Tm
tBu
NiI.
75
 Hydrogen atoms 
and t-butyl groups are omitted for clarity. 
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modeling.
85
 Addition of 3-Me-HPT to NiCl2∙6H2O affords Ni(3-Me-HPT)2 (Figure 1.8A), 
a complex with distorted square-planar geometry, O2S2 coordination, and an Ni-S bond 
distance of 2.131(1) Å for the symmetrically equivalent sulfur atoms.
86
 
Scorpionate-thione complexes with nickel. Seeking to investigate new structural 
and functional model compounds for nickel hydrogenases, the scorpionate-thione ligand 
bis(2-mercapto-1-methylimidazolyl)borate (Bm
Me
, Figure 1.3) was treated with 
NiCl2∙6H2O to afford Ni(Bm
Me
)2 (Figure 1.8B). This air-stable complex adopts octahedral 
geometry around Ni(II) with Ni-S bond distances of 2.362(2) and 2.389(1).
62
 The S4H2 
coordination around the Ni(II) center is unique among nickel complexes and provides a 
structural model for the active form of NiFe hydrogenase enzymes. 
Scorpionate thione complexes of Ni(II) also have been synthesized from  NiX2 (X 
= Cl, Br, or I) and LiTm
R
 to give a series of Tm
R
NiX (R = Me, 
t
Bu, Ph, and 2,6-
i
PrC6H3) 
complexes.  The structure of Tm
tBu
NiI is provided in Figure 1.8C. Each complex adopts 
distorted tetrahedral geometry with Ni-S bond distances ranging from 2.278 to 2.300 Å, 
shorter than the M-S bond distances in the analogous Fe(II) (2.366-2.388 Å) and Co(II) 
(2.298-2.333 Å) complexes.
75
  
As observed for Fe(II)- and Co(II)-thione complexes, the few reported Ni(II)-
thione complexes adopt primarily tetrahedral geometry, with similar Ni-S bond distances 
ranging from 2.130 to 2.300 Å.  All of these Ni-thione complexes were studied only for 
their structural characteristics, so additional reactivity and electrochemical studies to 
understand properties of these Ni(II)-thione complexes still remain to be performed. 
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1.10 Copper-thione complexes 
Coordination of heterocyclic thiones to copper results in diverse architectures 
ranging from mononuclear complexes to polynuclear networks with monodentate or 
bidentate coordination of the sulfur atoms. Mono-alkylated heterocyclic thiones can also 
bind metals via the non-alkylated nitrogen atom. Many different types of copper-thione 
complexes have been synthesized and characterized to study the sulfur-rich environments 
of copper coordination in proteins.
17
  
The biological coordination chemistry of methimazole (Figure 1.1) is of particular 
interest, due to its use as an anti-thyroid drug. One structural study reported addition of 
CuI, methimazole, and PPh3 to form Cu(methimazole)(PPh3)2I (Figure 1.9A). In this 
complex, Cu(I) is tetrahedrally coordinated with a Cu-S bond distance of 2.369(1) Å,
87
 
consistent with similar copper(I) thione complexes.
88,89
  
Heterocyclic thioamides are also of interest for their potential luminescence  
 
Figure 1.9. Crystal structures of A) Cu(methimazole)(PPh3)2I,
87
 B) Cu(pymSH)(PPh3)2Br,
90
 and 
[Cu(phen)2(dmit)][ClO4]2. 
91
 Hydrogen atoms and counterions are omitted for clarity. 
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properties 
92
 as well as their medicinal purposes,
93,94
 and complexes of these ligands have 
been studied with numerous metals, including copper, mercury, silver, and palladium.
90
 
One example of this diversity of heterocyclic thioamide complexes was reported 
when pyrimidine-2-thione (pymSH, Figure 1.3) was treated with CuX (X = I, Br, or Cl) 
and PPh3, resulting in synthesis of the unusual dimer Cu2(pymSH)(PPh3)2I2, where the 
two copper ions are bridged by N and S atoms of pymSH and two iodide ions, as well the 
monomers Cu(pymSH)(PPh3)2Br (Figure 1.9B) and Cu(pymSH)(PPh3)2Cl.
90
 Changing 
the halide from I to Cl or Br results in formation of monomeric rather than dimeric 
complexes; however, all three complexes have the expected tetrahedral Cu(I) 
coordination and similar Cu-S bond distances (2.3530(3), 2.3340(6), and 2.3720(3) Å, 
respectively).
90
  
Cu(II) phenanthroline (phen) complexes have been widely examined in vivo and 
in vitro for their cytotoxic,
95
 genotoxic,
96
 and antitumor effects.
97
 Pivetta, et al.
91
 
synthesized and characterized four penta-coordinate copper(II) complexes 
[Cu(phen)2(L)][ClO4]2 (L = disubstituted imidazolidine-2-thione ligands with mixed H, 
Me, and Et substituents; Figure 1.3) to study their formation constants, cytotoxicity, and 
antiprion activity. In all four complexes, copper(II) adopts distorted trigonal–bipyramidal 
geometry, as seen for [Cu(phen)2(dmit)][ClO4]2 (Figure 1.9C), with similar but fairly 
long Cu-S bond distances ranging from 2.385(2) to 2.427(1) Å. Although at least one 
imidazole nitrogen is unsubstituted in three of the four compounds, Cu(I) binds 
exclusively through the thione sulfur atoms.  In the first study to quantify thione ligand 
binding, formation constants (log K values) for these copper-thione complexes in 
22 
 
acetonitrile were measured between 1.75 and 3.20, following the same trend as the Cu-S 
bond lengths.
91
 From these data, Pivetta, et al.
91
 concluded that alkyl substitution of the 
thione ligand, even if increasing thione nucleophilicity, did not improve the donor ability 
of the thione ligand.  
No antiprion activity was observed when these [Cu(phen)2(L)][ClO4]2 complexes 
were tested in scrapie-prion-protein-infected mouse neuroblastoma cells at non-cytotoxic 
levels; however, these compounds exhibited significant cytotoxicity, with cytostatic 
concentrations (CC50 values) between 0.41 and 0.54 µM.
91
 These effects were consistent 
with the cytotoxicity of other Cu-phen complexes and proposed to occur through 
oxidative damage to DNA and other cellular targets. 
 In addition to phenanthroline-thione copper complexes, complexes of the 
formulae Cu(dmit)2X (X = I, Br, and Cl) were synthesized and characterized by Kimani, 
et al.
19
 Changes in the halide ligand have little effect on Cu–S bond distances: 
2.2376(6) Å for trans-Cu(dmit)2Cl, 2.2298(9) Å for trans-Cu(dmit)2Br, 2.234(1) Å for 
trans-Cu(dmit)2I (Figure 1.10A), and 2.240(1) Å for cis-Cu(dmit)2I (Figure 1.10B).  All 
of these Cu(I) complexes are unstable to copper oxidation in air. Only the iodide complex 
has both trans and cis structural isomers, with pi-stacking of the dmit imidazolium rings 
in the cis conformer observed in the solid state and confirmed by density functional 
theory calculations.
19
 Infrared spectra of these complexes show C=S stretching 
frequencies 8-10 cm
-1
 lower than unbound dmit (1181 cm
-1
), indicating weak Cu-S 
backbonding.
19
 The 
1
H NMR resonance for the olefinic protons of the copper- bound 
dmit ligand (δ 7.27-7.32) shift downfield  relative to unbound dmit (δ 6.64), and the  
23 
 
 
Figure 1.10. Crystal structures of A) trans-Cu(dmit)2I,
19
 B) cis-Cu(dmit)2I,
19
 C) Tp*Cu(dmit),
14
 and D) 
[Cu(dmit)3][OTf].
20
 Hydrogen atoms and counterions are omitted for clarity. 
 
13
C{
1H} resonance of the C=S carbon also shifts downfield by δ 3 to 8 upon copper 
complexation, characteristic increasing the zwitterionic form of the thione ligand (Figure 
1.2) upon metal binding.
19
 
 The same thione ligand was also used to synthesize the copper-thione complexes 
[TpmCu(dmit)][BF4], [Tpm*Cu(dmit)][BF4], and Tp*Cu(dmit) (Tpm = 
tris(pyrazolyl)methane, Tpm* = tris(3,5-dimethylpyrazolyl)methane, and Tp* = 
hydrotris(3,5-dimethylpyrazolyl)borate; Figure 1.10D) with trinitrogen donor scorpionate 
ligands to determine how thione coordination alters the redox potentials of the copper 
center.
14
 In these complexes, the Cu(I) ion is in a distorted tetrahedral environment with 
Cu-S bond lengths ranging from 2.191(8) to 2.202(7) Å.
14
 Thione C=S infrared stretching 
frequencies in these complexes range from 1172 to 1178 cm
-1
 (Table 1), and the olefinic 
1
H NMR and C=S 
13
C{
1
H} NMR resonances shift downfield by  0.18-0.40 and  
2.3-7.8, respectively, relative to unbound dmit,
14
 similar to coordination effects observed 
24 
 
for the Cu(dmit)2X complexes.
19
  
 Electrochemical studies of these tris(pyrazolyl) copper-thione complexes in 
acetonitrile showed Cu(II/I) potentials between 70 and -160 mV, lowered by 374 to 617 
mV compared to the non-thione-coordinated [TpmCu(NCCH3)]
+
 complex.
14
 In addition, 
increasing steric bulk on the tris(pyrazolyl) ligand stabilizes Cu(II) relative to Cu(I).
 
 
Although this represents a significant shift in this copper potential upon thione binding, 
the resulting potentials are well above that of the cellular reductant NADH (-324 mV
98
), 
indicating that similar Cu(I) compounds in vivo still may be capable of redox cycling and 
generation of damaging reactive oxygen species.  
Adding four equivalents of dmit to Cu(OTf)2 yields the reduced [Cu(dmit)3][OTf] 
complex (Figure 1.10D) with concomitant oxidation of the thione to the imidazolium 
disulfide,
20
 the first imidazolium disulfide synthesized by Cu(II) reduction. The 
[Cu(dmit)3]
+
 cation adopts distorted trigonal-planar geometry with Cu-S bond distances 
ranging from  2.226(1) to 2.260(1) Å. Kinetic studies were performed in acetonitrile, 
demonstrating that dmit reduces Cu(II) to Cu(I) at a rate of 0.18 s
-1
,
20
 and establishing 
that these thione ligands are capable of promoting copper redox cycling under these 
conditions. 
Only a few structurally characterized complexes of 2,4-dithiouracil (dtucH2; 
Figure 1.3) coordinated to Cu(I), Ti(III), and Ru(III) have been reported.
99-102
 Cu(I) 
halides combined with this ligand form [Cu(dtucH2)(PPh3)X]n (X = Cl, Br, and I; Figure 
1.11A with X = Br), with tetrahedral Cu(I) geometry and an average Cu–S bond length of 
2.332 Å.
103
 The two sulfur atoms of the 2,4-dithiouracil ligands are coordinated to  
25 
 
 
Figure 1.11. Crystal structures of A) [Cu(l-S,S-dtucH2)(PPh3)Br]n,
103
 B) Cu(PPh3)2(pmtH)(SH),
104
  C) 
Cu(PPh3)2(pmt),
104
 D) Cu2(PPh3)2(pmt)2
∙
0.5CH3OH,
104
 and E) [Cu2(tsac)2(sbim)2(CH3CN)].
105
 Hydrogen 
atoms are omitted for clarity. 
 
separate copper ions, forming a polymeric chain. The infrared spectra of the 
[Cu(dtucH2)(PPh3)X]n complexes display a γ(C=S) band between 1090 and 1125 cm
-1
, 
significantly shifted from that of the unbound ligand at 1135 cm
-1
, and consistent with 
copper coordination through the sulfur rather than through the nitrogen atoms as well as 
backbonding of copper to the thione.
103
 
The structural and antioxidant properties of Cu(PPh3)2(pmtH)Cl, 
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Cu(PPh3)2(pmtH)(SH) (Figure 1.11B), Cu(PPh3)2(pmt) (Figure 1.11C), and 
Cu2(PPh3)2(pmt)2
.
0.5CH3OH (Figure 1.11D; pmtH = 2-mercaptopyrimidine; Figure 1.3) 
have also been reported.
104
 2-Mercaptopyrimidine readily binds copper(I) chloride in the 
presence of PPh3 to form the monomeric complex Cu(PPh3)2(pmtH)Cl. The acidic nature 
of the H(N) proton on the pmtH ligand in Cu(PPh3)2(pmtH)Cl was established by treating 
this complex with sodium hydroxide to form the dimeric Cu(PPh3)(pmt)2∙0.5CH3OH 
(Figure 1.11D).
104
 In this complex of the deprotonated ligand, pmt binds each tetrahedral 
Cu(I) through the nitrogen atom and a bridging sulfur atom from the thione (Cu-S bond 
distances of 2.67(1) and 2.31(1) Å.  A terminal PPh3 ligand completes the tetrahedral 
copper coordination.  The thione-bridged copper ions are close enough (2.699(2) Å) to 
form a Cu-Cu bond. In contrast, treatment of pmtH with Cu(CH3COO) and PPh3 in 
ethanol results in the formation of the monomeric Cu(PPh3)2(pmt) (Figure 1.11C), with 
the tetrahedral Cu(I) terminally bound through the nitrogen and sulfur atoms of the 
deprotonated pmt ligand.
104
  As expected, the Cu-N distance in this complex (2.144(1) Å) 
is similar to the Cu-N distance in the dimeric complex (2.052(1) Å), but the terminal Cu-
S bond (2.400(1) Å) is significantly shorter.
104
 
Reaction of copper(II) sulfate or nitrate with pmtH and PPh3 in refluxing 
methanol/acetonitrile solution forms the unusual Cu(PPh3)2(pmtH)(SH) complex (Figure 
1.11B) with two PPh3 ligands and the sulfur atom of the pmtH ligand (Cu-S 2.3652(6) Å) 
coordinated to Cu(I).
104
 Tetrahedral geometry around Cu(I) is completed by a terminal 
thiol group, with a Cu-S bond distance of 2.3718(5) Å.  
These Cu(I) pmtH and pmt complexes were tested for their ability to inhibit 
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linoleic acid peroxidation by lipogenase (LOX), an enzyme that controls cancer cell 
proliferation. Although all four complexes prevent LOX activity with 50% inhibitory 
concentrations of 7 to 47 µM, the dimeric Cu2(PPh3)2(pmt)2 was the most effective.
104
 
Direct LOX binding by these complexes was observed using 
1
H NMR spectroscopy, and 
computational studies suggested that the most effective inhibitors interact close to the 
LOX active site but not in a single binding pocket.
104
  
Dennehy, et al.
105
 report the synthesis of copper complexes of the ternary 
thiosaccharin (tsac) and 1H-benzimidazole-2(3H)-thione (sbim; Figure 1.3) to form 
Cu2(tsac)2(sbim)2(NCCH3) (Figure 1.11E) and Cu2(tsac)2(sbim)3. In both these 
complexes, the tsac and the sbim ligands have monodentate and bidentate coordination.  
In Cu2(tsac)2(sbim)2(NCCH3), the two copper ions are bridged by the N atom and thione 
S of one tsac ligand as well as through the sulfur of the second tsac ligand.  The two sbim 
ligands are bound only through the sulfur atoms, in monodentate and bidentate fashion, to 
give an NS3 core around one Cu(I) and an S3 core around the second Cu(I). Distorted 
tetrahedral geometry around the second Cu(I) is completed by coordinated acetonitrile.  
The Cu-S bond distance for the terminal sbim is 2.209(1) Å, somewhat shorter than for 
the bridging sbim ligand (2.238 Å).
105
 The Cu-S bond distances for the tsac ligand vary 
more significantly, with a µ-N,S-Cu distance of 2.2799(9) compared to the average Cu-S 
distance of 2.523 Å for the tsac bridging through only the sulfur atom.
105
 
 Monodentate thione ligands bind to Cu(I) in trigonal planar tetrahedral geometries 
and to Cu(II) in trigonal planar geometry. The majority of the monodentate thione-copper 
complexes contain Cu(I), as expected for polarizable sulfur donor ligands, but 
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electrochemistry of the tris(pyrazolyl) Cu(I) thione complexes indicate that thione 
coordination destabilizes Cu(I) relative to acetonitrile coordination.
14
 In all cases, the 
thiones predominantly bind through the sulfur atom rather than other available nitrogen 
atoms as observed with the pmt, a characteristic also observed for both iron and cobalt 
complexes. Although these complexes are relatively easy to synthesize, the reactions to 
synthesize Cu(I) complexes typically require air-free techniques and the products oxidize 
over time. Similar to iron-thione complexes, copper-bound thione ligands favor the 
zwitterionic resonance structure (Figure 1.2), as determined by NMR spectroscopy 
showing increased aromaticity within the ring upon metal binding.  
Scorpionate-thione complexes with copper. Many copper coordination studies 
have used tridentate thione-containing scorpionate ligands that permit tetrahedral Cu(I) 
coordination with a substitutable binding site. One example of this type of complex is 
Tr
R,R’
Cu(PPh3) (Tr
R,R’ 
= tris(mercaptoimidazoyl)borate; Figure 1.12A), where the Cu(I) is 
bound to the three thiones of the Tr
R,R’ 
ligand (Figure 1.3), with average Cu-S bond 
distances of 2.367 Å, and a PPh3 ligand.
106
 Further characterization, including infrared 
and electrochemical studies, would be useful to determine details of the thione-copper 
interactions and how coordination of these chelating ligands affects copper redox 
behavior. 
A similar study was conducted by Rabinovich, et al.
107
 to study the effects on 
bonding and structure of the sterically bulkier thione chelating ligand  Tm
tBu
 (Figure 1.3). 
Tm
tBu
Cu(PPh3) was prepared by combining equimolar amounts of NaTm
tBu
, PPh3, and  
CuCl. In contrast to Cu(I) complexes of monodentate thione ligands, the Tm
tBu
Cu(PPh3) 
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complex is air and light stable, a feature typical of these thione-scorpionate complexes. 
The symmetry equivalent Cu–S bond distance of 2.3435(7) Å in TmtBuCu(PPh3) (Figure 
1.12B) is similar to those in Tm
Me
Cu(PAr3) (2.357(2) and 2.332(1) Å for Ar = m-tolyl 
and p-tolyl groups, respectively), suggesting that the steric bulk of the secondary ligand 
does not affect the binding modes of the scorpionate Tm
R
 ligand.
107
  
 In some cases thione-scorpionate ligands bridge multiple metal centers. The 
dimeric Cu(I) complexes Tr
Mes,Me
2Cu2 and Tr
Mes,o-Py
2Cu2 (Tr
R
 = 
hydrotris(thioxotriazolyl)borate; Figure 1.12C), are air stable and exhibit similar 
coordination geometries in the solid state,
108
 where every copper ion is surrounded by 
three thione groups from two Tr
R
 ligands in a trigonal arrangement. The presence of a [B-
H-Cu] three-center-two-electron interaction in both compounds causes the overall 
coordination to become tetrahedrally distorted (with S3H coordination for each copper 
center). In Tr
Mes,Me
2Cu2, the symmetrically equivalent non-bridging Cu-S distances are 
2.265(1) and 2.355(1) Å, and the bridging Cu-S distance is 2.253(2) Å.
108
 Similarly, the 
Tr
Me,o-Py
2Cu2 complex has symmetrically equivalent, non-bridging Cu-S bond distances 
of 2.285(1) and 2.305(1) Å  and bridging Cu-S bond lengths of 2.252(1) Å. The tridentate 
ligand hydro[bis(thioxotriazolyl)-3-(2-pyridyl)pyrazolyl]borate (Br
Mes
pz
o-Py
; Figure 1.3) 
with only two thione groups also forms a dimeric complex, (Br
Mes
pz
o-Py
)2Cu2, with 
trigonal copper(I) coordination from a bridging pyrazolyl nitrogen atom and two terminal 
thione sulfur atoms.
108
 The symmetrically equivalent Cu-S distances in (Br
Mes
pz
o-Py
)2Cu2 
are 2.245(2) and 2.268(3) Å, significantly shorter than the terminal Cu-S bonds in Tr
Me,o-
Py
2Cu2 with the tridentate thione ligand Tr
Me,o-Py
. 
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Figure 1.12. Crystal structures of A) Tr
R,R’
Cu(PPh3),
106
 B) Tm
tBu
Cu(PPh3),
107
 and C) Tr
Me,o-Py
2Cu2.
108
 
Hydrogen atoms, t-butyl groups, o-pyridyl groups, and phenyl groups are omitted for clarity. 
 
To examine the stability of these dinuclear complexes and to determine relative 
formation constants of monodentate and scorpionate ligands bound to Cu(I), NMR  
titrations of Tr
Mes,Me
2Cu2, Tr
Mes,o-Py
2Cu2, and (Br
Mes
pz
o-Py
)2Cu2 with PPh3, thiourea, and 
pyridine were performed.
106
 Addition of two equivalents of PPh3 ligand to each of the 
dinuclear complexes was sufficient to give the corresponding monomeric Cu(I) PPh3 
complexes, whereas thiourea titrations reached completion only at a much higher ligand 
to complex ratios. Pyridine titrations showed no reactivity with any dimeric complexes 
even upon addition of 40-64 equivalents,
106
 indicating that these Cu(I) complexes have a 
much greater affinity for phosphorus- and sulfur-donor ligands compared to nitrogen-
donor ligands.  
Al-Harbi and Parkin
109
 treated the [Bm
MeBenz
]
-
 and [Tm
MeBenz
]
-
 ligands (Figure 
1.3) with [Me3PCuCl]4 to yield [Bm
MeBenz
]Cu(PMe3) (Figure 1.13A) and  
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Figure 1.13. Crystal structures of A) [Bm
MeBenz
]Cu(PMe3),
109
 B) [Tm
MeBenz
]Cu(PMe3),
109
 and C) [
Pn
Bm]Cu 
(PPh3).
110
 Hydrogen atoms are omitted for clarity. 
 
[Tm
MeBenz
]Cu(PMe3), (Figure 1.13B), the first structurally related bis- and 
tris(mercaptoimidazolyl)hydroborato copper(I) compounds. [Tm
MeBenz
]Cu(PMe3) has  
an approximately tetrahedral [S3P] motif with a four-coordinate τ4 geometry.
109
 In 
contrast, the [Bm
MeBenz
]Cu(PMe3) complex adopts a trigonal planar [S2P] coordination 
motif.
109
 
There are very few ligands which feature a mix of heterocycles, so in an attempt 
to further develop and explore this ligand class, Owen et al.
111
 synthesized the first hybrid 
version of the flexible S scorpionates, 
mp
Bm (Figure 1.3). The addition of 1 equiv of 
[
mp
Bm] to CuCl in methanol with the corresponding phosphine ligand resulted in the 
formation of [(
mp
Bm)]Cu(PR3)] complexes (where R = Ph and Cy). 
1
H and 
13
C NMR 
spectra were consistent with only one chemical environment for the two methyl-2-
mercaptoimidazole arms.
112
 Each Cu metal center adopts a highly distorted trigonal 
pyramidal with average Cu-S bond distances of 2.303(1) Å.
112
 
Mösch-Zanetti
110
 reported a second such ligand, 
Pn
Bm (Figure 1.3), and its Cu 
complexes.  Addition of CuCl to a solution of PR3 in methanol yielded complexes with 
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the formula [Cu{
Pn
Bm}(PR3)] (R = cyclohexyl, phenyl; Figure 13C).
110
  From the X-ray 
diffraction structure of Cu{
Pn
Bm}(PPh3), the average Cu-S bond distance was 
2.278(5).
110
  In absence of phosphine, the reaction of the hybrid scorpionate ligand 
Pn
Bm 
with CuCl in methanol yielded [Cu{
Pn
Bm}]2.
110
 Variable-temperature NMR 
spectroscopic data of this complex provided evidence for a dimeric structure in solution 
with fluxionality between the two coordination isomers.
110
    
 The Tr
R
, Tm
R
, Bm
R
, and Br
R
pz
R
 ligands bind Cu(I) in two coordination 
environments: mononuclear complexes with tetrahedral geometry and dinuclear 
complexes with trigonal planar geometry. In contrast to the majority of mononuclear 
Cu(I) complexes, Cu(I) complexes with these tridentate thione ligands are substantially 
more air stable. Since most reports of copper-thione complexes are entirely structural, 
there is a great need for characterizing the reactivity of these complexes, to determine 
how thione coordination affects copper oxidation and redox cycling, a major factor in 
ergothioneine antioxidant behavior, and how well these copper-thione complexes model 
sulfur-rich copper sites in metalloproteins.  
 
1.11 Zinc-thione complexes 
A large number of zinc enzymes perform thiolate alkylations for various 
purposes,
50
 the most prominent of which are cobalamin-independent methionine 
synthase
113
 and the Ada DNA repair protein.
114
 In these enzymes, zinc is bound to 
histidine and cysteine residues in N2S, NS2, or S3 donor environments, and it is 
generally believed that thiolate alkylation is facilitated by zinc binding.
115
 Although thiols 
33 
 
and thiones do not behave identically, synthesis of zinc-thione complexes allows the 
study of sulfur-rich zinc sites in these metalloproteins.
115
  
The [Zn(diap)2(OAc)2]∙H2O complex (Figure 1.14A) was synthesized with 1,3-
diazepane-2-thione (Figure 1.3), a ligand similar to thiourea but with sufficient steric bulk 
to restrict the coordination number. The distorted tetrahedral coordination around the zinc 
ion in [Zn(diap)2(OAc)2] consists of two terminal S-donating thione ligands and one 
oxygen atom from each of two acetate anions. The Zn–S bond distances (2.322(1) and 
2.340(1) Å) are very similar to Zn–S bond distances in other reported pseudo-tetrahedral 
zinc–thiolate complexes.116  
A similar coordination study of N,N’-bis(3-aminopropyl)ethylene-diamine 
(bapen) was performed by the synthesis of the mononuclear 
[Zn(bapen)(ttcH)]∙CH3CH2OH complex (Figure 1.14B) (ttcH3 = trithiocyanurate dianion, 
Figure 1.3), where ttcH is bound to the zinc as a bidentate ligand in the cis configuration 
through N and S donors. The Zn(II) ion in this complex adopts a substantially distorted 
octahedral geometry, coordinated to the four N atoms of the bapen ligand (Zn-N =  
 
Figure 1.14. Crystal structures of A) Zn(diap)2(OAc)2,
116
 and B) Zn(bapen)(ttcH).
46
 Hydrogen atoms are 
omitted for clarity. 
. 
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2.104(2) Å) and the two S and N atoms of the ttcH
2-
 anion (Zn-S = 2.5700(7) Å  and Zn-
N = 2.313(2) Å) in the cis configuration.
46
  
Scorpionate complexes with zinc. The tripodal sulfur ligand hydrotris(t-
butylthioimidazolyl)borate (Tti
tBu
) was also reported to coordinate zinc to form 
Tti
tBu
Zn(OClO3). Recrystallization of Tti
tBu
Zn(OClO3) from methanol in the presence of 
2-butylmercaptan forms the cationic zinc tetramer [Tti
tBu
Zn]4[ClO4]4 (Figure 1.15A) as 
determined by X-ray structural analysis.
117
 In this tetramer, each Tti
tBu
 ligand is 
coordinated through one of its sulfur atoms to each of two neighboring zinc ions, with the 
third sulfur atom bridging them. The bridging Zn–S bonds (2.402(3) - 2.479(2) Å) are 
approximately 0.15 Å longer than those to the terminal sulfur atoms (2.291(5) - 2.342 (2) 
Å), and the intraring S–Zn–S angles of 91.90(6) to 105.16(7)o are among the smallest of 
all S–Zn–S angles in the molecule.117  
 The tris(thioimidazolyl)borate scorpionate ligands  (Tti
R
; Figure 1.3) provide a S3 
donor set and were used to synthesize 11 new complexes of the formula Tti
RZn(SR’) (R 
= xylene, t-butyl, tolyl, cumenyl; SR’ = Et, iPr, tolyl, Ph, C6H4(p-NO2), C6H3(o-OCH3)2, 
C6F5, and others) to understand why unusual sulfur-rich donor environments are common 
for zinc-containing enzymes.
115
 To synthesize these zinc-thione-thiolate complexes, 
KTti
R
 was combined with zinc nitrate or zinc perchlorate to generate Tti
R
Zn(ONO2) or 
Tti
R
Zn(OClO3) in situ, and then the desired sodium thiolate was added. The structure of 
an example thione-thiolate complex, Tti
Xyl
Zn(SEt), is shown in Figure 1.15B. Tti
R
 ligand 
conformation in this series of Zn(II) complexes varies little, with the Zn-S distances of 
2.33(1) to 2.39(1) Å.
115
 The terminal Zn-S thiolate bond lengths range from 2.252(6) to  
35 
 
 
Figure 1.15. Crystal structures of A) [Tti
tBu
Zn]4[ClO4],
117
 B) Tti
Xyl
Zn(SEt),
115
 and C) L
1
Zn(SEt).
118
 Xylyl 
groups, t-butyl groups, and hydrogen atoms are omitted for clarity. 
 
2.305(3) Å in these complexes, with a slight tendency for the aliphatic thiolates to have 
shorter Zn-S bonds than the aromatic thiolates.
115
  
The tripodal thione ligands bis(pyrazolyl)(3-tert-butyl-2-thioimidazol-1-
yl)hydroborate) (L
1
) and bis(pyrazolyl)(3-isopropyl-2-thioimidazol-1-yl)hydroborate (L
2
, 
Figure 1.3) are similar to the tris(thioimidazolyl)borates, but provide N2S coordination. 
Combined with zinc nitrate or zinc chloride and the corresponding thiolate, these ligands 
yielded a total of 17 (L
1
)Zn(SR) and (L
2
)Zn(SR) complexes (R = Et, CH2CF3, tolyl, Ph, 
C6H4(p-NO2), C6H3(o-OCH3)2, C6F5, and others).
118
 X-ray structural analysis of 
(L
1
)Zn(SEt) (Figure 1.15C) confirmed tetrahedral N2S2 coordination of zinc, with Zn-
thione and Zn-SEt bond distances of 2.349(3) and 2.228(3) Å, respectively.
118
 There is a 
remarkable similarity between all 17 structures; the comparable bond lengths vary not 
more than 0.02 Å, and the Zn-S thiolate bonds are characteristically shorter than the Zn-S 
thione bonds by 0.132 Å.
118
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To understand why sulfur-rich coordination environments are necessary for zinc-
catalyzed thiolate alkylations, methylation reactions were performed with Zn(II)-
scorpionate complexes. Effects of systematic variation on the zinc coordination 
environment were determined using zinc-thiolate complexes of tris(3,5-
dimethylpyrazolyl)borate (Tp*) ligands as N3 donors,
119
 L
1
 and L
2
 ligands as N2S 
donors,
118
 and the Tti
R
 ligands as S3 donors.
115
 Methyl iodide in chloroform solution was 
used as the methylating agent instead of the biological methyltetrahydrofolate, a 
methylammonium species. Methylammonium salts and trimethyl phosphate were not 
reactive enough for efficient alkylation of the model zinc-thiolate complexes.
119
 
Methylation reactions of the Tti
RZn(SR’) complexes to yield TtiRZnI and MeSR’, were 
the fastest of the tested model complexes, several orders of magnitude faster (10 min to 
several hours for complete methylation)
115
 than methylation of the Tp*Zn-thiolate 
complexes,
119
 and significantly faster than the L
1
 and L
2
 copper complexes (one day to 
two weeks).
118
 These methylation studies indicate that zinc coordination by sulfur donors 
is the most effective way to increase zinc-thiolate electron density and nucleophilicity, 
and support the zinc-bound thiolate mechanism of alkylation, but methylation rates for 
these model complexes are far lower than those observed in enzymes.
115,118
 Thus, these 
methylation studies complexes have established mechanistic details for this reaction, but 
researchers are still far from understanding the factors controlling alkylation efficiency in 
zinc enzymes.  
Unsurprisingly, thione ligands typically bind zinc(II) though the sulfur atom in a 
tetrahedral geometry; however the six-coordinate Zn(bapen)(ttcH) complex
46
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demonstrates that thione ligands may also bind through available nitrogen atoms, similar 
to a few reported Fe(II), Ni(II), and Cu(I) thione complexes.
69,104
 Synthesis of Zn(II) 
complexes with scorpionate thione ligands to study thiolate methylation reactions has 
resulted in a multitude of structurally characterized, tetrahedral Zn(II) thione/thiolate 
complexes. Zinc-thione complexes with the Tti
R
 ligands are the most promising models 
for zinc-containing thiolate alkylation enzymes, but their slow alkylation rates 
demonstrate the need to adjust the electronic properties of the thione scorpionate ligands 
to better model these reactions. 
The bidentate [S2]-donor bis(mercaptoimidazolyl) ligands, [Bm
Me
]
-
 and [Bm
Mes
]
-
, 
(Figure 1.3) were treated with ZnX2 (X = Me, I, NO3) to yield [Bm
Me
]ZnMe (Figure 
1.16A), [Bm
Me
]ZnI and [Bm
Mes
]Zn(NO3).
120
 The [Bm
Me
] ligand is insufficiently bulky to 
prevent formation of the tetrahedral homoleptic complex, [Bm
Me
]2Zn, (Figure 1.16B) 
formed from a redistribution reaction of [Bm
Me
]ZnMe in CHCl3.
120
 The average Zn-S 
bond distances were 2.310 Å for the 1:1 complexes [Bm
Me
]ZnX and 2.340 Å for the 
homoleptic [Bm
Me
]2Zn complex.
120
  
Parkin et al. 
120
 have investigated coordination chemistry of the  
 
Figure 1.16. Crystal structures of A) [Bm
Me
]ZnMe
120
 and B) [Bm
Me
]2Zn.
120
 Hydrogen atoms are omitted 
for clarity. 
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bis(thioimidazolyl)(pyrazolyl) hydroborato (Bm
Me
pz) ligand to model active sites of zinc 
enzymes that are closely related to liver alcohol dehydrogenase (LADH).  [Bm
Me
pz]
-
treated with ZnI2 forms [Bm
Me
pz]CuI, adoping a distorted tetrahedral geometry about the 
Zn(II) metal center with an average Zn-S bond distance of 2.335(2) Å.
120
 Most 
importantly, [Bm
Me
pz]CuI closely resembles the active site of LADH by bonding Zn(II) 
via the N and S donors of [Bm
Me
pz]
-
. Thus, these ligands may also be useful for the 
investigating other  Zn enzymes with a [ZnNSS] coordination environment.
64
 
 
1.12 Selone compounds as ligands 
 Reports of metal-selone complexes are rare and primarily limited to structural 
studies, likely because biological selone compounds were not identified until 
recently.
4,12,34,121
 Selone compounds are expected to be more nucleophilic than their 
thione analogs, resulting in stronger coordination bonds,
122-124
 although formation 
constants of these ligands have never been measured for comparison. Metal-selone 
complexes are more readily oxidizable than their thione counterparts, resulting in 
increased air sensitivity, but their synthesis is no more difficult than that of the air-
sensitive thione complexes. 
 
1.13 Iron-selone complexes 
Very few iron-selone complexes have been reported, possibly due to the facile 
oxidation of Fe(II) or the selone ligand, and the need for air-free synthesis. The only 
report of iron-selone complexes is the synthesis and characterization of the mononuclear  
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complexes Fe(dmise)2Cl2, [Fe(dmise)4][OTf]2, and [Fe(dmise)4][BF4]2 (dmise = 1,3-N,N-
dimethylimidazole selone; Figure 1.3).
74 These selone compounds are synthesized by 
addition of dmise (Figure 1.3) to FeCl2∙H2O, Fe(OTf)2, and Fe(BF4)2, respectively,
74
 and 
are analogous to the previously discussed iron-thione compounds. The selone complexes 
Fe(dmise)2Cl2 (Figure 1.17A) and [Fe(dmise)4][BF4]2 (Figure 1.17B) crystallize in 
distorted tetrahedral geometry with Fe-Se bond distances ranging from 2.455(2) to 
2.510(1) Å. When dmise coordinates Fe(II), the infrared stretches for the Se=C bonds 
shift very slightly to higher energies (1149-1155 cm
-1
) compared to unbound dmise (1148 
cm
-1
), indicating primarily σ and π donor bonding.74 This strengthening of the Se=C bond 
in Fe(II) selone complexes upon dmise binding is similarly observed for the Fe-thione 
complexes Fe(dmit)2Cl2, [Fe(dmit)4][OTf]2, and [Fe(dmit)4][BF4]2.
74
  
The 
1
H NMR spectra of these three Fe(II)-selone complexes show imidazole 
proton resonances shifting downfield by δ 0.4-0.5 compared to the unbound ligand (δ 
6.77), indicating increased aromaticity of the selone imidazole ring (Figure 1.2) upon 
coordination, similar to analogous Fe-thione complexes.
74
 As observed for the analogous 
thione complexes, the electrochemistry of these iron-bound selone ligands also change  
 
Figure 1.17. Crystal structures of A) Fe(dmise)2Cl2 and B) [Fe(dmise)4][BF4]2.
74
  Hydrogen atoms and 
counterions are omitted for clarity.  
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when bound to iron, with the Epa of dmise shifting by 40 mV compared to unbound 
dmise (372 mV), indicating that iron-bound selones are more readily oxidizable.
74
  
 
1.14 Cobalt-selone complexes 
 In 1997, Williams, et al. synthesized Co(dmise)2C12 (Figure 1.18A), the first 
metal halide complex to be prepared with the dmise ligand, by combining CoCl2 and 
dmise in methanol and heating. Upon cooling, blue-green crystals of Co(dmise)2C12 
(Figure 1.18A) precipitated.
125
 In this complex, the Co(II) center adopts distorted 
tetrahedral geometry with Co-Se distances of 2.277(3) and 2.456(3) Å.
126
 No further 
characterization was reported; thus, additional infrared and electrochemical studies are 
required to understand cobalt-selone binding and for comparison with selone complexes 
of other metal ions.  
Similar reactions were also carried out with the ethyl- and methyl-bridged selone 
ligands, ebis and mbis (Figure 1.3). Treating CoCl2 with mbis or ebis (Figure 1.3) in 
tetrahydrofuran forms the polymeric [Co(mbis)Cl2]n (Figure 1.18B) or [Co(ebis)Cl2]n 
complexes.
82
 In both complexes, the Co(II) metal center adopts distorted tetrahedral 
geometry, bound to two terminal chloride ligands and two Se atoms from different  
 
Figure 1.18. Crystal structures of A) Co(dmise)2C12
125
 and B) [Co(mbis)Cl2]n.
82
 Hydrogen atoms are 
omitted for clarity. 
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bidentate selone ligands to form diselone-Co(II) chains. In these mbis and ebis 
complexes, the symmetrically equivalent Co–Se bond distances are 2.447(4) and 
2.423(5) Å, respectively. The most unusual structural feature in [Co(mbis)Cl2]n is the 
formation of infinite helical chains that are of different chiralities (right and left handed), 
despite the fact that they contain the same components and linking sequence.
82
 In 
contrast, the [Co(ebis)Cl2] molecules form zigzag chains. The infrared spectrum of 
[Co(mbis)Cl2]n  shows a shift of the C=Se stretching frequency to lower energy (1096 
cm
-1
) compared to unbound mbit (1128 cm
-1
), indicating weak backbonding of Co(II) to 
mbis.
82
 In [Co(ebis)Cl2]n, however, the C=Se stretching frequency is shifted to higher 
energy (1135 cm
-1
) relative to unbound ebis (1126 cm
-1
; Table 1), indicating donor bond 
formation.
82
 
 As expected, the few structurally characterized cobalt-selone complexes 
demonstrate that selone ligands bind primarily to Co(II) through the selenium atom with 
distorted tetrahedral geometry. Similar to their thione analoges mbit and ebit, the 
bidentate ligands mbis and ebis form polymeric complexes with Co(II). The shifts in 
C=Se stretching frequencies observed for [Co(mbis)Cl2]n and [Co(ebis)Cl2]n indicate that 
there is no single binding mode of these multidentate ligands to Co(II). Further synthesis 
and structural characterization of Co(II)-selone complexes as well as infrared and 
electrochemical studies are required for a comprehensive understanding of cobalt-selone 
binding. 
 
 
42 
 
1.15 Nickel-selone complexes 
 Reports of Ni-selone complexes are limited to structural studies. A single paper 
investigates the substitution reaction of [NiL(MeCN)][BF4]2 (L = 2,5,8-trithia(2,9)-1,10-
phenanthrolinophane) with dmise to yield [NiL(dmise)][BF4]2 (Figure 1.19A).
127
 This 
Ni(II) complex has octahedral geometry, with a Ni-Se bond distance of 2.592(1) Å.  
Mononuclear Ni(II) diselone complexes were also synthesized by addition of 
mbis or ebis to Ni(PPh3)2Br2 under nitrogen to afford Ni(mbis)Br2 (Figure 1.19B) and 
Ni(ebis)Br2.
82
 Unlike the analogous thione complexes, these selone complexes are very 
sensitive to air and moisture. Ni(mbis)Br2 has distorted tetrahedral geometry around the 
Ni(II), with symmetry equivalent Ni-Se bond distances of 2.394(1)Å. Infrared C=Se 
stretches for nickel-bound mbis and ebis are at 1133 and 1128 cm
-1
, respectively, very 
slightly shifted to higher energies compared to the unbound ligands (Table 1.1), 
indicating no Ni(II)-selone backbonding.
82
  
 Nickel-selone complexes have not been widely investigated; however, the few 
complexes that have been synthesized demonstrate both octahedral and distorted  
 
 
Figure 1.19. Crystal structures of A) [NiL(dmise)][BF4]2 (L = 2,5,8-trithia(2,9)-1,10-
phenanthrolinophane)
127
 and Ni(mbis)Br2. 
82
 Hydrogen atoms are omitted for clarity. 
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tetrahedral geometry around Ni(II). In contrast to their polymeric complexes with Co(II), 
the bidentate selone ligands mbis and ebis form monodentate complexes with Ni(II). The 
infrared C=Se stretching frequencies for  Ni(mbis)Br2 and Ni(ebis)Br2 are similar to that 
of [Co(ebis)Cl2]n, Fe(dmise)2Cl2, and [Fe(dmise)4]
2+
 indicating primarily donor bond 
formation in these complexes.  In contrast, weak backbonding is observed for the Co(II)-
selone bond in [Co(mbis)Cl2]n.  Since so little is known, any additional synthetic, 
computational modeling, or reactivity studies would greatly elucidate metal-selone 
bonding in these complexes. 
 
1.16 Copper-selone complexes 
In the only reported example of a Cu(II) selone complex, the distorted trigonal-
bipyramidal Cu(II) center in [Cu(phen)2(dmise)][ClO4]2 (phen = 1,10-phenanthroline; 
Figure 1.20A) is coordinated by four nitrogen donors from the two phenanthroline 
ligands and by the selenium atom from the dmise ligand. In this complex, the Cu-Se 
distance of 2.491(3) Å is slightly longer than expected for a Cu(II)-selone complex, likely 
due to the strong π-conjugation properties of the phenanthroline ligands.128 Trigonal-
bipyramidal coordination geometry is not common for Cu(II) complexes, particularly 
when they contain ligands with reducing properties.
129
  
Using the same dmise ligand, the distorted-trigonal-planar copper-selone 
complexes trans-Cu(dmise)2Cl, cis-Cu(dmise)2Br (Figure 1.20B), and cis-Cu(dmise)2I 
were synthesized by combining the respective Cu(I) halides with two equivalents of 
dmise.
19
 Similarly to their thione counterparts, these copper selone complexes have  
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Figure 1.20. Crystal structures of A) [Cu(phen)2(dmise)](ClO4)2,
128
 B) cis-Cu(dmise)2Br,
19
 C) Cu(μ-
dmise)4(μ-Br)2Br2,
19
 D) Tp*Cu(dmise),
14
 and E) [Cu(dmise)4](OTf)2.
20
 Hydrogen atoms and counterions 
are omitted for clarity. 
 
identical Cu–Se bond distances of 2.34 Å, but unlike the thione analogs, cis geometry is 
favored upon selone coordination, likely due to the greater polarizability of the selenium 
atom in addition to the polarizable halides.  When CuI and CuBr are treated with only 
one equivalent of dmise,  the tetrameric Cu4(μ-dmise)4(μ-Br)2Br2·0.5CH3CN (Figure 
1.20C) and Cu4(μ-dmise)4(μ-I)2I2·1.5CH3CN complexes are formed.
19
 The structures of 
both these complexes are similar, and notable for the two different coordination 
geometries around the copper(I) ions. In Cu4(μ-dmise)4(μ-Br)2Br2, two selenium atoms 
45 
 
and one bromide ion each coordinate the Cu(2) and Cu(2A) ions in a distorted trigonal 
planar geometry, with average Cu–Se bond distances of 2.41 Å. The two additional 
copper centers (Cu(1) and Cu(1A)) adopt distorted tetrahedral geometries, with a Cu2(μ-
Br)2 core, two bridging selenium atoms from the dmise ligand, and an average Cu–Cu 
distance of 2.631(2) Å.
19
  
In contrast to the backbonding observed for their thione analogs, the infrared 
spectra of trans-Cu(dmise)2Cl, cis-Cu(dmise)2Br (Figure 1.20B), and cis-Cu(dmise)2I, 
Cu4(μ-dmise)4(μ-Br)2Br2·0.5CH3CN, and Cu4(μ-dmise)4(μ-I)2I2·1.5CH3CN show copper-
bound C=Se bond stretching frequencies (1149-1163 cm
-1
) shifting to higher energies 
relative to unbound dmise (1148 cm
-1
), indicating Cu-Se donor bonding.
19
 
77
Se{
1
H} 
NMR spectra of these complexes show significant upfield shifts for the copper-bound 
dmise resonance, ranging from δ -13.4 to -75.0 compared to unbound dmise (δ 21.8).19 
Cu(II/I) reduction potentials for these Cu(I) selone complexes range from -340 to -360 
mV, significantly lower than their thione counterparts (-177 to -284 mV).
19
  
 In an effort to understand the role of copper-selenium coordination in metal-
mediated DNA damage prevention, Kimani, et al.
14
 synthesized biologically relevant 
Cu(I) dmise complexes with trinitrogen donor ligands. For each of the complexes, 
[TpmCu(dmise)][BF4], [Tpm*Cu(dmise)][BF4], [Tpm
iPr
Cu(dmise)][BF4], and 
Tp*Cu(dmise) (Tpm = tris(pyrazolyl)methane, Tpm* = tris(3,5-
dimethylpyrazolyl)methane, Tpm
iPr
 = tris(3,5-isopropylpyrazolyl)methane, Tp* = 
hydrotris(3,5-dimethylpyrazolyl)borate),
14
 each copper ion adopts distorted tetrahedral 
coordination with similar Cu-Se bond lengths ranging from 2.294(6) to 2.33(8) Å. The 
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short Cu-Se bond distances for all four complexes suggest strong donor interactions 
between the soft selenium ligand and the soft copper metal ion, consistent with slight 
shifts to higher C=S bond stretching energies in the infrared spectra (2-3 cm
-1
; Table 
1.1),
14
 but only a limited number of non-bridging copper selone complexes are available 
for structural comparison. As is the case with Fe(II) selone complexes, 
1
H NMR 
resonances of the imidazole protons and 
13
C{
1
H} NMR resonances of the C=S carbon 
atom shift downfield by δ 0.20-0.41 and δ 2.4-8.0 compared to unbound dmise, 
comparable to NMR shifts observed for the analogous Cu(I)-thione complexes.
14
 Thus, 
both copper-bound dmit and dmise favor the zwitterionic resonance form of the 
chalcogenone ligand (Figure 1.2) in these complexes, despite the slight backbonding 
observed for Cu-S interactions and primarily donor interactions for the Cu-Se bonding as 
determined by infrared spectroscopy.  
Electrochemical studies of [TpmCu(dmise)][BF4], [Tpm*Cu(dmise)][BF4], 
[Tpm
iPr
Cu(dmise)][BF4], and Tp*Cu(dmise) in acetonitrile showed very low Cu(II/I) 
redox potentials for these complexes (-283 to 390 V), lower by 0.635 to 0.874 V relative 
to the analogous complexes with acetonitrile ligands in place of dmise, and an average of 
0.224 V lower than their thione analogs.
17
  Thus, selone binding to Cu(I) stabilizes Cu(II) 
in these complexes much more effectively than analogous thione binding.  In fact, the 
very low potentials for these copper-selone complexes are near or below the potential of 
NADH (-324 mV
98
), suggesting that similar Cu(I)-selone binding in vivo may prevent 
copper redox cycling and generation of damaging reactive oxygen species.  
 Additional studies to determine the ability of selone coordination to reduce Cu(II) 
47 
 
to Cu(I) were carried out by the addition of 5.5 equiv dmise to Cu(OTf)2 to afford the 
reduced [Cu(dmise)4][OTf] complex (Figure 1.20E) and the oxidized [(dmise)3][OTf)2].
20
 
This reaction represents the first synthesis of an imidazolium triselenide by Cu(II) 
reduction. The Cu(I) center of the [Cu(dmise)4]
+
 cation has tetrahedral geometry with 
symmetrically equivalent Cu-Se bond distances of 2.454(1) Å.
20
 A similar reaction with 
the analogous thione dmit results in formation of the trigonal planar complex 
[Cu(dmit)3][OTf],
20
 illustrating the significant differences in binding and coordination 
chemistry that can exist between similar ligands. This difference is also observed in the 
infrared spectra of the two complexes, with the C=Se stretching vibration shifting much 
less to lower energy than the C=S stretching vibration (2 cm
-1
 vs. 34 cm
-1
) upon 
chalcogenone binding,
20
 indicating significantly more backbonding interactions in the 
Cu-S bond.  
 Dmise was also added to Cu(OTf)2 in acetonitrile, and the increasing absorbance 
of [Cu(NCCH3)4]
+
 was monitored to determine the kinetics of copper reduction by this 
selone. Initial rates indicated that dmise reduces Cu(II) to Cu(I) three times faster than 
dmit (0.50 vs. 0.18 s
-1
) in a first-order reaction with respect to ligand concentration.
20
 
Under oxygen-free conditions, this reduction was four orders of magnitude slower, 
indicating the involvement of O2 in this reaction. Thus, biological selone coordination to 
Cu(II) in the presence of oxygen may promote reduction to ROS-generating Cu(I) faster 
than thione binding. 
 Only a few copper-selone complexes have been reported, but these complexes 
display a wide variety of coordination environments, ranging from tetrahedral and 
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trigonal geometry with Cu(I) to trigonal bipyramidal geometry with Cu(II). Similar to the 
thiones, selone ligands can be terminal and bridging ligands, although so few complexes 
have been reported that it is difficult to compare the prevalence of selone binding modes 
with their thione analogs. Copper-selone complexes behave similarly to other late-
transition-metal-selone complexes in that infrared spectroscopy indicates little or no 
backbonding in the metal-selone interaction, in contrast to their thione analogs that can 
show significant weakening of the C=S bond due to Cu-S backbonding (Table 1.1).  In 
the few electrochemical studies conducted, copper-selone binding significantly lowers the 
Cu(II/I) redox potential compared to thione binding, a result that may indicate increased 
antioxidant ability of selones relative to analogous thione compounds. 
 
1.17 Zinc-selone complexes 
 Very few zinc-selone complexes have been reported, with the first being 
Zn(dmise)2Cl2 (Figure 1.21), prepared by combining ZnCl2 and dmise in boiling 
acetonitrile. X-ray crystallographic studies of this complex show the expected tetrahedral 
geometry about the zinc(II) center with Zn-Se bond distances of  2.4691(4) Å and 
2.4873(4) Å.
130
 Although this is the only example of a zinc-selone complex with 
monodentate selone ligands, this and future complexes may be of interest in the  
 
Figure 1.21. Crystal structure of Zn(dmise)2Cl2.
130
 Hydrogen atoms are omitted for clarity. 
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development of precursors for zinc selenide-based materials used in optical electronics, 
laser technology, semiconductor research, and blue-green light emitting diode 
materials.
131-133
  
Parkin et al.
123
 have synthesized a novel bidentate ligand featuring two selenium 
donor atoms [Bse
Me
] (Bse
Me
 = bis(2-seleno-1-methylimidazolyl)hydroborato)) and 
reported its reactions with ZnX2 (X = Cl and I) in 1:1 and 2:1 ratios, resulting in 
{[Bse
Me
]ZnX}2 ({[Bse
Me
]ZnCl}2; Figure 1.22A) and [Bse
Me
]2Zn (Figure 1.22B), 
respectively. X-ray diffraction structures show that Bse
Me
 can act as both a monomer and 
a bridging ligand, and in {[Bse
Me
]ZnX}2, the bridging ligand is one of the 2-seleno-1-
methylimidazolyl selenium atoms rather than a halide.
123
 For {[Bse
Me
]ZnX}2 complexes, 
the Se,Se,X geometry about the Zn(II) is trigonal planar with Zn-Se bond distances 
averaging 2.441 Å.
123
 The monomer [Bm
Me
]ZnX exhibits tetrahedral geometry with bond 
lengths averaging 2.445 Å, similar to the dimeric complexes.
123
 Although [Bse
Me
] is an 
analog of the mercapto ligand [Bm
Me
], structural comparison of the analogous zinc iodide 
compounds, {[Bse
Me
]ZnI}2 and [Bm
Me
]ZnI, demonstrated that the seleno ligand exhibits 
a greater tendency to bridge metal centers than the mercapto ligand.
123
  
 
Figure 1.22. Crystal structures of A) {[Bse
Me
]ZnCl}2 and B) [Bse
Me
]2Zn.
123
 Hydrogen atoms are omitted 
for clarity. 
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Metal-selone complexes are rare; however, they have become more investigated 
in the past few years due to the recent discovery of selenoneine and other biological 
selones.
10,11
 The few reported metal-selone complexes are easily synthesized with a 
variety of late-transition-metal ions, including Fe(II), Co(II), Ni(II), Cu(I), Cu(II), and 
Zn(II). Typical metal thione interactions involve significant backbonding from the metal 
center, but most metal-selone complexes interact primarily through donor bonds with 
little or no evidence of metal backbonding. Selone complexes are often similar to 
analogous thione complexes, but seemingly minor M-S and M-Se bonding differences 
can result in different coordination numbers and binding modes.  Drawing wide-ranging 
conclusions about selone coordination or comparisons to analogous thione complexes is 
difficult, however, due to the paucity of well-characterized complexes and lack of 
reactivity studies. 
The metal coordination properties of thione- and selone-containing ligands have 
been investigated for multiple applications, including antitumor and antioxidant 
properties, protein active-site models, and optical materials. The wide structural diversity 
exhibited by thione and selone donor ligands upon binding to first-row-transition metals 
explains the considerable recent interest in their coordination chemistry. Many studies of 
thione and selone complexes with these metal ions demonstrate rich coordination 
chemistry with varying coordination numbers and geometries, reinforcing the fact that 
subtle differences in both metal and ligand properties can have significant consequences 
for resulting structure and reactivity.   
Although electrochemical studies of metal-thione and -selone complexes are still 
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uncommon, they indicate that both ligand and metal redox properties are altered upon 
coordination. Copper-selone complexes have lower Cu(II/I) reduction potentials 
compared to their thione analogs, and this difference might be at least partly responsible 
for the greater antioxidant activity observed for selones. The thione-scorpionate classes of 
ligands have provided a facile system for modeling sulfur-rich metalloenzyme active 
sites, including nickel-containing hydrogenases and zinc-containing thiolate alkylation 
enzymes. Despite the utility of thione-scorpionate ligands, a limited number of 
selone-scorpionate metal complexes have been reported. Reactivity studies of thione- and 
selone-metal complexes are also scarce, and such studies related to antioxidant activity 
and functional metalloenzyme modeling would be particularly relevant. 
Sulfur and selenium should behave similarly due to their near-identical 
electronegativities; however, their different atomic radii (1.04 and 1.17 Å, 
respectively)
134
 result in increased bond distances and polarizability for selenium 
compared to sulfur. Selenium’s longer bond distances and greater polarizability may 
reduce backbonding and result in the observed differences in analogous thione- and 
selone-metal coordination, but current studies of these ligands do not provide decisive 
conclusions as to the specific properties that account for differences in their coordination 
chemistry.  Irrespective of the specific cause, these differences between sulfur and 
selenium as well as differences in the properties of thione and selone ligands result in 
varied coordination complexes. This is not surprising, since organisms go to significant 
lengths to include selenium in place of sulfur in amino acids.  In large part, it remains to 
be determined how much of the rich coordination chemistry demonstrated by both 
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thiones and selones impacts the biological functions of naturally occurring thione and 
selone compounds. 
The review in this introductory Chapter is reprinted with permission from 
Stadelman, B. S.; Brumaghim, J. L. In Biochalcogen Chemistry: The Biological 
Chemistry of Sulfur, Selenium, and Tellurium; American Chemical Society: Washington, 
2013, p 33-70. Copyright 2013 American Chemical Society; appropriate permissions can 
be found in Appendix A.) The research presented in this dissertation involves 
understanding the interactions of chalcogenone-containing compounds similar to 
ergothioneine, selenoneine, and methimazole with iron(II) and Zn(II) as well as an 
investigation into their antioxidant mechanisms when bound to to these metal ions.  
The work presented in Chapter 2 investigates the effects of N,N’-1,3-
dimethylimidazole thione (dmit) and selone (dmise), bis(thioimidazolyl)ethane (ebit), and 
bis(selenoimidazolyl)ethane (ebis) ligand coordination on the redox properties of the 
thiones and selones as well as the effects on the redox properties of Fe(II). Experimental 
results and DFT calculations both demonstrate that when bound to Fe(II), the thiones and 
selones favor their zwitterionic resonance structures. Thione and selone coordination to 
Fe(II) lowers the Fe(II/III) reduction potentials with a greater decrease for Fe(II)-dmise 
than Fe(II)-bound dmit. Also, bound thione and selone oxidation potentials increase 
significantly, indicating that iron-bound thione and selone ligands should undergo 
oxidation prior to Fe(II).  
The research described in Chapter 3 describes the reactivity of dmit, dmise and 
their Fe(L)2Cl2 (L= N,N’-1,3-dimethylimidazole thione (dmit) and selone (dmise)) 
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complexes with H2O2. 
1
H NMR titrations and mass spectrometry studies demonstrate that 
Fe(II)-bound dmit and dmise undergoes oxidation, forming the imidazolium cation and 
S/Se oxide species. Fe(dmise)2Cl2 requires 4 equiv of H2O2 for complete oxidation, while 
dmit required 6 equiv of H2O2. While dmit undergo oxidation, it does not protect Fe(II) 
from oxidation, however dmise significantly protects iron Fe(II) from oxidation. 
 Chapter 4 discusses the synthesis of Zn(II)-dmit and –dmise complexes and their 
reactivity towards H2O2 to understand what role the metal center plays in the redox and 
antioxidant properties of dmit and dmise. Upon coordination to Zn(II), dmit and dmise 
reduction potentials decrease, indicating that oxidation becomes more difficult. Oxidation 
studies of Zn(L)2Cl2 (L= N,N’-1,3-dimethylimidazole thione and selone) complexes 
indicate that Zn(II) binding decreases ease of oxidation of the thiones and selones in 
which dmise requires 4 equiv of H2O2, while upon treatment with 6 equiv of H2O2 dmit 
bound to Zn(II) does not undergo C=S bond cleavage forming the imidazolium cation but 
instead oxidizes to a hydroxy bound thione.  
Work described in Chapter 5 investigates the synthesis of novel thione and selone 
compounds. Chapter 5 also introduces a novel synthetic route for the synthesis of novel 
thione compounds. Testing these novel thiones and selones for their ability to bind iron 
and copper and to prevent metal-mediated DNA damage will allow us to better 
understand and tune the antioxidant properties of these compounds.  
Chapter 6 describes the synthesis of novel Fe(II)-thione and –selone complexes 
and demonstrates that altering the electronic structure of the coordinated thione and 
selone ligands affects their binding properties towards Fe(II). Fe(II) and Zn(II) complexes 
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of the formula M(L)2Cl2 and M(L’)Cl2 (L = methimazole or 2-mercaptoimidazole and L’ 
= (mim
R
)2 or (seim
Me
)2  (R = H or Me) were synthesized and characterized to see how the 
altered aromaticity of the thiones and selones effects the binding mechanisms. The work 
presented in Chapters 2, 3, 4, 5, and 6 will promote our understanding of sulfur and 
selenium antioxidant activity and metal coordination properties as well as their ability to 
scavenge reactive oxygen species such as H2O2. 
ABREVIATION LIST 
DNA = deoxyribonucleic acid 
ROS = reactive oxygen species 
NMR = nuclear magnetic resonance 
GPx = glutathione peroxidase 
DPPH = 2,2-diphenyl-1-picrylhydrazyl 
PTU = 6-n-propyl-2-thiouracil  
MTU = 6-methyl-2-thiouracil  
amt = 4-amino-3-methyl-1,2,4-triazole-5-thione 
dmit = N,N’-dimethylimidazole thione  
dmise = N,N’-dimethylimidazole selone  
mbit = 1,1’-methylenebis(1,3-dihydro-3-methyl-2H-imidazole-2-thione) 
mbis = 1,1’-methylenebis(1,3-dihydro-3-methyl-2H-imidazole-2-selone) 
ebit = 1,1’-(1,2-ethanediyl)bis(3-methyl-imidazole-2-thione)  
ebis = 1,1’-(1,2-ethanediyl)bis(3-methyl-imidazole-2-selone)  
ttcH3 = 2,4,6-trimercaptotriazine 
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sbim = 1H-benzimidazole-2(3H)-thione 
tsacH = thiosaccharinate 
diap = 1,3-diazepane-2-thione 
3-Me-HPT = l-hydroxy-3-methylpyridine-2(1H)-thione 
Tp
R
 = tris(pyrazolyl)borate  
Tm
R
 = hydrotris(methimazolyl)borate  
Bm
R
 = hydrobis(methimazolyl)borate  
Tr
R
 = hydrotris(thioxotriazolyl)borate  
Br
R
 = hydrobis(thioxobiazolyl)borate 
HBmit3 = hydrotris(1-methylimidazol-2-ylthio)borate 
Epa = anodic (oxidation) potential 
LOX = lipogenase 
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CHAPTER TWO 
SYNTHESIS, CHARACTERIZATION, DFT CALCULATIONS, AND 
ELECTROCHEMICAL COMPARISON OF NOVEL IRON(II) 
COMPLEXES WITH THIONE AND SELONE LIGANDS 
 
2.1 Introduction 
Reactive oxygen species (ROS) are byproducts of cellular respiration that damage 
lipids, proteins, and DNA.
1-7
 Iron(II) and copper(I) generate damaging hydroxyl radical 
(Reaction 2.1)
8-10
 and this reaction becomes catalytic in vivo when cellular reductants 
such as NADH reduce Fe(III)/Cu(II) to Fe(II)/Cu(I). This metal-mediated oxidative 
damage to cells is an underlying cause of cardiovascular diseases, neurodegenerative 
diseases, and cancer.
3-7
 
Fe
2+
/Cu
+
  +  H2O2    Fe
3+
/Cu
2+
  +  
•
OH  +  OH
-
                (2.1) 
Biological functions of the naturally occurring thione- (C=S) and selone- (C=Se) 
containing compounds ergothioneine and selenoneine (Figure 2.1) are not well 
established, but several studies indicate that they are antioxidants.
11-17
 Because 
ergothioneine and selenoneine are not biosynthesized by humans, ergothioneine 
concentrations in the blood serum of middle-aged and older adults vary between 1 and 
9 μM due to differences in dietary consumption.18,19 Concentrations of recently 
discovered selenoneine are much lower, with blood concentrations up to 9 nM in a 
Japanese population with high bluefin tuna consumption.
17
  
Ergothioneine and selenoneine are potent radical-scavenging antioxidants.
13,17,20
 
In addition, ergothioneine is an established metal-binding antioxidant, and selenoneine 
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may also act as an antioxidant through metal coordination.
17,21,22
 Ergothioneine binding 
prevents Cu(I)-mediated oxidative DNA damage,
22
 and ergothioneine-Cu(I) coordination 
has been investigated using DFT methods.
21,22
 Selenoneine prevents iron auto-oxidation 
by binding iron(II) in hemoglobin and myoglobin.
17
 Methimazole (Figure 2.1) is a 
hyperthyroidism drug structurally similar to ergothioneine.
23
 In hyperthyroidism patients, 
methimazole blood concentrations range from 4-13 μM,24,25 and it also scavenges ROS to 
prevent oxidative DNA damage.
26,27
 Although ergothioneine, selenoneine, and 
methimazole have at least one NH group potentially available for metal binding, these 
ligands universally bind at the S/Se atoms in preference to the NH site.
28
 
Although iron concentrations in humans are difficult to measure and vary by 
tissue, blood serum iron concentrations in healthy human adults range from 20-30 μM,29 
and much higher concentrations of iron (0.1 – 17 mM) have been found in liver tissues of 
men that died of natural causes.
30
 Non-protein-bound iron pools in human cells also vary 
from 30 μM in the cytoplasm to over 200 μM in mitochondria.31  Since both iron and 
thione- and selone-containing molecules are present in humans, iron-thione, and to a 
lesser extent iron-selone, interactions are likely, warranting their thorough investigation. 
 
Figure 2.1. Biologically relevant chalcogenone compounds and selone and thione ligands. 
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Metal-thione complexes are widely studied and have been previously 
reviewed.
32-37
  Rabinovich et al.
38
 determined the coordination chemistry of Cu(I), Ag(I), 
and Au(I) with heterocyclic thiones and selones, and the coordination chemistry of 
Hg(II)
39-42
 and Cd(II)
43,44
 with heterocyclic thiones is also reported. In addition, a few 
Fe(II) complexes with tris(mercaptoimidazolyl)borate -type ligands are characterized 
have been also been reported.
45-48
 Co(II) and Zn(II) complexes of the formula 
M(dmise)2Cl2 (dmise = N,N’-dimethylimidazole selone; Fig. 1),
49,50
 as well as tetrakis 
Cd(dmise)4
51
 and Zn(dmit)4
52
 (dmit = N,N’-dimethylimidazole thione; Fig. 1) also are 
reported. Devillanova et al.
53
 investigated the Cu(I) coordination chemistry of 2-
pyrrolidineselone, 2-imidazolidineselone, and 2-thiazolidineselone ligands. Other Cu(I)-
thione complexes of the formula Cu(L)2Cl (L = 1,3-dimethylimidazoline-2-thione, N,N’-
dimethylimidazolidine-2-thione, N,N’-diethylimidazolidine-2-thione, and N-ethyl-1,3-
imidazolidine-2-thione)
54-56
 and a Cu(II)-thione complex of the formula Cu(L)2Cl2 (L = 
1,3-diisopropyl-4,5-dimethylimidazoline-2-thione)
57
 are also known. 
Dmit and dmise bind Cu(I) and Cu(II) in a variety of coordination modes.
58-61
 
Dmise-copper binding significantly lowers the Cu(II/I) redox potential in 
[Tpm
R
Cu(dmise)]
+
 complexes (Tpm
R
 = tris(3,5-di-R-pyrazolyl)methane; R = H, CH3, 
and 
i
Pr) compared to analogous acetonitrile-coordinated complexes, resulting in Cu(II/I) 
potentials that occur at or below -0.32 V, the potential at which NADH cannot reduce 
Cu(II) to Cu(I).
10,62
 If NADH cannot reduce Cu(II), copper-mediated catalytic generation 
of hydroxyl radical (Reaction 1) may be prevented.
59
 However, copper-thione 
coordination may not be similarly effective at preventing catalytic radical formation, 
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since the analogous dmit-Cu(I) complexes have Cu(II/I) reduction potentials significantly 
higher than their selone counterparts.
58,59,61
  
Although several sulfur- and seleno-amino acids and related compounds prevent 
iron-mediated DNA damage by coordinating Fe(II),
63-65
 there are few biologically 
relevant studies of thione-Fe(II) coordination
66-68
 and no reports of isolated selone-Fe(II) 
complexes. However, selenoneine binds iron(II) in heme proteins and prevents its 
oxidation.
17
 The recent discovery of selenoneine in tuna and human blood,
16,17
 has 
spurred examination of selones to determine their antioxidant behavior and ability to bind 
biologically common metals such as iron,
69
 copper,
58,59,61,70,71
 and zinc.
72
 We report the 
synthesis and characterization of novel, mononuclear Fe(II) complexes of the formulae 
FeL2Cl2, [FeL2(CH3CN)2]
2+
, [FeL4]
2+
 (L = dmit or dmise), and {Fe(ebit/ebis)Cl2}n (ebit = 
bis(thioimidazolyl)ethane; ebis = bis(selenoimidazolyl)ethane; Figure 2.1) and an 
investigation of how thione and selone binding alters Fe(II) redox potentials. 
Understanding the coordination and electrochemical properties of these complexes may 
elucidate possible iron-binding mechanisms for biological selone and thione antioxidants. 
 
2.2 Results and Discussion 
Synthesis of Fe(II)-thione and -selone complexes. Treating FeCl2·4H2O with two 
equivalents of dmit or dmise in a mixture of dichloromethane and triethylorthoformate (to 
remove water from the Fe(II) starting material) forms four-coordinate Fe(L)2Cl2 (L = 
dmit (1) or dmise (2)) complexes (Scheme 2.1A). Both complexes decompose in air 
within a few hours in the solid state and in 10-20 min in solution.  
68 
 
To understand how labile solvato ligands affect the binding properties of Fe(II)-
thione and -selone complexes, Fe(II)-dmit and –dmise acetonitrile compounds were also 
synthesized. Treating Fe(BF4)2∙6H2O with two equiv of dmit or dmise (Scheme 2.1B) 
afforded peach and yellow powders of [Fe(dmit)2(CH3CN)2]
2+
 (3) and 
[Fe(dmise)2(CH3CN)2]
2+
 (4), respectively. The air stability of 3 and 4 is far less than the 
Scheme 2.1 
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chloride complexes 1 and 2, with decomposition in solution and solid states occurring 
within 5 to 10 min. To compare homoleptic complexes of dmise and dmit, [Fe(dmit)4]
2+ 
(5) and [Fe(dmise)4]
2+ 
(6) were synthesized. Similar to 3 and 4, treating Fe(OTf)2 or 
Fe(BF4)2 with 4 equivalents of dmit or dmise affords green and yellow powders of 
[Fe(dmit)4]
2+ 
(5) and [Fe(dmise)4]
2+ 
(6) (Scheme 2.1C).  
Under similar conditions, bidentate ebit and ebis ligands afford the polymeric 
Fe(II) complexes {Fe(ebit)Cl2}n and {Fe(ebis)Cl2}n, similar to previously reported 
{FeLCl2}n complexes (L = bis(3-tert-butyl-2-thione-imidazolyl)methane).
68
  Treating 
FeCl2·4H2O with one molar equivalent of ebit or ebis in triethylorthoformate and 
dichloromethane solution and filtration of the resulting precipitate yields tan 
{Fe(ebit)Cl2}n (7) or pale yellow {Fe(ebis)Cl2}n (8; Scheme 2.1D). After 24 h, these solid 
iron(II) complexes decompose in air. Solubility of complexes 7 and 8 are significantly 
lower than for complexes 1 - 6, similar to that of the polymeric {Fe(L
1
/L
2
)Cl2}n 
complexes (L
1
 = 1,1’-methylenebis(3-methylimidazole-2-thione) and L2 = 1,1’-
methylenebis(3-tert-butyl- imidazole-2-thione).
68
 MALDI mass spectrometry of 7 and 8 
also suggests formation of a polymeric structure with fragmentation patterns different 
from monomeric complexes 1 - 6, and polymeric complex formation for 7 is confirmed 
by X-ray crystallography (vide infra).  
Structural analysis of iron-thione and -selone complexes. Single crystals of 
Fe(dmit)2Cl2 (1; Figure 2.2A), Fe(dmise)2Cl2 (2; Figure 2.2B), [Fe(dmit)4][BF4]2 (5b; 
Figure 2.2C), and [Fe(dmise)4][BF4]2 (6b; Figure 2.2D) were grown via slow diffusion of 
ether into acetonitrile solutions of the corresponding complexes, and their structures 
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determined by X-ray diffraction. Similar compounds such as Co(dmise)2Cl2
49
 and 
Zn(dmise)2Cl2
50
 have been synthesized, but compounds 2 and 6b represent the first 
structurally characterized iron-selone complexes. Selected bond distances and angles are 
summarized in Table 1, and their structures are shown in Fig. 2. Complexes 1 and 2 are 
an isomorphous pair containing Fe(II) bound to two Cl atoms and two S/Se atoms from a 
heterocyclic chalcogenone (Figure 2.2; crystal packing diagrams for 1 and 2 are shown in 
Figures. 2.8 and 2.9, respectively). In 5b and 6b, Fe is coordinated to four S (5b) or Se 
(6b) atoms to form the tetrakis [Fe(dmit/dmise)4]
2+
 complexes (Figure 2.2; crystal 
packing diagrams for 5b and 6b are shown in Figures 2.10 and 2.11, respectively), 
likewise forming an isomorphous pair. The Fe(II) valence was confirmed by the two 
coordinated Cl
-
 ions in 1 and 2, and the presence of uncoordinated [BF4]
-
 counterions in a 
2:1 ratio with Fe in 5b and 6b.  
Table 2.1. Selected bond lengths and angles for Fe(dmit)2Cl2 (1), Fe(dmise)2Cl2 (2), [Fe(dmit)4][BF4]2  (5b), 
[Fe(dmise)4][BF4]2 (6b).  
1 2 5b 6b 
Fe1—S1 2.3687 (18) Fe1—Se1 2.4882 (7) Fe1—S1 2.3395 (9) Fe1—Se1 2.4533 (9) 
Fe1—S2 2.3950 (19) Fe1—Se2 2.5140 (10) Fe1—S1i 2.3395 (9) Fe1—Se1i 2.4533 (9) 
Fe1—Cl1 2.2977 (18) Fe1—Cl1 2.2977 (8) Fe1—S2 2.3495 (8) Fe1—Se2 2.4566 (8) 
Fe1—Cl2 2.2887 (19) Fe1—Cl2 2.2877 (8) Fe1—S2i 2.3495 (8) Fe1—Se2i 2.4566 (8) 
S1—C2 1.719 (6) Se1—C2 1.873 (3) S1—C1 1.711 (3) Se1—C1 1.861 (5) 
S2—C7 1.715 (6) Se2—C7 1.869 (3) S2—C6 1.715 (3) Se2—C6 1.864 (6) 
        
Cl1—Fe1—S1 110.36 (7) Cl1—Fe1—Se1 109.71 (3) S1i—Fe1—S1 120.14 (6) Se1i—Fe1—Se1 122.83 (6) 
Cl1—Fe1—S2 109.32 (7) Cl1—Fe1—Se2 109.42 (3) S1i—Fe1—S2 105.20 (3) Se1i—Fe1—Se2 104.77 (2) 
Cl2—Fe1—S1 118.62 (7) Cl2—Fe1—Se1 118.34 (2) S1i—Fe1—S2i 105.62 (3) Se1i—Fe1—Se2i 103.80 (2) 
Cl2—Fe1—S2 106.82 (7) Cl2—Fe1—Se2 106.89 (2) S1—Fe1—S2 105.62 (3) Se1—Fe1—Se2 103.80 (2) 
S1—Fe1—S2 100.01 (7) Se1—Fe1—Se2 99.09 (2) S1—Fe1—S2i 105.20 (3) Se1—Fe1—Se2i 104.77 (2) 
Cl2—Fe1—Cl1 110.83 (7) Cl2—Fe1—Cl1 112.29 (3) S2—Fe1—S2i 115.64 (5) Se2—Fe1—Se2i 117.91 (5) 
C2—S1—Fe1 104.9 (2) C2—Se1—Fe1 101.67 (8) C1—S1—Fe1 101.33 (9) C1—Se1—Fe1 98.64 (15) 
C7—S2—Fe1 101.3 (2) C7—Se2—Fe1 98.24 (8) C6—S2—Fe1 99.68 (9) C6—Se2—Fe1 98.13 (15) 
i symmetry operator for symmetrically equivalent atoms: -x, y, -z+3/2 
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Figure 2.2. Crystal structure diagrams with 50% probability density ellipsoids for A) Fe(dmit)2Cl2 (1), B) 
Fe(dmise)2Cl2 (2), C) [Fe(dmit)4][BF4]2  (5b), and D) [Fe(dmise)4][BF4]2 (6b).  Hydrogen atoms and 
counterions are omitted for clarity. 
 
All the Fe(II) centers in these complexes adopt a distorted tetrahedral 
coordination geometry with bond angles ranging from 99.09(2) to 122.83(6)°, possibly 
due to ligand steric bulk.  The angular distortion about Fe in 6b is comparable to that 
observed in 1 and 2, whereas complex 5b is distorted to a somewhat lesser degree. Using 
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the τ4 geometry index of Yang and coworkers,
73
 four-coordinate geometry indices of 
0.93, 0.92, 0.90, and 0.85 are calculated for complexes 1, 2, 5b, and 6b, respectively. 
Thus, complexes 1, 2, and 5b appear to be intermediates of tetrahedral and trigonal 
pyramidal geometries, while 6b closely approaches the trigonal pyramidal threshold. The 
observed Fe-S-C (99.68(9) to 104.9(2)°) and Fe-Se-C (98.13(15) to 101.67(8)°) bond 
angles fall within the expected ranges.
66,67
 Average Fe-S bond distances for 1 and 5b 
(2.382(2) and 2.345(1) Å, respectively) are similar to previously reported Fe(II)-thione 
complexes (2.298 - 2.474 Å).
66,67  
 The mean Fe-Se bond distances for 2 and 6b (2.501(1) 
and 2.454(1) Å, respectively) are slightly longer than other reported iron(II)-selenolate 
bond distances (2.443(1) Å in an iron tetrakis phenyl selenolate),
74
 an expected result for 
these Fe(II)-selones, since the number of available electrons and greater negative charge 
on the Se atom of the selenolate should result in a shorter bond. The average C=Se 
distance (1.867(6) Å) in 2 and 6b is only slightly elongated compared to the unbound 
ligand (1.843 Å
75
).  The observed average C-S (1.715(6) Å) and C-Se (1.867(6) Å) bond 
distances in all of the structures are indicative of C=S and C=Se in thiones and selones 
compared to single bonds (typically 1.808(1) Å and 1.970(1) Å for C-S and C-Se, 
respectively
76
). The bis-thione and -selone complexes 1 and 2 exhibit longer Fe-S/Se 
bond distances than their tetrakis (5b and 6b) counterparts, perhaps due to the better π-
donor abilities of the chloride ligands in 1 and 2. 
The average C2-C3, N1-C1, and N2-C1 bond lengths for dmit complexes 1 and 
5b (1.32(1) and 1.318(5) Å for C2-C3; 1.350(9) and 1.346(4) Å for the averages of N1-
C1 and N2-C1, respectively) are not significantly different from unbound dmit (1.3255(3) 
73 
 
and 1.3489(3) Å
77
). Likewise, the average N1-C2 and N2-C3 bond lengths in 1 and 5b 
are similar (1.385(8) and 1.379(5) Å, respectively) to dmit (1.394(6) Å
77
) and close to the 
analogous bond lengths for the aromatic imidazolium cation (1.363(3) Å
78
), indicating 
that the bound dmit ligands in these complexes may favor the zwitterionic form (Figure 
2.3A).  
For complex 2, The average C2-C3 bond length for iron-coordinated dmise 
(1.348(4) Å) does not differ from that of unbound dmise (1.345(7) Å
75
), but the C2-C3 
bond length for the tetrakis-dmise complex 6b is slightly shorter (1.32(1) Å). Although 
the average N1-C1 and N2-C1 bond lengths for 2 and 6b are not significantly different 
from uncoordinated dmise (1.343(7) Å
75
), the average N1-C2 and N-C3 bond lengths in 
these complexes are slightly longer than those of unbound dmise (1.371(7) Å
75
). This is 
opposite the trend observed in dmit complexes 1 and 5b, and indicates slightly different 
coordination properties for dmit and dmise. X-ray diffraction analysis also showed that 
the [Fe(dmit)4]
2+
 (5a) and  [Fe(dmise)4]
2+
 (6a) cations crystallized with triflate 
counterions are effectively identical to their tetrafluoroborate analogs (5b and 6b).  The 
 
Figure 2. 3. A) Chalcogenone resonance forms (E = S/Se), and B) illustration of - (left) and -donor (left) 
bonding for chalcogenone coordination to a metal. 
 
NN
E
NN
E
+
-
NN + NN +
N
N
N
N
E M E M
E M E M
A
B
74 
 
triflate counterions in these structures are not well-behaved, however, resulting in poor 
statistical residuals despite consistency of all supporting characterization with the 
molecular structure. Complexes 7 and 8 proved difficult to crystallize as X-ray-quality 
single crystals due to low solubility of the complexes. A discussion of the crystal growth 
attempts and structure of 7 are provided at the end of the experimental section (Figures 
2.12 and 2.13 and Tables 2.7 and 2.8).   
 Density functional theory calculations. Density functional theory (DFT) geometry 
optimizations were performed for 1-6 assuming tetrahedral coordination of a high spin 
state Fe(II) center. Bond lengths and angles for the DFT structures are generally 
consistent with X-ray structures of 1, 2, 5 and 6 (Table 2.2). For 1 and 2, the dmit/dmise 
ligands do not have the same conformation as the X-ray structure and prefer to rearrange 
to a C2v orientation with CH···Cl interactions to the dmit/dmise methyl groups (Figure 
2.4). We note that the conformation in the X-ray structures (~4 kcal/mol above the C2v  
Table 2.2. Selected DFT(mPW1PW91) bond lengths (Å) and angles (˚) for FeCl2(dmit)2 (1), FeCl2(dmise)2 
(2), [Fe(dmit)2(MeCN)2]
2+
 (3), [Fe(dmise)2(MeCN)2]
2+
 (4), [Fe(dmit)4]
2+
 (5) and [Fe(dmise)4]
2+
 (6). 
                     1  3A 3B 5a 
Fe-S 2.437 Fe-S 2.345 2.344 Fe-S 2.381 
Fe-Cl 2.290 Fe-N 2.066 2.065 S-C 1.735 
S-C 1.721 S-C 1.737 1.738   
  C-N 1.149 1.150   
Cl-Fe-S 110.1 N-Fe-S 103.1, 113.2 112.2, 116.4 S-Fe-S 105.3, 118.3 
S-Fe-S 97.0 S-Fe-S 120.1 96.4 Fe-S-C 108.2 
Cl-Fe-Cl 117.6 N-Fe-N 102.2 103.7   
Fe-S-C 97.0 Fe-S-C 113.4 113.0   
                   2  4A 4B 6a 
Fe-Se 2.555 Fe-Se 2.469 2.467 Fe-Se 2.501 
Fe-Cl 2.293 Fe-N 2.070 2.067 S-C 1.889 
S-C 1.875 S-C 1.891 1.894   
  C-N 1.149 1.150   
Cl-Fe-Se 110.0 N-Fe-Se 103.2, 113.6 113.2, 117.1 Se-Fe-Se 103.8, 120.9 
Se-Fe-Se 98.6 Se-Fe-Se 121.2 93.7 Fe-Se-C 105.9 
Cl-Fe-Cl 116.6 N-Fe-N 101.1 103.3   
Fe-Se-C 92.8 Fe-Se-C 109.9 110.2   
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structures) is stabilized by intermolecular interactions that are not represented in the gas-
phase calculations. Two possible conformations of the dmit/dmise ligands for 3 and 4 
were found in which the imidazole groups are either tilted toward (3A, 4A) or away from 
(3B, 4B) the iron (Figure  2.4). The latter structure is 1-3 kcal/mol more stable and has a 
larger E-Fe-E angle in its distorted tetrahedral coordination (Table 2). Fe-E bond 
distances in these complexes are shorter than the dichloro and tetrakis complexes due to 
reduced steric effects around the metal and lesser electrostatic competition with the 
acetonitrile ligands.  
 Trends in the DFT bond distances for the dmit and dmise ligands in the 
complexes versus free thione and selone are consistent with increased contribution of the 
zwitterionic resonance structure upon Fe(II) coordination. The structures of free dmit and 
dmise themselves show significant contribution of the zwitterionic resonance structure 
(Fig. 3A). The dmit/dmise C-E bonds (1.684 and 1.838 Å, respectively) are significantly 
longer than the “true” chalcogenones thioacetone (1.638 Å) or selenoacetone (1.779 Å) 
 
Figure 2.4. Conformations of 1, 2, 3 and 4 obtained by DFT geometry optimizations. Bond distances given 
in Å. 
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calculated at the same level of theory, but similar to the N,N’-dimethyl thio- and  
selenoureas (1.686 and 1.843 Å, respectively). The shift to the zwitterionic resonance 
structure is also evident in the partial charge of E in dmit/dmise (qS = -0.633e, qSe = 
-0.544e) relative to the ketones (qS = -0.396e, qSe = -0.322e). The zwitterionic character 
of dmit/dmise is consistent with the HOMO, which is of C-E * character weighted 
toward the E, much like a p-type lone pair localized on E. Therefore, the dmit/dmise 
ligands should be assumed to coordinate as the zwitterion with -donation through one p-
type E lone pair orbital and -donation from a second p-type orbital perpendicular to the 
bond axis similar to thiolate/selenolate ligands (Fig. 3B).  As a result, changes in bond 
length upon complex formation are not as significant as would be expected from a “true” 
chalcogenone, and coordination only further shifts the ligand toward the zwitterionic 
form as indicated by the slight increase in the C-E bond (0.04-0.05 Å). The longest bond 
distances are found in the cationic complexes 3B and 4B that are better able to stabilize 
the partial thiolate/selenolate character of the zwitterionic ligand. 
 Infrared spectroscopy. Infrared spectroscopy was used to characterize all the 
synthesized Fe(II)-thione and -selone complexes (Table 2.3). Upon Fe(II) binding, the 
dmit ligands in complexes 1, 3, 5a, and 5b show a C=S stretch ranging from 1174-1178 
cm
-1
, slightly shifted to lower energy compared to unbound dmit (1181 cm
-1 79
). The CN 
stretches at 2372 and 2343cm
-1
 for 3 and 4, respectively, confirm iron(II)-acetonitrile 
binding due to the shift to higher energies compared to unbound acetonitrile (2282 cm
-1
), 
in accord with reported values for Fe(NCCH3)2Cl2.
80
 In contrast, selone complexes 2, 4, 
6a, and 6b have C=Se stretching vibrations ranging from 1149-1155 cm
-1
, slightly shifted 
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Table 2.3. Comparison of C=E stretching modes (cm
-1
) in Fe(II) dmit/dmise complexes. 
 
 
 
 
 
to higher energies compared to unbound dmise (1147 cm
-1 81,82
) indicating primarily 
donor bond character interactions for dmise-Fe(II) binding. Similar differences in 
bonding modes of thione and selone ligands have been observed for complexes with 
Cu(I),
58,59,61
 Ni(II),
82
 and Co(II).
83
 DFT calculations of 1 - 5 agree well with the 
experimental spectra and trends in the C=E bands (Table 2.3) which are shown to couple 
with the modes of the imidazole ring. 
 In the polymeric complexes {Fe(ebit)Cl2}n (7) and {Fe(ebis)Cl2}n (8), the C=S/Se 
stretch shifts to significantly higher energy (1152 and 1139 cm
-1
, respectively) compared 
to unbound ebit or ebis (1136 and
 
1126 cm
-1
, respectively
84
), an effect opposite that 
observed for the mononuclear thione complexes but similar to other Fe-dmise complexes.  
Similar shifts to higher energy for the C=E stretches of bound ebit and ebis ligands are 
also observed for polymeric {Co(ebit/ebis)Cl2}n.
82
 
 NMR spectroscopy. Although these Fe(II) complexes are paramagnetic, 
1
H NMR 
spectra are observed after only a few scans, and 
13
C{
1
H} NMR can be acquired in less 
than 24 h. Both 
1
H and 
13
C{
1
H} NMR resonances show shifting and broadening 
commonly observed in paramagnetic NMR spectra. For example, the 
1
H NMR spectrum 
of Fe(dmit)2Cl2 (1) shows a large downfield shift for the methyl proton resonance (δ 
 experimental DFT 
dmit 1181 1215 
dmise 1148 1177 
1 1176 1206 
2 1149 1180 
3 1177 1201 (3B) 
4 1153 1178 (4B) 
5 1178 1203, 1204 
6 1155 1178, 1181 
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15.3) and a large upfield shift of the olefinic proton resonance (δ 2.12) compared to 
unbound dmit (δ 3.53 and δ 6.64, respectively85), as confirmed by peak integrations and 
the increased broadening of the methyl resonances due to closer proximity of the methyl 
groups to paramagnetic Fe(II).
86
 Thione complexes 3, 5a, and 5b also show similar, but 
less pronounced, downfield shifts for the methyl proton resonances and upfield shifts for 
the olefinic proton resonances in their 
1
H NMR spectra. 
1
H and 
13
C{
1
H} NMR data for 
complexes 1-8 are given in Table 2.4, and 
1
H NMR spectra are provided in Figures. 2.14 
- 3.22.  
In contrast to the Fe(II)-thione complexes, 
1
H NMR spectra of Fe(II)-selone 
complexes 2 (Figure 2.5A), 4, 6a, and 6b show much less downfield shifting of the 
methyl and olefinic resonances compared to unbound dmise.
85
 Although similar 
downfield shifts 
Table 2.4. 
1
H and 
13
C{
1
H} NMR chemical shifts of Fe(II)-thione and -selone complexes and unbound 
ligands. 
  1H shift (δ) 13C{1H} shift (δ) 
Ligand or Fe(II) complex  CH3 H-4/5 CH2 CH3 CH-4/5 C=S/Se CH2 
dmit  3.61 6.72 
 
35.7 117.9 162.6 
 
Fe(dmit)2Cl2  (1) 15.3 2.12  
30.9 100.1 91.0 
 
[Fe(dmit)2(CH3CN)2][BF4]2 (3) 8.94 5.65  
23.6 108.2 147.7 
 
[Fe(dmit)4][OTf]2   (5a) 7.40 5.94  
27.5 111.1 141.8 
 
[Fe(dmit)4][BF4]2  (5b) 8.51 5.81  
23.8 108.9 139.0 
 
dmise 3.71 6.88 
 
37.2 119.7 155.7 
 
Fe(dmise)2Cl2  (2) 3.62 7.19  
37.6 121.9 151.5 
 
[Fe(dmise)2(CH3CN)2][BF4]2 (4) 4.69 6.69  
36.9 114.8 168.6 
 
[Fe(dmise)4][OTf]2   (6a) 6.08 7.26  
28.2 111.4 146.5 
 
[Fe(dmise)4][BF4]2  (6b) 6.41 5.77  
37.0 116.3 132.9 
 
ebit  3.77 7.09, 6.84 4.31 35.2 118.8 162.4 45.6 
{FeCl2(ebit)}n   (7) 3.42 6.71, 6.10 4.71 n.o. n.o. n.o. 54.4 
ebis 3.85 7.30, 7.03 4.07 37.2 119.9 155.8 47.3 
{FeCl2(ebis)}n   (8) 3.81 7.13, 6.94 4.61 n.o. n.o. n.o. n.o. 
n.o. = not observed 
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Figure 2.5. A) 
1
H NMR spectrum and B) 
13
C{
1
H} NMR spectrum of Fe(dmise)2Cl2 (2) in CD3CN. 
for the olefinic resonances upon metal binding have been reported for copper- and 
platinum-thione complexes and attributed to increased aromaticity of the thione ligand 
upon metal binding,
58,59,87
 Fe(II) paramagnetic effects make similar ligand binding trends 
in complexes 1-8 difficult to determine by NMR spectroscopy. Differences in 
1
H NMR 
chemical shifts for 5a/5b and 6a/6b may result from varying cation-anion interactions. 
 Unlike the monodentate dmit complexes, the 
1
H NMR spectrum of {Fe(ebit)Cl2}n 
(7) shows upfield shifts for both the imidazole and methyl resonances, whereas the 
bridging ethylene protons shift downfield compared to unbound ebit.
84
 {Fe(ebis)Cl2}n (8) 
shows similar upfield shifts for the imidazole and methyl resonances and downfield shifts 
for the bridging ethyl resonances compared to unbound ebis.
84
  
Paramagnetic broadening and shifting, particularly for the C=S/Se carbon 
resonance, is also observed in the 
13
C{
1
H} NMR for complexes 1 - 6.  Unlike in the 
1
H 
NMR spectra, methyl resonances ( 27.6 - 37.6) always appear upfield of the olefinic 
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resonances ( 100.1 – 121.9) in the 13C{1H} NMR spectra of these complexes, as 
confirmed by DEPT-90 spectra. Upon Fe(II) binding, the S/Se=C carbon resonances in 
the iron-thione complexes 1, 3, and 5 show upfield shifts of δ 15 to 72 compared 
unbound dmit.  The 
13
C{
1
H} NMR spectrum of Fe(dmise)2Cl2 (2) is shown in Figure 
2.5B, and the C=Se resonance for this complex is shifted upfield by δ 4 compared to 
unbound dmise.
85
 Similar upfield shifts in the C=S/Se
 13
C{
1
H} NMR resonances are also 
observed for Hg(II)- and Cu(I/II)-thione complexes as well as Cu(I/II)-selone 
complexes.
40,58,59,61
 However, Fe(II)-selone complexes 4, 6a, and 6b show significant 
broadening and both upfield and downfield shifts of this resonance relative to that of 
unbound dmise, due to paramagnetic effects from proximity to Fe(II). Most 
13
C{
1
H} 
NMR resonances for complexes 7 and 8 were not observed due to the low solubility of 
these complexes in any solvent.  
Cyclic voltammetry. Electrochemical studies of Cu(I) [Tpm
R
Cu(dmit/dmise)]
+
 
complexes showed that dmit or dmise coordination decreased the Cu(II/I) redox potential 
by 347–847 mV relative to acetonitrile binding.59 If similar thione and selone complexes 
form in vivo, these Cu(II/I) potentials may sufficiently low to prevent Cu(II) reduction by 
NAD(P)H, inhibiting catalytic metal-mediated hydroxyl radical generation.
10,62
 In 
addition, hydrogen-peroxide oxidation studies of [Tpm
Me
Cu(dmit/dmise)]
+
 demonstrated 
that the dmit and dmise ligands oxidize prior to Cu(I).
59
 Thus, electrochemical studies of 
Fe(II)-thione and -selone complexes 1 - 8 were of particular interest to determine whether 
thione and selone coordination significantly alters iron and/or ligand-based 
electrochemical potentials.  
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 The electrochemical behavior of thiones and selones is complex, reflecting the 
redox accessibility typical of sulfur and selenium compounds.  Although these studies are 
conducted in acetonitrile, it is expected that the electrochemical trends would not be 
significantly altered in aqueous solution because these thiones and selones cannot be 
protonated. The cyclic voltammogram of dmit (Figure 2.6A) shows irreversible reduction 
(Epa) and oxidation (Epc) waves at -0.14 and 0.59 V, respectively (Table 2.5). The 
voltammogram of dmise (Figure 2.6A) shows similar irreversible redox behavior (Epa = -
0.15 V and Epc = 0.37 V). However, preventing reduction by starting the negative scan at 
0.30 for dmit or 0.16 V for dmise results in only an oxidation wave (Figure 2.6B), 
indicating that reduction occurs only after oxidation of dmit or dmise to the 
corresponding disulfide or diselenide. This dependence of reduction on prior oxidation 
has been previously reported for methimazole.
88,89
 The two-electron process is confirmed 
in the negative differential pulse voltammogram (DPV) for dmit (Figure 2.27A), where 
two, one-electron waves are observed upon reduction of oxidized dmit. The cyclic 
voltammograms of ebit and ebis (Figure 2.23A) also show irreversible reduction and 
oxidation waves, with a similar dependence of the reduction wave on prior ebit or ebis 
oxidation (Table 2.5 and Figure 2.23B).  The DPV of ebis shows two reduction waves in 
the DPV (Figure 2.29), corresponding to two, one-electron reductions of the oxidized 
product.  Due to the dependence of the reduction waves on prior thione and selone 
oxidation, E1/2 values are not reported for the ligand-based redox potentials in Table 5. 
Dmise and ebis undergo oxidation more readily than dmit and ebit, with an average 
oxidation potential 0.21 V lower than their thione analogs.  
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Figure 2.6. Cyclic voltammograms of 10 mM dmit (dashed) and dmise (solid) with initial potentials of A) 
1.0 V and B)  0.30 V and 0.16 V, respectively, showing dependence of the dmit and dmise reduction wave 
upon prior oxidation. 
  
The cyclic voltammograms of Fe(II)-thione complexes 1, 3, 5a, and 7 (Figures 2.7 
and 2.24) show both ligand-based reduction (Epc) and oxidation (Epa) waves, similar to 
electrochemistry observed for unbound dmit and ebit (Figure 2.23). As is the case for the 
unbound thiones, the thione-based ligand reduction waves are dependent upon prior 
ligand-based oxidation (Figure 2.25). Two, ligand-based, one-electron reductions of the 
oxidized disulfides observed in the negative DPV for 1, 3, 5a, and 7 (Figures 2.31, 2.33, 
2.35, and 2.37).  Fe(II) binding in 1, 3, and 5a increases the dmit-based oxidation and  
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Table 2.5. Redox potentials of selone and thione ligands and their iron complexes versus NHE. 
  
Ligand-
based 
Potentials 
(V) 
FeII/0-based Potentials (V) FeIII/II-based Potentials (V) 
Ligand or Complex Epc
a
  Epa  Epc  Epa  ∆E  E1/2  Epc  Epa  ∆E E1/2  
FeCl2 · 4H2O - - -1.31 -0.24 1.07 -0.78 0.11 0.26 0.15 0.18 
dmit  
-
0.14 
0.59 - - - - - - - - 
Fe(dmit)2Cl2   (1) 0.15 0.69 -1.54 -0.50 1.05 -1.02 -0.55 0.23 0.78 0.16 
[Fe(dmit)2(CH3CN)2][OTf]2   (3) 0.05 0.59 -1.23 -0.09 1.14 -0.66  -  -  -  - 
[Fe(dmit)4][OTf]2   (5a) 0.12 0.69 -1.04 -0.01 0.94 -0.53 -0.52  -  -  -  
dmise 
-
0.15 
0.37 - - - -  -  -  -  - 
Fe(dmise)2Cl2    (2) 0.14 0.41 -1.53 -0.50 1.04 -1.01 -0.57 0.13 0.70 0.22 
[Fe(dmise)2(CH3CN)2][OTf]2   (4) 0.05 0.36 -1.10 -0.10 0.94 -0.63  -  -  -  - 
[Fe(dmise)4][OTf]2   (6a) 0.11 0.36 -1.01 -0.08 0.93 -0.54 -0.40  -   -   -  
ebit  
-
0.01 
0.51 - - - -  -  -  -  - 
{Fe(ebit)Cl2}n   (7) 0.08 0.64 -1.48 -0.55 0.94 -1.02 -0.56 0.19 0.75 -0.18 
ebis 
-
0.27 
0.32 - - - -  -  -  -  - 
{Fe(ebis)Cl2}n   (8) 
-
0.06 
0.38 -1.44 -0.46 0.98 -0.95 -0.60 -0.17 0.43 -0.38 
aLigand and ligand-based reduction potentials are dependent on oxidation to the disulfide and diselenide. 
 
Figure 2.7. Cyclic voltammograms of Fe(dmit)2Cl2 (1; dashed) and Fe(dmise)2Cl2 (2; solid) in acetonitrile. 
Initial scan starting at +1.53 V running negative to -1.67 V. 
reduction potentials by an average of 0.14 and 0.27 V, respectively, compared to 
unbound dmit, indicating that iron-bound dmit is more easily oxidized and reduced.  For 
{Fe(ebit)Cl2}n (7) the ligand-based oxidation wave also increases by 0.13 V, whereas the 
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ligand-based reduction wave decreases by 0.05 V compared to that of unbound ebit.  
 Cyclic voltammograms of Fe(II)-selone complexes 2, 4, 6a, and 8 (Figure 2.7 and 
2.24) also exhibit selone-ligand-based oxidation and reduction waves where the ligand-
based reductive wave is dependent upon prior ligand-based oxidation (Figure 2.25). 
Similar to the Fe-thione complexes, two, selone-based, one-electron reduction waves are 
also observed in the negative DPV for complexes 2, 4, 6a, and 8, and one selone-based 
oxidation wave is observed in their positive DPV spectra (Figures 2.32, 2.34, 2.36, and 
2.38).  Changing the counterion from triflate to tetrafluoroborate in the tetrakis Fe(II)-
dmit and -dmise complexes 5a, 5b, 6a, and 6b does not significantly alter their 
electrochemistry.  
 The cyclic voltammograms of Fe(II)-dmise complexes 2, 4, and 6a have ligand-
based oxidation potentials more negative by an average of 0.15 V relative to Fe(II)-dmit 
complexes 1, 3, and 5a (Table 2.5), indicating that iron-coordinated dmit is more readily 
oxidized than iron-coordinated dmise. When the chlorides in complexes 1 and 2 are 
replaced with solvato ligands in complexes 3 and 4, all ligand-based potentials are 
reduced by 0.05-0.10 V.  Replacing the chlorides in 1 and 2 with additional dmit and 
dmise ligands to form the Fe-tetrakis complexes 5a and 6a results in a slight decrease in 
the dmit-based reduction potential for 5a (-0.03 V) and both dmise-based reduction and 
oxidation potentials for 6a (-0.03 and -0.05 V, respectively).  The cyclic voltammograms 
for polymeric complexes 7 and 8 have ligand-based oxidation potentials for Fe(II)-bound 
ebit and ebis lower than those of Fe(II)-bound dmit and dmise in complexes 1 and 2 by 
an average of 0.40 V, indicating that Fe(II)-bound ebit and ebis are more susceptible to 
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oxidation than Fe(II)-bound dmit and dmise. 
Two-electron, irreversible redox behavior is observed for the Fe(II/0)-derived 
redox potentials (E1/2) in the CV of complexes 1 - 7, whereas the CV of complex 8 only 
exhibits a Fe(II/0)- derived reduction potential. When thione and selone ligands bind 
Fe(II) in 1, 2, 7, and 8, the Fe(II/0)-derived
 
reduction potentials become more negative by 
an average of 0.22 V compared to FeCl2·4H2O (Table 1.5 and Figure 2.26). In contrast, 
the Fe(II)-dmit/dmise acetonitrile complexes 3 and 4 and the tetrakis dmit/dmise 
complexes 5a and 6a show a 0.12-0.25 V increase in Fe(II/0) reduction potentials 
compared to FeCl2·4H2O. The significantly lower Fe(II/0)-derived E1/2 values for the 
dichloride complexes 1, 2, 7, and 8 relative to 3, 4, 5a, and 6a indicate that the chloride 
ligands stabilize Fe(II) relative to additional  dmit, dmise, or acetonitrile ligands. 
The cyclic voltammograms of complexes 1, 2, 7, and 8 also show one-electron, 
quasi-reversible redox waves attributable to Fe(III/II)-derived E1/2 reduction potentials, 
whereas only Fe(III/II)-derived reduction waves are observed for the tetrakis complexes 
5a and 6a (Table 2.5).  Fe(III/II)-derived reduction waves in 5a and 6a and all Fe(III/II)-
derived waves for complexes 3 and 4 are not observed in their voltammograms due to 
overlap with ligand-based waves. When dmit or ebit binds Fe(II) in complexes 1 and 7, 
the Fe(III/II)-derived reduction potentials become substantially more negative by 0.34 
and 0.36 V, respectively, compared to FeCl2·4H2O. When dmise or ebis binds Fe(II) in 
complexes 2 and 8, the Fe(III/II)-derived reduction potentials become even more negative 
by 0.40 and 0.56 V, respectively. The more negative shift for iron-selone Fe(III/II)-
derived reduction potentials compared to those of their thione analogs indicates that 
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selone binding stabilizes Fe(III) more than thione binding. Similar Cu(II) stabilization 
trends upon selone and thione coordination are also observed for Cu(I)-dmit and -dmise 
complexes.
58,59
 
These electrochemical data provide insight into whether similar Fe-thione and 
selone complexes formed in vivo could cycle between Fe(III/II). Complexes with 
reduction potentials lower than -0.32 V (versus NHE) cannot be reduced by cellular 
reductants such as NADH, preventing catalytic hydroxyl radical formation.
62,90
 The 
iron-selone complexes 2 and 8 have Fe(III/II)-derived reduction potentials of -0.22 and 
-0.38 V, respectively, significantly lower potentials than for their iron-thione 
counterparts. This same trend has been previously observed for [Tpm
R
Cu(dmit/dmise)]
+
 
complexes with Cu(II/I) redox potentials ranging from -0.28 to -0.39 V for the copper-
dmise complexes and -0.07 to -0.23 V for copper-dmit complexes.
59
 Selone-copper 
binding shifts Cu(II/I) reduction potentials near or outside the range of cellular 
reductants, but the same cannot be said for dmit- or dmise-iron binding. Although 
Fe(III/II)-derived E1/2 potentials for FeCl2·4H2O are significantly higher than dmit- and 
dmise-bound Fe(II), the Fe(III/II)-derived potentials for 1, 2, and 7 still fall above -0.32 
V, suggesting that similar biological complexes would not inhibit catalytic hydroxyl 
radical formation by Fe(II).  Only the Fe(III/II)-derived E1/2 potential for ebis complex 8 
falls outside the reducing range of NAD(P)H, but biological bidentate selones are not 
known.  However, the significant electrochemical potential differences between ligand-
based thione/selone and Fe(II/III)-derived oxidation potentials for complexes 1, 2, 7, and 
8 (0.46, 0.28, 0.45, and 0.55 V, respectively) suggests that the bound thione or selone 
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would undergo oxidation prior to Fe(II). Thus, thione and selone binding may protect 
Fe(II) from oxidation to Fe(III) by sacrificial ligand oxidation. Overall, our results 
suggest that further investigation of the biological antioxidant behavior of selone and 
thione-containing compounds should explore the role of iron binding. 
 
2.3 Conclusions 
 Biologically relevant Fe(II)-thione and -selone complexes have been synthesized 
and characterized, the first such report of Fe(II)-selone complexes. DFT calculations and
 
1
H and 
13
C{
1
H} NMR studies are consistent with dmit and dmise ligands favoring the 
zwitterionic resonance structures when bound to Fe(II). Cyclic voltammetry studies 
indicate that Fe(II/III)-derived reduction potentials of Fe-thione and most Fe-selone 
complexes fall well within the window of biological reductants such as NADH (-0.32 V 
versus NHE
62
). However, the thione and selone ligands in these Fe(II) complexes have 
significantly higher ligand-based oxidation potentials then their corresponding Fe(II/III)-
derived potentials, suggesting that bound thiones and selones would more readily 
undergo oxidation and potentially protect Fe(II) from oxidation.  Oxidation studies of 
these complexes and of iron bound to other thione and selone ligands, including 
methimazole and 2-mercaptoimidazole, are ongoing. 
 
2.4 Experimental Methods  
General procedures. The handling and synthesis of all iron complexes were 
carried out under an inert atmosphere of nitrogen or argon with dry solvents using 
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standard glove-box and Schlenk techniques. Iron(II) triflate,
91
 dmit,
92
 dmise,
92
 ebit,
68
 and 
ebis
68
 ligands were synthesized following reported procedures. Hydrated iron(II) chloride 
(Acros) and hydrated iron(II) tetrafluoroborate (Acros) were used as received, as were all 
other reagents.  
Instrumentation.  
1
H and 
13
C NMR spectra were obtained on a Bruker-AVANCE 
300 MHz NMR spectrometer. 
1H NMR chemical shifts are reported in δ relative to 
tetramethylsilane (δ 0) and referenced to solvent. 1H NMR and 13C{1H} chemical shifts 
of complexes 1-8 are listed in Table 2.4, and all 
1
H NMR spectra for complexes 1-8 are 
provided in Figures 2.2 and 2.14 – 2.22. Infrared spectra were obtained using Nujol mulls 
on KBr salt plates with a Magna 550 IR spectrometer. Abbreviations used in the 
description of vibrational data are as follows: vs, very strong; s, strong; m, medium; w, 
weak; b, broad. MALDI mass spectrometry experiments were performed using a Bruker 
Microflex MALDI-TOF mass spectrometer with trans-2-[3-(4-tert-butylphenyl)-2-
methyl-2-propenyldiene (250.34 m/z) as the matrix. Electrospray ionization mass 
spectrometry (ESI-MS) was conducted using a SYNAPT G2 LC/MS/MS System from 
Waters via direct injection of sample (0.10 mL/min flow rate) into a Turbo Ionspray 
ionization source. Samples were run under positive mode in acetonitrile, with an ionspray 
voltage of 2500 V and in QTOF scan mode.  All observed peak envelopes match 
theoretical calculations for their ions. UV-vis spectra were collected using a Shimadzu 
UV-3101 PC spectrophotometer in quartz cuvettes with a path length of 1 cm. 
Cyclic voltammetry. A three-compartment cell was used with an Ag/AgCl 
reference electrode, a Pt counter-electrode, and a glassy carbon working electrode. 
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Acetonitrile (distilled and stored over 4Å molecular sieves) was used as solvent with 
tetra-n-butyl ammonium phosphate as the supporting electrolyte. Solutions containing 0.1 
M electrolyte were deaerated for 10 minutes by vigorous nitrogen purge. All E1/2 values 
were calculated from (Epa + Epc)/2 at a scan rate of 100 mV/s. The ferrocenium/ferrocene 
couple was measured under the same conditions to correct for junction potentials. The 
measured potentials were adjusted from Ag/AgCl to NHE (-0.197 V
93
) and then corrected 
with the measured ferrocenium/ferrocene couple vs. NHE (0.400 V
94
).  Cyclic 
voltammograms for unbound ebis and ebit and complexes 1, 2, 5a, 6a, 7, 8, and 
FeCl2∙4H2O are provided in Figures 2.23 - 2.26 and DPV data for all compounds are 
given in Figures 2.27 -2.38). 
Synthesis of Fe(dmit)2Cl2  (1). FeCl2∙4H2O (256 mg, 1.31 mmol) was dissolved in 
triethylorthoformate (5 mL) and to this was added dmit (334 mg, 2.61 mmol) in a mixed 
solvent system of triethylorthoformate/dichloromethane 2:1 (6 mL) via cannula. Upon 
addition of dmise to the FeCl2∙4H2O solution, a brown precipitate immediately formed. 
The reaction mixture was stirred for 6 h, filtered, and dried under vacuum to afford a 
brownish solid. The solid was washed with diethyl ether (10 mL) to afford a pale beige 
solid. Crystals for X-ray analysis were grown via slow vapor diffusion of ether into 
acetonitrile. Yield: 430 mg, 86%. IR (cm
-1
): 3400 (b), 3121 (s), 2925 (s,b), 2728 (w), 
1704 (w), 1559 (w,b), 1563 (s), 1482 (s,b), 1397 (s), 1231 (s), 1176 (s), 1127 (s), 1090 
(s), 1017 (w), 858 (w), 756 (s), 678 (s), 632 (w), 612 (w), 499 (s). UV-vis λmax (nm): 215 
(sh), 255, 303, 352. MALDI-MS (m/z) = 130 [FeCl2H]
+
, 256 [Fe(dmit)Cl2H]
+
, and 349 
[Fe(dmit)2Cl]
+
. Anal. Calcd. for C10H16Cl2FeN4S2: C, 31.35; N, 14.65; H, 4.21. Found: C, 
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31.11; N, 14.36; H, 4.22. Melting point: 189 
o
C (dec.). 
Synthesis of Fe(dmise)2Cl2 (2). Complex 2 was prepared following the procedure 
for 1 except that FeCl2∙4H2O (208 mg, 1.04 mmol) dmise (368 mg, 2.08 mmol) was used 
in place of dmit. Crystals suitable for X-ray analysis were grown via slow vapor diffusion 
of ether into acetonitrile. Yield: 420 mg, 84%. IR (cm
-1
): 3400 (b), 3112 (s), 2919 (b), 
2856 (w), 2723 (w), 1701 (w), 1606 (w), 1564 (vs), 1467 (vs), 1386 (vs), 1226 (m), 1149 
(m), 1090 (m), 864 (w), 752 (w) 664 (w), 468 (w). UV-vis λmax (nm): 232 (sh), 269, 318, 
354. MALDI-MS (m/z) = 130 [FeCl2H]
+
, 304 [Fe(dmise)Cl2H]
+
. Anal. Calcd. for 
C10H16Cl2FeN4Se2: C, 25.18; N, 11.75; H, 3.38. Found: C, 25.08; N, 11.50; H, 3.35. 
Melting point: 147 
o
C (dec.). 
Synthesis of [Fe(dmit)2(CH3CN)2][BF4]2 (3). Complex 3 was prepared following 
the procedure for 1 except that Fe(BF4)2
.
6H20 (297 mg, 0.176 mmol) instead of 
FeCl2∙4H2O and dmit (226 mg, 0.176 mmol) was used. The acetonitrile reaction mixture 
was stirred for 4 h, and the solvent was reduced to 5 mL. The product was precipitated 
with diethyl ether to afford a peach colored solid that was air-dried under argon. Yield: 
321.3 mg, 70%. 
1
H and 
13
C{
1
H} NMR resonances for the bound acetonitrile ligands were 
not observed, likely due to a combination of paramagnetic line broadening and exchange 
with CD3CN. IR (cm
-1
): 3165 (w), 2925 (s,b), 2726 (w), 2372 (w), 2343 (w), 1568 (m), 
1488 (w), 1460(s), 1397 (w), 1376 (m), 1303 (w), 1239 (m), 1177 (m), 1054 (s), 743 (m), 
675 (w). UV-vis λmax (nm): 217 (sh), 256, 324. ESI-MS (m/z) = 197.24 
[Fe(dmit)2(CH3CN)2]
2+
. Anal. Calcd. for C14H22B2F8FeN6S2C14H22B2F8FeN6S2: C, 29.61; 
N, 14.80; H, 3.90. Found: C, 29.96; N, 14.90; H, 4.01. Melting point: 188
o
C (dec.). 
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Synthesis of [Fe(dmise)2(CH3CN)2][BF4]2 (4). Compound 4 was prepared 
following the procedure for 3 except for dmise (308.7 mg, 1.41 mmol) was used in place 
of dmit yielding a yellow solid. Yield: 327.9 mg, 70%. 
1
H and 
13
C{
1
H} NMR resonances 
for the bound acetonitrile ligands were not observed, likely due to a combination of 
paramagnetic line broadening and exchange with CD3CN. IR (cm
-1
): 3463 (s,b), 3138 
(w), 2926 (s,b), 2727 (w), 2673 (w), 2370 (w), 2344 (w), 2315 (w), 2267 (w), 1654 (m), 
1568 (m), 1448(w), 1457 (s), 1377 (s), 1288 (w), 1240 (m), 1153 (m), 1066 (s,b), 754 
(w), 742 (w), 723 (w), 662 (m). ESI-MS (m/z) = 268.72 [Fe(dmise)2(CH3CN)2]
2+
. Anal. 
Calcd. for C14H22B2F8FeN6Se2FeN6Se2: C, 25.41; N, 12.70; H, 3.35. Found: C, 25.32; N, 
12.65; H, 3.29. Melting point: 188
o
C (dec.). 
Synthesis of [Fe(dmit)4][OTf]2  (5a). Fe(OTf)2 (102.4 mg, 0.288 mmol) was 
dissolved in acetonitrile (5 mL), and to this was added dmit (147.7 mg, 1.153 mmol) in 
acetonitrile (10 mL) via cannula. The solution was stirred for 12 h, and the solvent was 
reduced to 5 mL. The product was precipitated with diethyl ether then dried under 
vacuum, affording a yellow solid. Yield: 175 mg, 70%. IR (cm
-1
): 3400 (b), 3121 (s) 
2925 (s,b), 2727 (w), 1706 (w), 1557 (w,b), 1565 (s), 1483 (s,b), 1395 (s), 1232 (s), 1177 
(s), 1127 (s), 1090 (s), 1016 (w), 859 (w), 755 (s), 676 (s), 633 (w), 613 (w), 498 (s).  
UV-vis λmax (nm): 217 (sh), 256, 324. MALDI-MS (m/z) = 284.4 [Fe(dmise)4]
2+
. Anal. 
Calcd. for C22H32F6FeN8O6S4C22H32F6 FeN8O6S4: C, 30.49; N, 12.93; H, 3.72. Found: C, 
30.26; N, 12.80; H, 3.73. Melting point: 188 
o
C (dec.). 
Synthesis of [Fe(dmit)4][BF4]2  (5b). Complex 5b was prepared following the 
procedure for 5a, except Fe(BF4)2
.
6H2O (226 mg, 0.670 mmol) was used in place of 
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Fe(OTf)2 and more dmit (345 mg, 2.69 mmol) was used. Crystals suitable for X-ray 
crystallography were grown via slow diffusion of ether into acetonitrile. Yield: 370 mg, 
74%. IR (cm
-1
): 3433 (s,b), 3168 (m), 3141 (m), 3115 (w), 2920 (s,b), 2729 (w), 1569 (s), 
1490 (w), 1463 (w), 1399 (s), 1377 (s), 1241 (m), 1178 (m), 1056 (b), 1015 (w), 850 (w), 
801 (w), 746 (s), 677 (m), 521 (m), 499 (m). UV-vis λmax (nm): 217 (sh), 256, 324. 
MALDI-MS (m/z) = 284.4 [Fe(dmise)4]
2+
. Anal. Calcd. for C20H32B2F8FeN8S4: C, 32.26; 
N, 15.15; H, 4.35. Found: C, 25.82; N, 12.02; H, 3.53. Melting point: 188 
o
C (dec.). 
Synthesis of [Fe(dmise)4][OTf]2 (6a). Complex 6a was prepared following the 
procedure for 5a except that dmise (168 mg, 1.30 mmol) was used in place of dmit. 
Yield: 213 mg, 85%.  IR (cm
-1
): 3400 (b), 3122 (s) 2926 (s,b), 2727 (w), 1705 (w), 1556 
(w,b), 1563 (s), 1483 (s,b), 1398 (s), 1233 (s), 1151 (s), 1128 (s), 1092 (s), 1015 (w), 858 
(w), 756 (s), 678 (s), 633 (w), 612 (w), 497 (s).  UV-vis λmax (nm): 233 (sh), 267, 240. 
MALDI-MS (m/z) = 378.1 [Fe(dmise)4]
2+
. Anal. Calcd. for 
C22H32F6FeN8O6S2Se422FeN8O6S2Se4: C, 25.06; N, 10.63; H, 3.06. Found: C, 24.55; N, 
10.45; H, 3.00. Melting point: 188 
o
C (dec.). 
Synthesis of [Fe(dmise)4][BF4]2 (6b). Complex 6b was prepared following the 
procedure for 5b except Fe(BF4)2
.
6H2O (180.9 mg, 0.536 mmol) and dmise (0.377 mg, 
214 mmol) was used in place of dmit. Crystals suitable for X-ray analysis were grown via 
slow vapor diffusion of ether into acetonitrile. Yield: 400 mg, 80%. IR (cm
-1
): 3166 (w), 
3139 (w), 3112 (w), 2913 (s,b), 2727 (w), 1708 (w), 1569 (m), 1488 (w), 1463 (s,b), 1378 
(m), 1344 (w), 1287 (w), 1240 (m), 1155 (w), 1052 (b), 861 (w), 754 (m), 663 (m), 614 
(w), 521 (w), 470 (w).  UV-vis λmax (nm): 233 (sh), 267, 240. MALDI-MS (m/z) = 378.1 
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[Fe(dmise)4]
2+
. Anal. Calcd. for C20H32B2F8FeN8Se4: C, 25.83; N, 12.05; H, 3.47. Found: 
C, 25.82; N, 12.02; H, 3.53. Melting point: 188 
o
C (dec.). 
Synthesis of {Fe(ebit)Cl2}n (7). FeCl2
.
4H2O (130.5 mg, 0.65 mmol) was dissolved 
in triethyl orthoformate (5 mL) and to this was added ebit (160.9 mg, 0.65 mmol) in a 
mixed solvent system of triethyl orthoformate/dichloromethane (6 mL; 2:1) via cannula. 
Upon addition of dmise to FeCl2
.
4H2O a precipitate was immediately formed. The 
reaction was stirred for 6 h, filtered and dried under vacuum to afford a tan solid. Crystals 
suitable for X-ray analysis were grown via slow vapor diffusion of ether into acetonitrile. 
Yield: 237.5 mg, 95%. %. IR (cm
-1
): 3400 (b), 3147 (m), 3100 (m), 3027 (s), 2925 (b), 
2855 (w), 2724 (s), 1720 (s), 1610 (s), 156s (m), 1464 (s), 1385 (s), 1318 (m), 1263 (vs), 
1231 (s), 1211 (s), 1152 (m), 1089 (s), 1072 (s), 953 (s), 869 (s), 789 (vs), 764 (m), 750 
(m), 679 (s), 662 (s), 649 (s), 605 (vs), 501 (m). UV-vis λmax (nm): 231 (sh), 262, 326. 
MALDI-MS (m/z) = 345.35 [Fe(ebit)Cl]
+
, 380.96 [Fe(ebit)Cl2]H
+
, 504.35 
[Fe2(ebit)Cl4]H
+
, 599.11 [Fe(ebit)2Cl]
+
, 724.92 [Fe2(ebit)2Cl3]
+
. Anal. Calcd. for 
C10H14Cl2FeN4S2: C, 31.51; N, 14.70; H, 3.70. Found: C, 31.41; N, 14.61; H, 3.75 
Melting point: 220 
o
C (dec.). 
Synthesis of {Fe(ebis)Cl2}n (8). Compound 8 was prepared following the same 
procedure as 7 except that ebis (183.8 mg, 0.52 mmol) was used in place of ebit. Crystals 
suitable for X-ray analysis were grown via slow vapor diffusion of ether into acetonitrile. 
Yield: 195 mg, 78% of a yellow powder. IR (cm
-1
): 3368 (b), 3146.8 (s), 3091 (s), 2894 
(b), 2728 (s), 1717 (s), 1564 (s), 1462 (m), 1405 (vs), 1377 (vs), 1244 (m), 1211 (vs), 
1174 (vs), 1139 (s), 1091 (vs), 1075 (vs), 1020 (vs), 802 (s), 758 (s), 742 (vs), 714 (vs), 
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673 (m), 622 (vs), 487 (vs). UV-vis λmax (nm): 232 (sh), 271, 360. MALDI-MS (m/z) = 
476.83 [Fe(ebis)Cl2H]
+
, 600.163 [Fe2(ebis)Cl4]H
+
. Anal. Calcd. for C10H14Cl2FeN4Se2: C, 
25.29; N, 11.80; H, 2.97. Found: C, 25.30; N, 11.76; H, 3.05. Melting point: 210
o
C 
(dec.). 
 Single crystal X-ray data collection. Single crystals of Fe(dmit)2Cl2 (1), 
crystallized as colorless rods, Fe(dmise)2Cl2 (2), crystallized as brown rods, 
[Fe(dmit)4][BF4]2 (5b), crystallized as colorless prisms, and [Fe(dmise)4][BF4]2 (6b), 
crystallized as light green prisms, were grown from vapor diffusion of diethyl ether into 
an acetonitrile solution, were mounted on a glass filament with epoxy glue, and 
immediately placed on the diffractometer in a room-temperature nitrogen gas stream. 
Intensity data were collected using a Rigaku Mercury CCD detector and an AFC8S 
diffractometer. The space groups P21/n, P21/n, Pbcn, and Pbcn were determined from the 
systematic absences for complexes 1, 2, 5b, and 6b respectively (Table 6). Fluorine 
atoms around the boron centers in 5b were disordered based on residual electron density 
identified in this region during refinements. Data reduction, including application of 
Lorentz and polarization effects and absorption corrections, was performed using the 
CrystalClear
95
 program. The structures were solved by direct methods and subsequent 
Fourier difference techniques, and refined anisotropically, by full-matrix least squares, on 
F
2
 using SHELXTL 6.10.
96,97
  The quantity minimized by the least squares program was 
Σw = (Fo
2
 - Fc
2
)
2
 where w = {[σ2(Fo
2
)]+(0.0307P)
2
 + 1.57P} where P = (Fo
2
)+2Fc
2
)/3. In 
the final cycle of least squares, independent anisotropic displacement factors were refined 
for the non-hydrogen atoms, and hydrogen atoms were fixed in idealized positions with 
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Table 2.6. Summary of crystallographic data for complexes 1, 2, 5b, and 6b. 
  1 2 5b 6b 
Chemical formula C10H16Cl2FeN4S2 C10H16Cl2FeN4Se2 C20H32B2N8F8FeS4 C20H32B2N8F8FeSe4 
F.W. (g/mol
-1
) 383.14 476.94 742.25 941.83 
Space group P21/n P21/n Pbcn Pbcn 
Crystal system monoclinic monoclinic orthorhombic orthorhombic 
a, Å  9.416 (2) 9.1566 (19) 12.022 (2) 12.0512 (2) 
b, Å 13.653 (2) 13.693 (3) 21.648 (4) 21.7092 (4) 
c, Å 13.120 (3) 13.279 (3) 12.825 (3) 13.1986 (3) 
α, deg 90 90 90 90 
β, deg 109.477 (8) 108.25 (3) 90 90 
γ, deg 90 90 90 90 
V, Å
-3
 1590.6 (6) 1643.4 (6) 3337.7 (12) 3453.04 (12) 
Z 4 4 4 4 
Dcal, mg/m
3
 1.6 1.928 1.477 1.798 
indices (min) [-11, -16, -10] [-11, -16, -16] [-14, -25, -14] [-14, -23, -15] 
indices (max) [11, 15, 15] [11, 17, 16] [14, 25, 15] [14, 25, 15] 
parameters 176 176 233 231 
F(000) 784 928 1520 1808 
μ, mm-1 1.54 5.66 0.77 4.72 
2θ range, deg 2.7-26.4 2.7-26.4 3.0-25.3 2.4-30.3 
collected reflections 9758 15290 26627 33185 
unique reflections 2844 3351 3026 3060 
Final R (obs. data)
a
 R1 0.0734 0.0276 0.0481 0.0475 
wR
2
 0.1576 0.0641 0.1305 0.1210 
final R(all data), R1 0.0945 0.0276 0.0550 0.0578 
wR
2
 0.1798 0.0659 0.1417 0.1333 
goodness of fit (S) 1.1 1.14 1.10 1.093 
largest diff. peak 0.755 0.611 0.453 0.597 
largest diff. hole -0.689 -0.68 -0.334 -0.557 
a
 R1 = Σ ǁ F0| - |Fcǁ/Σ|F0|; wR
2
 = {Σw(F0
2
 - Fc
2
)
2
}
1/2. 
  C—H = 0.96 Å. Isotropic hydrogen atom displacement parameters were set equal to 1.5 
times Ueq of the attached carbon atom.  
For 1, the largest peak in the final Fourier difference map (0.76 e A
-3
) was located 
1.240 Å from Cl2 and the lowest peak (-0.69 e∙A-3) was located at a distance of 0.89 Å 
from Fe1. For 2 the largest peak in the final Fourier difference map (0.61 e A
-3
) was 
located 1.128 Å from H3A and the lowest peak (-0.68 e A
-3
) was located at a distance of 
0.80 Å from Se2. For 5b the largest peak in the final Fourier difference map (0.45 e A
-3
) 
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was located 1.128 Å from Fe1 and the lowest peak (-0.33 e A
-3
) was located at a distance 
of 0.83 Å from Fe1. For 6b the largest peak in the final Fourier difference map (0.60 e A
-
3
) was located 0.89 Å from Se1 and the lowest peak (-0.56 e A
-3
) was located at a 
distance of 0.84 Å from Se1. 
 DFT calculations. Geometries were optimized using the mPW1PW91
98
 exchange 
correlation functional in Gaussian 09.
99
 Iron was represented by the Wachters-Hay all-
electron basis set.
100,101
 Sulfur and selenium basis sets were represented by the Wadt-Hay 
relativistic effective core potential basis set
102
 modified to include a set of diffuse and 
polarization functions. Carbon, oxygen, nitrogen and hydrogen basis sets were of triple- 
quality augmented with diffuse and polarization functions.
103
 All structures were 
confirmed as minima on the potential energy surface through analysis of the vibrational 
frequencies.  
Crystallization attempts with {Fe(ebit)Cl2}n (7) and {Fe(ebis)Cl2}n (8) and X-ray 
structure of 7. Crystal growth for the polymeric complexes 7 and 8 was attempted by 
vapor diffusion of ether into acetonitrile, dichloromethane, and mixtures of these solvents 
at both room and low temperatures as well as evaporation of acetonitrile and 
dichloromethane solutions. Small crystals were obtained only in low yields for 
{Fe(ebit)Cl2}n (7), and its structure was determined using the best available crystal of the 
limited selection.  Complex 7 crystallizes in space group P21/c with a = 7.717(3), b = 
16.526 (5), c = 15.059(5) Å, and β = 104.36(1)°, and the structure and crystal data are 
provided in Fig. S5 and Tables S1 and S2. Fe(II) ions are in a distorted tetrahedral 
coordination environment with angles ranging from 93.0(1)° to 114.4(1)°, an average Fe-
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Cl distance of 2.275(3) Å, and an average Fe-S distance of 2.366(3) Å, similar to values 
observed in complex 1 and slightly shorter than {Fe(L
1
/L
2
)Cl2}n complexes (L
1
 = 1,1’-
methylenebis(3-methyl-imidazole-2-thione and L
2
 = 1,1’-methylenebis(3-tertbutyl-
imidazole-2-thione) with average Fe-S bond lengths of 2.3725(5) Å and 2.3819(5) Å, 
respectively.
1
 The ebit ligands bridge symmetry-related Fe atoms through the Fe-S bonds, 
propagating the structure in a chain-like fashion, similar to the polymeric {Fe(L
1
/L
2
)Cl2}n 
complexes.
1
 The chains are connected by C-H---Cl intermolecular hydrogen bonding 
(Figure 2.13) as well as hydrogen bonding with a crystallized acetonitrile molecule. The 
average bond lengths for ebit in complex 7 do not differ from those of the unbound ebit 
ligand.
2
 
 
 
Figure 2.8. Crystal packing diagram for Fe(dmit)2Cl2 (1) showing short Cl-Cl and Cl-H interactions as 
viewed along the a-axis with 50% probability density ellipsoids. 
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Figure 2.9. Crystal packing diagram for Fe(dmise)2Cl2 (2) showing short Cl-H interactions as viewed along 
the a-axis with 50% probability density ellipsoids. 
 
Figure 2.10. Crystal packing diagram for [Fe(dmit)4][BF4]2 (5b) showing short F-H interactions as viewed 
along the a-axis with 50% probability density ellipsoids  
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Figure 2.11. Crystal packing diagram for [Fe(dmise)4][BF4]2 (6b) showing short F-H interactions as 
viewed along the a-axis with 50% probability density ellipsoids. 
 
 
Figure 2.12. Crystal structure diagram with 50% probability density ellipsoids for {Fe(ebit)Cl2}n (7). 
Hydrogen atoms are omitted for clarity. 
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Figure 2.13. Crystal packing diagram for {Fe(ebit)Cl2}n (7) showing short Cl-H interactions as viewed 
along the a-axis with 50% probability density ellipsoids. 
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Table 2.7. Summary of crystallographic data for {Fe(ebit)Cl2}n (7). 
Parameter Value 
Chemical formula C12H17Cl2FeN5S2 
F.W. (g/mol
-1
) 422.18 
Space group P21/c 
Crystal system monoclinic 
a,Å 7.717 (3) 
b,Å 16.526 (5) 
c,Å 15.059 (5) 
α, deg 90 
β, deg 104.363 (12) 
γ, deg 90 
V,Å
-3
 1860.5 (12) 
Z 4 
Dcal, mg/m
3
 1.507 
indices (min) [-9, -19, -17] 
indices (max) [6, 19, 17] 
parameters 202 
F(000) 864 
μ, mm-1 1.32 
2θ range, deg 2.5-25.1 
collected reflections 11826 
unique reflections 3275 
final R(obs. data)
a
, R1 0.097 
wR2 0.343 
final R (all data), R1 0.126 
wR2 0.393 
goodness of fit (S) 1.49 
largest diff. peak 3.00 
largest diff.  hole -0.92 
a
 R1 = Σ ǁ F0| - |Fcǁ/Σ|F0|; wR2 = {Σw(F0
2
 - Fc
2
)
2
}
1/2
. 
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Table 2.8. Selected bond lengths and angles for {Fe(ebit)Cl2}n (7). 
Bond lengths (Å) Bond angles (
o
) 
Fe1—S1 2.362 (3) Cl1—Fe1—S1 111.23 (12) 
Fe1—S2 2.371 (3) Cl2—Fe1—S1 111.06 (13) 
Fe1—Cl1 2.271 (3) Cl1—Fe1—S2 111.48 (11) 
Fe1—Cl2 2.281 (3) Cl2—Fe1—S2 114.42 (12) 
S1—C1 1.723 (10) S1—Fe1—S2 92.95 (10) 
S2—C6 1.737 (11) C1—S1—Fe1 103.1 (3) 
  C6—S2—Fe1 102.4 (3) 
  Cl1—Fe1—Cl2 113.90 (12) 
 
 
 
Figure 2.14. 
1
H NMR spectrum of Fe(dmit)2Cl2 (1) in CD3CN. Spectra were acquired from δ -10 to 20 and 
no additional signals were observed. The asterisk indicates the resonance from residual CH3CN solvent. 
 
* 
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Figure 2.15. 
1
H NMR spectrum of [Fe(dmit)2(CH3CN)2][BF4]2 (3) in CD3CN. Spectra were acquired from 
δ -10 to 20 and no additional signals were observed. The asterisk indicates the residual CH3CN solvent 
resonance. 
 
Figure 2.16. 
1
H NMR spectrum of [Fe(dmise)2(CH3CN)2][BF4]2 (4) in CD3CN. Spectra were acquired from 
δ -10 to 20 and no additional resonances were observed. The asterisk indicates the resonance from residual 
CH3CN solvent. 
*
* 
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Figure 2.17. 
1
H NMR spectrum of  [Fe(dmit)4][OTf]2 (5a) in CD3CN. Spectra were acquired from δ -10 to 
20 and no additional signals were observed. The asterisk indicates the residual CH3CN solvent resonance. 
 
Figure 2.18.. 
1
H NMR spectrum of [Fe(dmise)4][OTf]2 (6a) in CD3CN. Spectra were acquired from δ -10 
to 20 and no additional signals were observed. The asterisk indicates the residual CH3CN solvent 
resonance. 
* 
* 
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Figure 2.19. 
1
H NMR spectrum of [Fe(dmit)4][BF4]2 (5b) in CD3CN. Spectra were acquired from δ-10 to 
20 and no additional signals were observed. The asterisk indicates the residual CH3CN solvent resonance. 
 
Figure 2.20. 
1
H NMR spectrum of [Fe(dmise)4][BF4]2 (6b) in CD3CN. Spectra were acquired from δ -10 to 
20 and no additional signals were observed.  The asterisk indicates the residual CH3CN solvent resonance. 
* 
* 
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Figure 2.21. 
1
H NMR spectrum of {Fe(ebit)Cl2}n (7) in CD3CN. Spectra were acquired from δ -10 to 20 
and no additional signals were observed except a residual CH3CN resonance at δ 1.94. 
 
 
Figure 2.22. 
1
H NMR spectrum of {Fe(ebis)Cl2}n (8) in CD3CN. Spectra were acquired from δ -10 to 20 
and no additional signals were observed. The asterisk indicates the residual CH3CN solvent resonance.. 
* 
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Figure 2.23. Cyclic voltammetry with initial starting potential at A) 0.94 V for ebis (solid) and 0.80 V for 
ebit (dashed) and B) 0.09 V for ebis (solid) and 0.26 V for ebit (dashed). 
 
Figure 2.24. Cyclic voltammograms of A) [Fe(dmit)2(CH3CN)2][OTf]2 (3; dashed line) and 
[Fe(dmise)2(CH3CN)2][OTf]2 (4; solid line) starting at 1.53 V; B) [Fe(dmit)4][OTf]2 (5a; dashed) and 
[Fe(dmise)4][OTf]2 (6a; solid) starting at 1.49 V; and C) {Fe(ebit)Cl2}n (7; dashed) and {Fe(ebis)Cl2}n (8; 
solid) starting at 1.48 V. All data were collected with 10 mM complex in acetonitrile.  
108 
 
 
Figure 2.25. Cyclic voltammograms of A) Fe(dmit)2Cl2 (1; dashed) and Fe(dmise)2Cl2 (2; solid) starting at 
0.5 V for 1 and 0.15 V for 2, respectively; B) [Fe(dmit)2(CH3CN)2][OTf]2 (3; dashed) and 
[Fe(dmise)2(CH3CN)2[OTf]2 (4; solid) starting at 0.4 V for 3 and 0.15 V for 4, respectively; C) 
[Fe(dmit)4][OTf]2 (5a; dashed) and [Fe(dmise)4][OTf]2 (6a; solid) starting at 0.45 V for 5a and 0.15 V for 
6a, respectively; and D) {Fe(ebit)Cl2}n (7; dashed) and {Fe(ebis)Cl2}n (8; solid) starting at 0.25 V for 7 and 
0.10 V for 8. All data were collected with 10 mM complex in acetonitrile. 
 
Figure 2.26. Cyclic voltammogram for FeCl2∙4H2O (10 mM) in acetonitrile starting at 1.48 V. 
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Figure 2.27. Differential pulse voltammograms of dmit (10 mM) in acetonitrile: A) negative mode and B) 
positive mode; potentials are reported vs. NHE. 
 
Figure 2.28. Differential pulse voltammograms of dmise (10 mM) in acetonitrile: A) negative mode and B) 
positive mode; potentials are reported vs. NHE. 
 
Figure 2.29. Differential pulse voltammograms of ebit (10 mM) in acetonitrile: A) negative mode and B) 
positive mode; potentials are reported vs. NHE. 
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Figure 2.30. Differential pulse voltammograms of ebis (10 mM) in acetonitrile: A) negative mode and B) 
positive mode; potentials are reported vs. NHE. 
 
Figure 2.31. Differential pulse voltammograms of Fe(dmit)2Cl2 (1; 10 mM) in acetonitrile: A) negative 
mode and B) positive mode; potentials are reported vs. NHE. 
 
Figure 2.32. Differential pulse voltammograms of Fe(dmise)2Cl2 (2; 10 mM) in acetonitrile: A) negative 
mode and B) positive mode; potentials are reported vs. NHE. 
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Figure 2.33. Differential pulse voltammograms of [Fe(dmit)2(CH3CN)2][OTf]2 (3; 10 mM) in acetonitrile: 
A) negative mode and B) positive mode; potentials are reported vs. NHE. 
 
Figure 2.34. Differential pulse voltammograms of [Fe(dmise)2(CH3CN)2][OTf]2 (4; 10 mM) in acetonitrile: 
A) negative mode and B) positive mode; potentials are reported vs. NHE. 
 
Figure 2.35. Differential pulse voltammograms of [Fe(dmit)4][OTf]2 (5a; 10 mM) in acetonitrile: A) 
negative mode and B) positive mode; potentials are reported vs. NHE. 
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Figure 2.36. Differential pulse voltammograms of [Fe(dmise)4][OTf]2 (6a; 10 mM) in acetonitrile: A) 
negative mode and B) positive mode; potentials are reported vs. NHE. 
 
Figure 2.37. Differential pulse voltammograms of {Fe(ebit)Cl2}n (7; 10 mM) in acetonitrile: A) negative 
mode and B) positive mode; potentials are reported vs. NHE. 
 
Figure 2.38. Differential pulse voltammograms of {Fe(ebis)Cl2}n (8; 10 mM) in acetonitrile: A) negative 
mode and B) positive mode; potentials are reported vs. NHE. 
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CHAPTER THREE 
OXIDATION OF FE(II)-THIONE AND –SELONE COMPLEXES WITH 
HYDROGEN PEROXIDE: A MECHANISTIC STUDY 
 
3.1. Introduction 
 In human cells under oxidative stress conditions, the cellular pathways used to 
maintain iron homeostasis and non-protein-bound iron concentrations in the 1-30 µM
1-6
 
range become overwhelmed, leading to an increase in non-protein-bound iron (100 - 
1000 µM
7
). More Fe
2+
 can result in overproduction of the hydroxyl radial (Reaction 1) 
and an increase in iron-mediated DNA damage, the primary cause of cell death under 
oxidative stress conditions.
5,8-10
 The resulting oxidative stress, DNA damage, and cell 
death is an underlying cause of cardiovascular diseases, neurodegenerative diseases, and 
cancer.
11-17
 
 Fe
2+
 + H2O2 → Fe
3+
 + 
•
OH + OH
-
    (1) 
 Antioxidants are of significant interest for prevention of damage caused by 
reactive oxygen species (ROS) and diseases caused by oxidative stress.
14,17-19
 Discovery 
of the antioxidant properties of thione (C=S) and selone (C=Se) compounds arose from 
studies of the amino acid ergothioneine and, more recently, its selone analog, selenoneine 
(Figure 3.1). Ergothioneine prevents copper-mediated oxidative deoxyribose damage
20
 
and scavenges ROS.
21-23
 Selenoneine also is a potent radical scavenger in 2,2-diphenyl-1- 
picrylhydrazyl (DPPH) studies
24
 and also binds Fe
2+
 in hemoglobin and myoglobin, 
preventing iron oxidation.
24-28
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Figure 3.1. Thione and selone antioxidants. 
 
N,N’-dimethylimidazole thione (dmit) and selone (dmise; Figure 3.1), compounds 
with structures similar to ergothioneine and selenoneine, are also antioxidants, preventing 
iron- and copper-mediated DNA damage in in vitro gel electrophoresis assays.
29
 Copper 
generates ROS and causes DNA damage in a manner similar to iron.
30-32
 Previous 
copper-coordination studies with [Tpm
R
Cu(dmit/dmise)] (R = H, CH3, iPr) complexes 
demonstrate that when bound to Cu
+
, dmit and dmise binding decreases the Cu
2+/+
 redox 
potentials by 374 - 874 mV relative to acetonitrile binding.
33
 Although dmit binding 
lowers the Cu
2+/+
 redox potentials in these complexes to 70 to -232 mV,
33
 they still fall 
within the range that the cellular reductant NADH can reduce Cu
2+
 to ROS-producing 
Cu
+
 (-324 mV vs NHE
34
).  In contrast, dmise binding lowers the Cu
2+/+
 redox potentials 
in these complexes to -283 to -390 mV
33
), sufficiently low enough that dmise binding 
might prevent Cu
2+
 reduction by NADH, inhibiting catalytic copper-mediated hydroxyl 
radical generation.
32,35
  
Oxidation studies of [Tpm
Me
Cu(dmit/dmise)]
+
 complexes with H2O2 in 
acetonitrile solution have shown that dmit and dmise undergo sacrificial oxidation to 
form imidazolium cation, and [S/SeO2H]
-
 species in addition to [Tpm
Me
Cu(CNCH3)]
+
 
(Reaction 2).
36
 This sacrificial thione or selone oxidation protects Cu
+
 from oxidation.
36
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Electrochemical studies of Fe(dmit/dmise)2Cl2 complexes (Chapter 2) have 
established that ligand-based, Fe
2+
-bound dmit and dmise potentials (0.41 and 0.59 V; 
respectively) are significantly higher than the metal-based Fe
2+/3+
oxidation potentials of 
these complexes (0.16 and 0.22 V, respectively).
37
 This large electrochemical difference 
suggests that Fe
2+
-bound dmit or dmise would undergo oxidation prior to Fe
2+
 oxidation 
to Fe
3+
. Thus, thione and selone binding may protect Fe
2+
 from oxidation to Fe
3+
 by 
sacrificial ligand oxidation.
37
 
To provide proof of this ROS-scavenging antioxidant mechanism for Fe
2+
-bound 
thione and selone complexes, Fe(dmit)2Cl2 and Fe(dmise)2Cl2 were treated with up to six 
equivalents of hydrogen peroxide (H2O2) and characterized by 
1
H and 
13
C{
1
H} NMR 
spectroscopy, MALDI-MS, and ESI-MS to identify their products of oxidation. These 
studies will provide insight into metal-coordination antioxidant mechanisms to aid in the 
development of more effective thione and selone antioxidants and may shed light on the 
antioxidant activity of biologically relevant thiones and selones.  
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3.2. Results and Discussion 
Reactivity of Fe(dmit)2Cl2 and Fe(dmise)2Cl2 with H2O2. Fe(dmit)2Cl2 and 
Fe(dmise)2Cl2 were dissolved in acetonitrile and treated with 1, 2, 4, and 6 equivalents of 
H2O2.  Upon addition of one equivalent of H2O2, both the Fe(dmit)2Cl2 and Fe(dmise)2Cl2 
reactions changed color from light yellow to nearly colorless, and the Fe(dmit)2Cl2 
reaction forms a dark reddish-brown precipitate, while the Fe(dmise)2Cl2 solution forms a 
orange/light red precipitate. Due to this precipitate formation, the acetonitrile in these 
reaction mixtures was removed under vacuum and the resulting solid was completely 
dissolved in deuterated dimethylsulfoxide for NMR studies. 
 Prior to H2O2 treatment, the 
1
H NMR spectrum of Fe(dmit)2Cl2 (Figure 3.2A) 
shows single methyl and olefinic proton resonances at δ 3.33 and 6.94, respectively. 
Upon treating Fe(dmit)2Cl2 with 1 equivalent of H2O2, these 
1
H NMR resonances (Figure 
3.2A) show significant broadening with unobservable resonances for oxidized products,  
 
Figure 3.2. 
1
H NMR spectra in (CD3)2SO for A) Fe(dmit)2Cl2, B) Fe(dmise)2Cl2 upon H2O2 treatment, and 
C) the resonance labeling scheme, with the primary symbol indicating resonances arising from oxidation. 
Residual H2O resonances are labeled with an asterisk. 
C
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due to Fe
3+
 paramagnetic effects as Fe
2+
 is oxidized. Upon treatment with 2 equivalents 
of H2O2, a new set of resonances emerge the 
1
H NMR spectrum at δ 3.75, 7.57, and 8.40, 
corresponding to N,N’-dimethylimidazolium cation formation as the S=C bond is 
cleaved. Similar imidazolium cation formation was observed upon H2O2 oxidation of 
[Tpm*Cu(dmit)]
+
.
36
 Upon addition of 4 equivalents of H2O2 to Fe(dmit)2Cl2, 63% of 
bound dmit becomes oxidized, based on olefinic proton resonance integrations. After 
adding 6 equivalents of H2O2, no distinguishable 
1
H NMR resonances are observed due 
to broadening of all resonances into the baseline from the extreme paramagnetism of Fe
3+
 
in the sample. Thus, dmit binding does not fully protect Fe
2+
 from oxidation under these 
conditions. 
The 
1
H NMR spectrum of Fe(dmise)2Cl2 prior to H2O2 treatment (Figure 3.2B) 
shows methyl and olefinic proton resonances at δ 3.55 and 7.51, respectively. The 1H 
NMR spectrum of Fe(dmise)2Cl2, upon treatment with 1 equivalent of H2O2, shows the 
emergence of three new resonances at δ 3.83, 7.68, and 9.10, similar to those observed 
upon oxidation of the iron-dmit complex and indicating imidazolium formation. The 
difference in imidazolium resonance shifts in H2O2-oxidized Fe(dmit)2Cl2 (δ 8.40) 
compared to oxidized Fe(dmise)2Cl2 (δ 9.10) may be due to the greater Fe
3+
 paramagnetic 
effects observed during Fe(dmit)2Cl2 oxidation. Upon addition of 4 equivalents of H2O2 
to Fe(dmise)2Cl2, the 
1
H NMR spectrum shows 85% oxidation of the iron- bound dmise 
ligands based on olefinic integrations. When treated with 6 equivalents of H2O2, the 
1
H 
NMR spectrum of Fe(dmise)2Cl2 shows 100% oxidation and a significant increase in 
resonance breadth, indicating significant oxidation of Fe
2+ 
to Fe
3+
.   
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The 
1
H NMR resonances of Fe(dmise)2Cl2 do not significantly broaden upon 
treatment with up to 4 equivalents of H2O2, unlike those of Fe(dmit)2Cl2 that broadened 
upon treatment with only one equivalent of H2O2, indicating that dmise binding protects 
Fe
2+
 from oxidizing more than dmit coordination. Because fewer equivalents of H2O2 are 
required for more complete iron-bound dmise oxidation than iron-bound dmit oxidation, 
dmise is more prone to H2O2 oxidation than its thione analog under these conditions. A 
similar trend was observed upon [Tpm*Cu(dmit/dmise)]
+
 oxidation: the dmise complex 
required addition 2 equivalents of H2O2 for complete oxidation, whereas the dmit analog 
required addition of 3 equivalents of H2O2 for the same degree of oxidation.
36
 
Mass spectrometry was used to further identify the products of H2O2 oxidation. 
Upon treatment of Fe(dmit)2Cl2 with 1 equivalent of H2O2, MALDI-MS confirmed 
formation of a major product N,N′-dimethylimidazolium cation (m/z 97.1) and a minor 
product [dmit-OH]
-
 (m/z 145.1). In addition, the Fe
2+
-containing product [FeCl3]
-
 (m/z 
160.8) and the Fe
3+
-containing product [FeCl4]
-
 (m/z 197.9) were observed in a 1:8 ratio 
based on isotopic peak intensities; this  [FeCl3]
-
 to [FeCl4]
-
 ratio increases with increasing 
equivalents of H2O2. When 1 is treated with 6 equivalents of H2O2, only [FeCl4]
-
 is 
observed, indicating complete oxidation of Fe
2+
 to Fe
3+
.  
Since MALDI-MS could not aid in identification of oxidized sulfur products, ESI-
MS experiment were also performed. ESI-MS indicated formation of sulfite [SO3H]
-
 (m/z 
79.9) and sulfate [SO4H]
-
 (m/z 96.8) from 3 to 6 equivalents of H2O2, indicating that dmit 
oxidized with concomitant C=S bond cleavage and oxidation of the S atom when treated 
with at least three equivalents of H2O2. Control samples of Na2SO3 and Na2SO4 were 
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analyzed using ESI-MS and showed small peaks of sulfite and sulfate, similar to those 
observed when Fe(dmit)2Cl2 was treated with with 3 – 6 equivalents of H2O2.  
N,N′-dimethylimidazolium was also observed by MALDI-MS upon treating of 
Fe(dmise)2Cl2 with 1 equivalent  of H2O2, along with [FeCl3]
-
 and [FeCl4]
-
 products in a 
1:2 ratio. This Fe
2+
:Fe
3+
 ratio remains fairly constant at a ratio of 1:2 - 1:3 upon adding 
up to 4 equivalents of H2O2, but treatment with 6 equivalents increases the Fe
2+
:Fe
3+
 ratio 
substantially to 1:7. ESI-MS results indicate oxidized [SeO2H]
-
 (m/z 113.0) is formed 
upon treatment of Fe(dmise)2Cl2 with 2 - 6 equivalents of H2O2. Control samples of SeO2 
and Na2SeO4 were also analyzed under similar conditions and showed small peakes for 
[SeO2H]
-
 as observed upon treatment Fe(dmise)2Cl2 with 2 – 6 equivalents of H2O2. 
To determine how much Fe
2+
 was oxidized to Fe
3+
 during sample preparation, 
MALDI mass spectrometry in the negative mode was also conducted on a FeCl2 ∙ 4H2O 
standard, and peaks for [FeCl3]
-
 and [FeCl4]
-
 were observed in a 1:4 ratio based on peak 
intensities.  Thus, a significant fraction of the Fe
2+
 in the standard was oxidized to Fe
3+
 
during preparation and/or analysis of the mass spectrometry samples. Nonetheless, the 
Fe
2+
:Fe
3+
 ratio of 1:8 observed upon oxidation of Fe(dmit)2Cl2 with 1 equivalent of 
hydrogen peroxide, indicates a significant increase in Fe
3+
 products observed compared 
to the untreated FeCl2 ∙ 4H2O standard. This increase in Fe
3+
 ratio indicates that dmit 
binding does not prevent Fe
2+
 from oxidizing to Fe
3+
 upon H2O2 addition.  In contrast, the 
Fe
2+
:Fe
3+
 ratio of 1:2 observed after treatment of Fe(dmise)2Cl2 with 1 equivalent of H2O2 
is lower than that observed for untreated FeCl2 ∙ 4H2O (1:4) and much lower than that 
observed for Fe(dmit)2Cl2 oxidation with H2O2 (1:8), indicating that dmise coordination 
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prevents Fe
2+
 oxidation, not only upon treatment with H2O2, but also during sample 
preparation and analysis. 
Taken together, the results of 
1
H NMR and mass spectroscopy experiments 
indicate that iron-bound dmit and dmise scavenge H2O2 by undergoing sacrificial 
oxidation (Reactions 3 and 4, respectively). Whereas dmise preferentially protects Fe
2+
 
from significant oxidation to Fe
3+
, its thione analog dmit does not, as demonstrated by an 
increase in 
1
H NMR paramagnetic effects and an increase in [FeCl4]
-
 species observed in 
MALDI-MS.  
 
Previous H2O2 oxidation studies with unbound dmit and dmise showed that the 
selone dmise requires 2 equivalents of H2O2 to fully oxidize, forming N,N′-
dimethylimidazolium cation and [SeO2H]
-
 as determined by 
1
H NMR and ESI-MS, 
whereas dmit requires 3 equivalents of H2O2 to form N,N′-dimethylimidazolium, 
[SO3H]
-
,
 
and [SO4H]
- 
species.
36
 Similar reactivity of the copper-bound dmit and dmise 
ligands was observed upon H2O2 oxidation of [Tpm*Cu(dmit/dmise)] complexes.
35
 
Similar to unbound dmit, unbound dmise, and [Tpm*Cu(dmit/dmise)]
+
 
complexes, the iron-bound dmise ligand in Fe(dmise)2Cl2 is more sensitive to H2O2 
oxidation, requiring 4 equivalents of H2O2 to oxidize Fe(dmise)2Cl2 to nearly 85% 
oxidized dmise, whereas the analogous Fe(dmit)2Cl2 complex, when treated with 4 
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equivalents of H2O2, shows only 63% ligand oxidation. Iron-bound dmise sacrificially 
oxidizes and protects Fe
2+
 from oxidation as determined by the lack of line broadening 
observed in the 
1
H NMR spectra (Figure 3.2) and by mass spectroscopy results that show 
a much smaller [FeCl3]
-
 to [FeCl4]
-
 ratio compared to the oxidized iron-dmit complex or 
the FeCl2 ∙ 4H2O control. Importantly, the results in these studies corroborate the reported 
electrochemical results (Chapter 2) for Fe(dmit/dmise)2Cl2 and definitively establish that 
these thione and selone compounds, when bound to iron, act as sacrificial antioxidants.  
In addition, these results indicate that biological ergothioneine and selenoneine also may 
prevent iron-mediated DNA damage via iron binding and sacrificial oxidation. 
 
3.3. Conclusions 
 Treatment of Fe(dmit)2Cl2 and Fe(dmise)2Cl2 with H2O2 results in oxidation of 
the S and Se atoms, cleavage of the C=S or C=Se bonds, and formation of the 
dimethylimidazolium cation and sulfur and selenium oxide species. When bound to Fe
2+
, 
dmise protects Fe
2+
 from oxidation to Fe
3+
 significantly more than dmit, as observed by 
1
H NMR and MALDI-MS. Similar sacrificial oxidation of iron-bound dmit is observed 
upon treatment by H2O2; however, because of the increase in paramagnetic effects 
observed in the 
1
H NMR titration studies and a significant increase in [FeCl4]
-
 formation, 
it is clear that the Fe
2+
 is not fully protected from oxidation. Therefore, iron-mediated 
oxidative damage may be prevented by coordination of selones more so than thiones via 
sacrificial oxidation in vivo. 
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3.4. Experimental Methods 
Materials. Acetonitrile was dried over calcium hydride and freshly distilled prior 
to use. Fe(dmit)2Cl2, and Fe(dmise)2Cl2 were synthesized according to published 
procedures.
36
 Hydrogen peroxide (30% by volume in water; VWR) was used as received. 
Instrumentation. 
1
H NMR spectra were obtained on Bruker 500 or 300 MHz 
NMR spectrometers. 
1
H NMR chemical shifts are reported in δ vs. trimethylsilane (TMS; 
δ 0) and referenced to solvent. MALDI mass spectrometry experiments were performed 
using a Bruker Microflex MALDI-TOF mass spectrometer with trans-2-3-(4-tert-
butylphenyl)-2-methyl-2-propenyldiene (m/z 250.3) as the matrix. Electrospray ionization 
mass spectrometry (ESI-MS) was conducted by Lynn Zang using a QSTAR XL Hybrid 
MS/MS System from Applied Biosystems via direct injection of sample (0.05 mL/min 
flow rate) into a Turbo Ionspray ionization source. Samples were run under both positive 
and negative ion mode, with an ionspray voltage of 5500 V, and TOF scan mode. All the 
peak envelopes obtained match calculated values. 
Reactivity of Fe(dmit)2Cl2 with H2O2. Fe(dmit)2Cl2 (50 mg, 0.131 mmol) was 
dissolved in acetonitrile (10 mL) and was treated with 1.0, 2.0, 4.0, or 6.0 equiv of H2O2 
(15, 30, 60, or 90 μL of 30% solution (9.44 M) in water, respectively). The reaction 
mixtures changed from yellow to reddish-brown immediately upon addition of H2O2, and 
a reddish-brown precipitate formed. The reaction mixtures were stirred for 10 min and 
dried in vacuo, yielding reddish-brown solids. Yield of N,N’-dimethylimidazolium upon 
addition of 4 equiv H2O2: 63% by 
1
H NMR spectroscopy. 
1
H NMR data for N,N’-
dimethylimidazolium based on imidazole proton resonances (d6-DMSO): δ 3.75 (s, 6H, 
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CH3), 7.57 (s, 2H, CH), 8.40 (S, 1H, CH). ESI-MS: m/z positive ionization: 97.1 
[C5H9N2]
+
; negative ionization: 79.9 [SO3H]
-
, 96.8 [SO4H]
-
. MALDI-MS: m/z positive 
ionization: 97.1 [C5H9N2]
+
;
 
negative ionization 160.8 [FeCl3]
-
, 197.9 [FeCl4]
-
. 
Reactivity of Fe(dmise)2Cl2 with H2O2. Fe(dmise)2Cl2  (50 mg, 0.105 mmol) was 
dissolved in acetonitrile (10 mL) and to this solution was added 1.0, 2.0, 4.0, or 6.0 equiv 
of H2O2 (11, 22, 44, or 66 μL of 30% solution (9.44 M) in water, respectively). Upon 
H2O2 addition, of the solution immediately changed from yellow to orange-red with 
formation of an orange precipitate. The reaction mixtures were stirred for 10 min and 
dried in vacuo, yielding light red/orange solids. Yield of N,N’-dimethylimidazolium upon 
addition of 4 equiv H2O2: 85% by 
1
H NMR spectroscopy. 
1
H NMR data for N,N’-
dimethylimidazolium based on imidazole proton resonances (d6-DMSO): δ 3.83 (s, 6H, 
CH3), 7.68 (s, 2H, CH), 9.10 (s, 1H, CH). ESI-MS: m/z positive ionization: 97.1 
[C5H9N2]
+
; negative ionization: 113.0 [SeO2H]
-
. MALDI-MS: m/z positive ionization: 
97.1 [C5H9N2]
+
;
 
negative ionization 160.8 [FeCl3]
-
, 197.9 [FeCl4]
-
. 
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CHAPTER FOUR 
ZINC(II)–THIONE AND –SELONE COMPLEXES: A MECHANISTIC 
STUDY OF THIONE AND SELONE ANTIOXIDANT ACTIVITY 
 
4.1 Introduction 
The biological thione- (C=S) and selone- (C=Se) containing compounds 
ergothioneine and selenoneine (Figure 4.1) have not been highly investigated, and their 
biological functions are not well established.
1-6
  Several studies have determined that both 
are potent radical-scavenging antioxidants,
7-13
 whereas only ergothioneine was tested for 
copper-binding antioxidant activity and found to prevent copper-mediated DNA 
damage.
14
 Selenoneine prevents iron auto-oxidation by binding to Fe(II) in hemoglobin 
and myoglobin.
6
  
The Brumaghim group has examined the metal binding properties of dmit and 
dmise (Figure 4.1) with Cu(I) and Fe(II), since they are thione and selone analogs of 
ergothioneine and selenoneine.
15-18
 When dmit and dmise bind Cu(I) and Fe(II), these 
ligands favor their zwitterionic over non-zwitterionic resonance structures (Figure 4.1) as 
confirmed by NMR spectroscopy, X-ray diffraction structures, and DFT calculations.
15-18
 
Upon H2O2 oxidation of [Tpm
Me
Cu(dmit/dmise)]
+
 (Tpm
Me
 = tris(3,5- 
 
Figure 4.1. Thione and selone antioxidants (left) and the resonance forms of dmit and dmise (right). 
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dimethylpyrazolyl)methane) and Fe(dmit/dmise)2Cl2, dmit and dmise undergo sacrificial 
oxidation, yielding the N,N’-dimethimidazolium cation and [SOnH]
-
 (n = 2, 3, or 4) or 
[SeO2H]
- 
(Chapter 3).
19
 This sacrificial ligand oxidation protects Cu(I) and Fe(II) from 
oxidation to Cu(II) and Fe(III). 
Dmise-copper and -iron binding was found to significantly lower the Cu(II/I) and 
Fe(III/II) redox potentials in [Tpm
R
Cu(dmise)]
+
 (Tpm
R
 = tris(3,5-di-R-
pyrazolyl)methane; R = H, CH3, and 
i
Pr)
16
 and Fe(dmise)2Cl2
18
 complexes. These 
Cu(II/I) and Fe(III/II) redox potentials occur near or below -0.32 V, the potential at which 
NADH cannot reduce Cu(II) to Cu(I) or Fe(III) to Fe(II).
20
 Analogous dmit-copper and 
-iron complexes have Cu(II/I) and Fe(III/II) redox potentials higher than their selone 
counterparts, suggesting that thione coordination may not be as effective at preventing 
metal oxidation as their selone counterparts.
16,18
 However, ligand-based potentials are 
significantly higher than Fe(III/II) redox potentials in Fe(dmit/dmise)2Cl2, indicating that 
bound dmit and dmise should undergo oxidation prior to Fe(II) and protect it from 
oxidation.
18
  
When Fe(dmit)2Cl2 was treated with H2O2 (Chapter 3), 
1
H NMR and mass 
spectrometry studies indicated formation of the imidazolium cation, [SO3H]
-
, and [FeCl4]
-
 
species, in which Fe(II) is oxidized to Fe(III). When Fe(dmise)2Cl2 was treated with H2O2 
the dmise ligand undergoes sacrificial oxidation to the imidazolium cation, and [SeO2H]
-
 
species similar to its sulfur analog, however Fe(II) does not become oxidized to Fe(III), 
indicating dmise may prevent iron-mediated hydroxyl production through sacrificial 
oxidation. These results indicate that dmise and dmit have different antioxidant 
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mechanisms for the prevention of metal-mediated oxidative DNA damage.  
Iron(II) and Cu(I) generate hydroxyl radical upon hydrogen peroxide oxidation 
(Reaction 1),
21-23
 and hydroxyl radical production becomes catalytic in vivo when cellular 
reductants such as NADH reduce Fe(III) to Fe(II) or Cu(II) to Cu(I). In cells, hydroxyl 
radical damages lipids, proteins, and DNA,
24-29
 leading to development of cardiovascular 
diseases, neurodegenerative diseases, and cancer.
25,27-29
 Unlike iron(II) and copper(I), 
zinc(II) lacks redox activity due to its d
10
 electron configuration, but it is a strong Lewis 
acid.
30
 This lack of redox activity makes Zn(II) a stable ion in biological systems, and it 
is incapable of generating hydroxyl radical by one-electron reduction of hydrogen 
peroxide.
31,32
 
Fe(II)/Cu(I)  +  H2O2    Fe(III)/Cu(II)  +  
•
OH  +  OH
-
                (1) 
 After iron, zinc is the second most abundant trace d-block metal in humans, with 
an average 2 - 4 g of  zinc in an adult human.
33
 Similar to iron(II), zinc(II) is classified as 
a “borderline” Lewis acid that will readily coordinate O, N, or S atoms,34 and many zinc-
containing proteins contain Zn-S bonds to the amino acids histidine and cysteine.
34
 Since 
zinc is known to bind sulfur-containing amino acids ergothioneine and its selenium 
analog, selenoneine, should also bind in a similar fashion through the sulfur and selenium 
atoms. Since dmit and dmise are analogs of ergothioneine and selenoneine, we have 
examined them as mimics of these biological thione and selone compounds. 
In this chapter, we describe the synthesis and characterization of the novel thione 
and selone complexes Zn(dmit)2Cl2 (1) and  [Zn(dmise)4][BF4]2 (4) as well as introduce a 
novel synthetic method for the synthesis of previously reported [Zn(dmit)4][BF4]2 (3).
35
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Crystal structures of Zn(dmise)2Cl2
36
 (2) and [Zn(dmit)4][BF4]2
35
 (3) have been reported; 
however, that is it extent of their characterization. In addition, we have examined the 
reactivity of Zn(dmit/dmise)2Cl2 (1 and 2) with H2O2 to determine how binding to a 
non-redox active metals effects the oxidation mechanisms of dmit and dmise.   
Syntheses of complexes 1 and 4 were carried out by undergraduates Amanda 
Owen, Hayden Smith, Mathew Wasilewski, and Caleb Cohen. Hayden Smith and 
Amanda Owen characterized complexes 1 - 4 by 
1
H and 
13
C{
1
H} NMR, and IR 
spectroscopy, and electrochemical and oxidation studies of 1 and 2 were carried out by 
Amanda Owen. These contributions to understanding how thiones and selones bind to 
zinc would not have been made possible without their dedication and hard work. 
 
4.2 Results and Discussion 
Synthesis of Zn(II)-thione and –selone complexes. Zn(dmit)2Cl2 (1) was 
synthesized following reported procedures for synthesis of the dmise analog, 
Zn(dmise)2Cl2 (2)
36
 (Scheme 4.1A). Synthesis of 1 and 2 were performed under 
atmospheric conditions, with yields of 84-86% as colorless crystals of 1 and pale yellow 
crystals of 2. Both complexes are stable in air and are soluble only in dimethylsulfoxide 
and dimethylformamide at room temperature. Single crystals of Zn(dmit)2Cl2 (1), as 
colorless rods, were grown from cooling a reaction mixture in acetonitrile.  
 To compare homoleptic complexes of dmise and dmit, the novel 
[Zn(dmise)4][BF4]2 (4) complex was synthesized according to the reaction shown in 
Scheme 4.1B. This new synthetic method was also used to synthesize the reported 
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[Zn(dmit)4][BF4]2 (3).
35
  Treating Zn(BF4)2 with four equivalents of dmit or dmise 
affords white or yellow powders of [Zn(dmit)2][BF4]2 (3) and [Zn(dmise)4][BF4] (4), 
respectively. The syntheses of 3 and 4 were originally carried out under atmospheric 
conditions utilizing ethanol as a solvent,
35
 but this procedure afforded less-than-desirable 
yields (50-55%), perhaps due to oxidation of dmit and dmise. Using air-free synthetic 
techniques increased yields of 3 and 4 to 74% and 80%, respectively. As observed for 1 
and 2, complexes 3 and 4 are air-stable in solution and in the solid state, but they are 
much more soluble than 1 and 2 in a variety of organic solvents. [Zn(dmise)4][BF4]2 (4), 
crystallized as light yellow prisms, were grown from vapor diffusion of diethyl ether into 
an acetonitrile solution. 
Scheme 4.1 
 
 Structural analysis of zinc-thione and –selone complexes. Structures of 
Zn(dmit)2Cl2 (1) and [Zn(dmise)4][BF4]2 (4) were determined by X-ray diffraction 
(Figure 4.2); structures of Zn(dmise)2Cl2
36
 and [Zn(dmit)4][BF4]2
35
 have been reported. 
Selected interatomic distances and angles for 1 and 4 are summarized in Table 4.1. 
138 
 
Complexes 1 and 2 are an isomorphous pair, containing Zn(II) bound to two Cl atoms 
and two S/Se atoms from a heterocyclic chalcogenone (Figure 4.2A; the crystal packing 
diagram for 1 is shown in Figure 4.4 at the end of the experimental section). In 3 and 4, 
Zn is coordinated to four S (3) or Se (4) atoms to form the tetrakis [Zn(dmit/dmise)4]
2+
 
complexes (Figure 4.2B; the crystal packing diagram for 4 is shown in Figure 4.5 at the 
end of the experimental section), likewise forming an isomorphous pair. The Zn(II)  
 
Figure 4.2. Crystal structure diagrams with 50% probability density ellipsoids for A) Zn(dmit)2Cl2 (1) and 
B) [Zn(dmise)4][BF4]2 (4). Hydrogen atoms and counterions are omitted for clarity. 
 
Table 4.1. Selected bond lengths (Å) and angles (°) for Zn(dmit)2Cl2 (1) and [Zn(dmise)4][BF4]2 (4). 
 
 
 
 
  
 
 
 
 
 
1 4 
Zn1—S1 2.3540 (9) Zn1—Se1 2.4635 (9) 
Zn1—S2 2.3766 (10) Zn1—Se1i 2.4635 (9) 
Zn1—Cl1 2.2616 (10) Zn1—Se2 2.4526 (10) 
Zn1—Cl2 2.2865 (9) Zn1—Se2i 2.4526 (10) 
S1—C1 1.713 (3) Se1—C1 1.860 (7) 
S2—C6 1.719 (4) Se2—C6 1.850 (7) 
Cl1—Zn1—S1 119.04 (4) Se2i—Zn1—Se2 122.42 (6) 
Cl2—Zn1—S1 107.26 (3) Se2i—Zn1—Se1i 103.85 (2) 
Cl1—Zn1—S2 108.01 (4) Se2—Zn1—Se1i 104.93 (3) 
Cl2—Zn1—S2 110.40 (4) Se2i—Zn1—Se1 104.93 (3) 
S1—Zn1—S2 103.65 (3) Se2—Zn1—Se1 103.85 (2) 
Cl1—Zn1—Cl2 108.30 (4) Se1i—Zn1—Se1 117.88 (6) 
C1—S1—Zn1 102.02 (11) C1—Se1—Zn1 96.43 (19) 
C6—S2—Zn1 100.55 (12) C6—Se2—Zn1 96.88 (19) 
i  symmetry operator for symmetrically equivalent atoms: -x, y, -z+3/2. 
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valence was confirmed by the two coordinated Cl
-
 ions in 1 and 2,
36
 and the presence of 
uncoordinated [BF4]
-
 counterions in a 2:1 ratio with Zn in 3
35
 and 4.  The Zn(II) 
complexes 1 - 4 are isostructural with their Fe(II) analogs.18 The novel zinc-thione and 
-selone complexes 1 and 4 favor tetrahedral coordination about the metal center similar to 
reported zinc
36
 and iron
18
 analogs. 
All the Zn(II) centers adopt a distorted tetrahedral coordination geometry with 
bond angles ranging from 103.65(3) to 119.04(4) degrees for 1, and 103.85(2) to 
122.42(6) degrees for 4. These correspond to τ4
 
distortion index values of 0.926 and 
0.881, respectively (Table 4.2). Thus, the tetrakis-dmit complex appears to be more 
distorted about the Zn(II) center compared to the bis-dmit complex, perhaps due to the 
larger size of the dmise ligand in 4 compared to chloride ligand in 1.  In particular, the τ4
 
index of 4 indicates a trigonal pyramidal distortion of the four- coordinate geometry. 
The tau value for the Fe(dmit)2Cl2 complex is very similar to 1, with only a 0.003 
difference. Comparable dichloride bis-selone complexes, M(dmise)2Cl2, (M = Fe(II), 
Zn(II), Co(II)) also have similar geometries (τ4 = 0.919 to 0.981).
18,36,37
  
 The M-S/Se bond distances for the complexes listed in Table 4.2 are all 
significantly shorter than the sum of their respective M-S/Se van der Waals radii (VDW) 
by an average of 1.86 Å, indicating significant orbital overlap and covalent bonding.  The 
average Zn-S bond length of Zn(dmit)2Cl2 (1: 2.365(1) Å) is shorter than the Fe-S bond 
length of Fe(dmit)2Cl2 (2.382(1) Å) by 0.017(1) Å. This difference is significantly shorter 
than the difference in the sums of their M-S van der Waals (VDW) radii (ΔVDW = 0.050 
Å). The average Zn-Se bond length of 2.478(1) Å is shorter than its iron analog, 
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Table 4.2. Selected structural parameters for M(dmit/dmise)2Cl2 and [M(dmit/dmise)4]
2+
 complexes. 
Complex τ4 
Average     
M-S/Se (Å) 
Sum of VDW radii 
of M-S/Se (Å)  Reference 
Zn(dmit)2Cl2 (1) 0.926 2.365(1) 4.28 This work 
Fe(dmit)2Cl2 0.929 2.382(1) 4.33 18 
     [Zn(dmit)4]
2+
 (3) 0.872 2.346 (1) 4.28 35 
[Fe(dmit)4]
2+
 0.881 2.345(1) 4.33 18 
     Zn(dmise)2Cl2 (2) 0.930 2.478(1) 4.21 36 
Fe(dmise)2Cl2  0.919 2.501(1) 4.26 18 
Co(dmise)2Cl2 0.981 2.346(1) 4.22 37 
     [Zn(dmise)4]
2+
 (4) 0.881 2.457(1) 4.21 This work 
[Fe(dmise)4]
2+
 0.846 2.455(1) 4.26 18 
 
Fe(dmise)2Cl2 (2.501(1) Å), by 0.023(1) Å and significantly shorter than the difference of 
the sums of the M-Se van der Waals radii (ΔVDW 0.050 Å). The decrease in M-S bond 
length for the zinc complexes 1 and 2 is expected due the smaller VDW radii of zinc 
compared to iron; however, the difference in M-S/Se bond length does not match the 
difference in their VDW radii, indicating strengthening of the C=S bond in dmit 
compared to the C=S bond in dmise when bound to zinc compared to iron. 
The Zn-S bond length in [Zn(dmit)4]
2+
 (3; 2.346(1) Å) is not significantly 
different than the Fe-S bond in its iron analog [Fe(dmit)4]
2+
 (2.345(1) Å18). The same true 
for the Zn-Se and Fe-Se bond lengths in their selenium analogs [Zn(dmise)4]
2+
 (4; 
2.457(1) Å) and [Fe(dmise)4]
2+
 (2.455(1) Å18). The difference in the M-S/Se ΔVDW sum 
of 0.05 Å seen for 1 and 2 is not observed for the Zn-S/Se bond lengths in 3 and 4, 
indicating a strengthening of the C=S/Se bond in these homoleptic complexes when dmit 
and dmise are bound to zinc compared to their iron analogs. 
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The Zn-S bond lengths of the dichloride complexes 1 and 2 increase by an 
average of 0.020 Å as compared to their tetrakis-thione and -selone analogs 3 and 4. This 
increase in bond length indicates a decrease in orbital overlap and a weakening of the 
M-S/Se bond when chlorides are bound to the zinc metal center, a trend similarly 
observed for their iron analogs.18 The increase in M-S/Se bond length for 1 and 2 also 
indicates a stronger C=S/Se bond as compared to 3 and 4. 
The average C-S bond distances in 1 (1.716(4) Å) also do not vary significantly 
from those of other M(L)2Cl2 (M = thione) complexes, ranging from 1.705(2) to 1.722(1) 
Å.
18,38-46
 For 4, the observed Zn-Se bond distances average 2.46(1) Å, comparable to Fe-
Se distances in [Fe(dmise)4]
2+
 (2.454(1) Å
18
). The average C-Se bond distance of 
1.855(7) Å in 4 falls within the expected range of other first row transition metal-selone 
complexes (1.862(3) – 1.873(6) Å).18,36,37  
 Infrared spectroscopy. Upon complexation with Zn(II), the bis-thione complex 
Zn(dmit)2Cl2 (1) shows a C=S stretching vibration at 1173 cm
-1
, slightly shifted to lower 
energy compared to unbound dmit (1181 cm
-1 23
). In contrast to 1, Zn(dmise)2Cl2 (2) has a 
C=Se stretching vibration at 1150 cm
-1
, not significantly different than unbound dmise 
(1148 cm
-1
 
32
). The tetrakis-thione complex 3 also shows no significant shift of the C=S 
stretching vibration (1180 cm
-1
) compared to free dmit, and the tetrakis-selone complex 4 
has a C=Se stretching vibration (1149 cm
-1
) similar to that of unbound dmise. Similar 
S/Se=C energies have also been observed for [Tpm
R
Cu(dmit)]
+
,
16 
Fe(dmit)2Cl2, and 
[Fe(dmit)4]
2+ 18 
complexes.  The C=S/Se stretches of zinc-bound dmit and dmise indicate 
that these ligands bind through primarily σ and π donation to the zinc, as previously 
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observed for their Fe
2+
 analogs.
18
 
NMR spectroscopy. 
1
H NMR spectra of Zn(dmit)2Cl2 (1), Zn(dmise)2Cl2 (2), 
Zn(dmit)4[BF4]2 (3), and [Zn(dmise)4][BF4]2 (4) were acquired in deuterated 
dimethylsulfoxide due to the limited solubility of 1 and 2. For Zn(dmit)2Cl2 (1), the 
methyl and imidazole proton resonances shift slightly downfield (δ 3.54 and 7.32, 
respectively) compared to unbound dmit (δ 3.43 and 7.10, respectively). However, in 
[Zn(dmit)4][BF4]2 (3), dmit resonances show no significant shifts for either the methyl or 
imidazole protons (δ 3.43 and 7.09, respectively) compared to unbound dmit.  
Similar trends are observed in the 
1
H NMR spectra of the Zn-dmise complexes. A 
slight downfield shift is observed for both the methyl and imidazole proton resonances of 
Zn(dmise)2Cl2 (2) (δ 3.56 and 7.38, respectively) compared to unbound dmise (δ 3.52 and 
7.30, respectively). However, the 
1
H NMR spectrum of [Zn(dmise)4][BF4]2 (4) 
demonstrates no significant resonance shifts for the dmise methyl and imidazole protons 
(δ 3.52 and 7.30, respectively). The slight downfield shifts observed for the 1H NMR 
resonances of bis-thione and -selone complexes 1 and 2 demonstrate that when two dmit 
ligands are bound to Zn(II), the bound thione ligands shift more toward the zwitterionic 
resonance structure compared to unbound dmit and dmise (Figure 4.1). In contrast, the 
1
H 
NMR spectra for the tetrakis-thione and –selone complexes 3 and 4, show no significant 
resonance structure shifting compared to unbound dmit and dmise, as similarly observed 
via bond length differences of the thione and selones when bound to zinc in their X-ray 
crystallographic data. 
 Oxidation studies with hydrogen peroxide. Previous studies involving the 
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treatment of free dmit with H2O2 demonstrated that dmit requires 3 equivalents of H2O2 
to fully oxidize to the N,N’-dimethylimidazolium cation, [SO3H]
-
, and [SO4H]
-
 species.
19
 
Similarly, treatment of free dmise with H2O2 yielded similar products, forming N,N’-
dimethylimidazolium and [SeO2H]
-
; however, dmise requires only 2 equivalents of H2O2 
for complete oxidation.
19
 Thus, unbound dmise more readily undergoes oxidation 
compared to its thione analog dmit.
19
  
Treatment of Zn(dmit)2Cl2 (1) and Zn(dmise)2Cl2 (2) with H2O2 were performed 
to determine how binding to a redox-inactive metal ion affects thione and selone 
antioxidant mechanisms. To oxidize these complexes, deuterated dimethylsulfoxide 
solutions of Zn(dmit/dmise)2Cl2 (1 and 2) were treated with up to six equivalents of 
H2O2. Upon oxidation of Zn(dmit)2Cl2 (1) with multiple equivalents of H2O2, new 
resonances emerge at δ 3.83, 7.67, and 9.01, corresponding to formation of the 
imidazolium cation (Figure 4.3A). Interestingly, a fourth new resonance appears at δ 
10.22, corresponding to a dmit-bound hydroxyl group, typically found in the range of δ 
10 - 11.
47
 This assignment was confirmed via IR spectroscopy with an observed strong, 
broad O-H vibration (3410 cm
-1
) and a S-O vibration (645 cm
-1
).
47
 The 
1
H NMR spectra 
of 1 treated with 6 or 8 equivalents of H2O2 show no change compared to the spectrum 
observed for treatment of 1 with only four equivalents of H2O2, indicating that the 
maximum complex oxidation has occurred with only 4 equiv of H2O2.
 
1
H NMR spectra of the oxidized Zn(dmise)2Cl2 (2) show similar emergences of 
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Figure 4.3. 
1
H NMR spectra in DMSO-d6 for A) Zn(dmit)2Cl2, B) Zn(dmise)2Cl2 upon H2O2 treatment, and 
C) the resonance labeling scheme, with the prime symbol indicating resonances arising from oxidation 
products. 
 
new resonances at δ 3.84, 7.67, and 9.07, corresponding to formation of the imidazolium 
cation (Figure 4.3B). Upon treatment of 2 with four equivalents of H2O2, 85% of zinc-
bound dmise becomes oxidized to the imidazolium cation as observed via the ratios of 
imidazole ring proton integrations. 
Mass spectrometry of the H2O2 oxidation reaction products of Zn(dmit)2Cl2 
indicate formation of N,N’-dimethylimidazolium (m/z 97.1), corroborating 1H NMR 
results.  Since Zn(II) is not redox active under these conditions, only the Zn(II) species 
A B
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[ZnCl3]
-
 (m/z 169.7) is observed. After treatment of Zn(dmit)2Cl2 (1) with one equivalent 
of H2O2, small intensity peaks for [dmit(OH)]H
+
 (m/z 146.6) and [dmit(OH)3]
-
 (m/z 
179.9) are observed, as well as multiple sulfur-oxide species, including [SO2]
-
 (m/z 64.2), 
[SO3]
-
 (m/z 79.5), and [SO4H]
-
 (m/z 97.1). Treatment of unbound dmit with two or three 
equivalents of H2O2 results in the cleavage of the C=S bond of the imidazole with the 
emergence of the oxidized sulfur products [SO3]
-
 and [SO4H]
-
 observed by ESI-MS.
19
 
Observation of dmit-OH species after treatment of 1 with up to 8 equivalents of H2O2 
also corroborates our 
1H NMR observations of the new resonance at δ 10.22, attributed to 
the this species. Thus, oxidation of zinc-bound dmit does not always result in cleavage of 
the C=S bond. 
Upon treatment of Zn(dmise)2Cl2 with H2O2, mass spectrometry data indicates 
formation of N,N’-dimethylimidazolium (m/z 97.1), similar to its dmit analog 1, as well 
as the selenium containing species [SeO2H]
-
 (m/z 113.0). Again, the sole zinc-containing 
species observed is [ZnCl3]
-
 (m/z 169.7).  In contrast to oxidation studies of 1, no 
evidence for dmise-OH species formed upon hydrogen peroxide treatment of 2 is 
observed by NMR spectroscopy or mass spectrometry.  
Oxidation of [Tpm
Me
Cu(dmit)]
+19
 and Fe(dmit)2Cl2 (Chapter 3) with H2O2 
demonstrated that dmit requires 3 equivalents of H2O2 to fully oxidize to the imidazolium 
cation when bound to copper and iron, similar to free dmit.
 
Although Cu(I) was protected 
from oxidation to Cu(II),
19
 the Fe(II) was not protected from oxidation to Fe(III) as 
observed by formation of the Fe(III) species [FeCl4]
-
 (Chapter 3). In contrast, when dmit 
is bound to non-redox active Zn(II) in 1 and treated with H2O2, dmit C=S bond cleavage 
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is reduced by the formation of a dmit-OH species as well as slight 
N,N’-dimethylimidazolium cation formation indicating thione coordination to non-redox 
active metals may hinder C=S bond cleavage by H2O2.  
Treatment of [Tpm
Me
Cu(dmise)]
+
 
19
 and Fe(dmise)2Cl2 (Chapter 3) complexes 
with H2O2 show that dmise undergoes sacrificial oxidation, protecting both Cu(I) and 
Fe(II) from oxidation and requiring 2 equivalents of H2O2 for formation of the maximally 
oxidized products: imidazolium cation and [SeO2H]
-
 species. These results indicate that 
dmise undergoes sacrificial oxidation to the same products when coordinated to both 
redox active and non-redox active metal ions. This redox-active metal-dependency of 
thione oxidation should to be further explored with other biological metals such as Co(II), 
Ni(II) since these are also redox-active, and Mg(II) since it is non-redox active biological 
metal.  
Electrochemistry. Cyclic voltammetry was used to determine how dmit and dmise 
ligand and zinc metal redox potentials are altered when bound in complexes 1-4 (Table 
4.3). The cyclic voltammogram of dmit shows irreversible reduction (Epa) and oxidation 
(Epc) waves at 0.69 V and 0.12 V, respectively. The voltammogram of dmise shows 
similar irreversible redox behavior (Epa = 0.58 V and Epc = 0.08 V). However, when 
preventing reduction by starting the negative scan at 0.30 V for dmit and 0.20 for dmise 
results in only an oxidation wave as previously observed for methimazole,
48
 dmit,
18
 and 
dmise,
18
 indicating reduction is dependent on prior ligand oxidation. Due to the 
dependence of reduction waves on prior thione and selone oxidation, E1/2 values are not 
reported for ligand-based redox potentials (Table 4.3).  
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The cyclic voltammograms for the zinc-dichloro complexes 1 and 2 show no 
observed zinc redox waves, since they are outside the observed electrochemical window. 
However, for the tetrakis complexes 3 and 4, Zn(II/0)
 
reduction and oxidation waves 
observed in their respective cyclic voltammograms. For 3, the observed Zn(II/0)
 
reduction wave is observed at -1.70 V, and the Zn(0/II) oxidation wave is observed at -
0.74 V. For its selenium analog 4, the Zn(II/0) reduction wave is observed at a more  
 
Figure 4.4. Cyclic voltammograms of A) Zn(dmit)2Cl2 (1; dashed line) and Zn(dmise)2Cl2 (2; sold line) 
and B) [Zn(dmit)4][BF4]2 (3; dashed line) and [Zn(dmise)4][BF4]2 (4; solid line). All data were collected 
with 10 mM complex in dimethylformamide. 
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Table 4.3. Redox potentials of selone and thione ligands and their Zn(II) and Fe(II) complexes vs NHE. 
Ligand or Complex 
Ligand-based 
Potentials (V)  
Epc* (V) Epa (V) Reference 
Dmise 0.08 0.58 This work 
Zn(dmise)2Cl2 (1) 0.03 0.53 This work 
[Zn(dmise)4][BF4]2 (3) 0.01 0.36 This work 
Fe(dmise)2Cl2 0.14 0.41 18 
[Fe(dmise)4][BF4]2  0.11 0.36 18 
Dmit 0.12 0.69 This work 
Zn(dmit)2Cl2 (2) 0.09 0.68 This work 
[Zn(dmit)4][BF4]2 (4) 0.02 0.66 This work 
Fe(dmit)2Cl2 0.15 0.69 18 
[Fe(dmit)4][BF4]2 0.12 0.69 18 
*Ligand-based reduction potentials are dependent on prior oxidation to the disulfide and diselenide. 
positive potential, -1.51 V, as is the Zn(0/II) oxidation wave at -0.47 V.   
The cyclic voltammograms of Zn-dmit and dmise complexes 1 – 4 (Figure 4.4) 
show both ligand-based reduction and oxidation waves, similar to that observed for 
unbound dmit and dmise
18
 and their Fe(II) complex analogs (Chapter 2), with ligand 
reduction dependent on prior ligand oxidation. Zn(II)-dmit binding in complexes 1 and 3 
decreases the dmit-based oxidation and reduction potentials by an average of 0.07 V and 
0.02 V, respectively, compared to unbound dmit (0.69 V), indicating zinc-bound dmit 
becomes less readily oxidizable. The cyclic voltammograms of Zn(II)-dmise complexes 2 
and 4 also exhibit dmise-based oxidation and reduction waves. Similar to the zinc-thione 
complexes 1 and 3, the ligand-based oxidation potentials become more negative by an 
average of 0.12 V compared to unbound dmise (0.58 V), indicating that zinc-bound 
dmise also becomes less readily oxidizable than the unbound ligand.  
When the chloride ligands in 1 and 2 are replaced with additional dmit and dmise 
ligands to form the zinc-tetrakis dmit and dmise complexes 3 and 4, a decrease in 
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reduction (0.02 and 0.07 V, respectively) and oxidation (0.02 and 0.17 V, respectively) 
potentials is observed. These lower oxidation potentials suggest that dmit and dmise 
ligands in 1 - 4 become less readily oxidizable when bound to zinc, in contrast to that 
observed for Fe(dmit/dmise)2Cl2 and [Fe(dmit/dmise)4]
2+
 complexes in which the ligand-
based oxidation potentials increase compared to unbound dmit and dmise.
18
  
Previous work by Goldberg et al.
49
 utilized functional models of the iron enzyme 
cycteine dioxygenase (CDO) of the formulae [Fe(II)(LN3S)][OTf] and its zinc analog 
[Zn(II)(LN3S)][OTf] (L = bis(imino)pyridine). Both [Fe(II)(LN3S)][OTf] and 
[Zn(II)(LN3S)][OTf] complexes were treated with excess O2. X-ray crystallography and 
laser desorption ionization mass spectrometry (LDIMS) identified the newly formed 
[Fe(II)(LN3SO3)][OTf], oxidized via sulfur oxygenation.
49
 However, when 
[Zn(II)(LN3S)][OTf] was treated with O2 over 7 days, no reactivity of the zinc-thiolate 
complex was observed, due to non-redox-active zinc coordination.
49
 Thus, the Fe(II) 
redox active metal center was found to be critical for sulfur oxygenation in this CDO 
analog, despite the fact that only the ligand was oxidized.
49
 However, these results 
indicate that thione oxidation occurs with both iron and zinc coordination for both thiones 
and selones; however, thione coordination to zinc does hinder C=S bond cleavage while 
thione coordination to iron as well as selone coordination to both iron and zinc allows 
S/Se=C bond cleavage when treated with H2O2. 
 Previous electrochemical studies of Cu(I) [Tpm
R
Cu(dmit/dmise)]
+
 complexes 
showed that dmit or dmise coordination decreased the Cu(II/I) redox potential by 347 - 
847 mV relative to acetonitrile binding, possibly inhibiting catalytic metal-mediated 
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hydroxyl radical generation.
16
 In contrast, electrochemical studies of Fe(dmit/dmise)2Cl2 
and {Fe(ebit/ebis)Cl2}n complexes showed that thione or selone coordination decreases 
the Fe(III/II) redox potential by 340 – 560 mV, relative to FeCl2·4H2O, however, the 
Fe(III/II) redox potentials still fall within the window of catalytic metal-mediated radical 
generation (Chapter 2). In addition, the ligand–based redox potentials increase when 
bound to iron and are significantly higher than the Fe(III/II) potentials, indicating an 
increase in ease of ligand oxidation and suggesting that sacrificial oxidation of the 
ligands should occur prior to iron oxidation to prevention of catalytic metal-mediated 
radical generation (Chapter 2). However, zinc bound dmit and dmise redox potentials 
decrease, suggesting a reduction in the ease of thione and selone oxidation. When zinc-
bound dmit was treated with H2O2 S=C bond cleavage is hindered cooraborating 
electrochemical results.  While the zinc-bound dmise redox potentials are also reduced, 
zinc-dmise oxidation mechanism is not hindered and readily undergoes Se=C bond 
cleavage as previously observed with copper
19
 and iron complexes (Chapter 3). These 
results indicate that thione C=S bond cleavage is metal-dependent while selones readily 
undergo oxidation cleaving the C=Se bond even when bound to non-redox active metals. 
 
4.3 Conclusions 
Zn(II)-thione and –selone complexes have been synthesized and characterized, 
and their reactivity with H2O2 and their electrochemical behavior have been investigated. 
Zn(dmit)2Cl2 (1) and [Zn(dmise)4][BF4]2 (4) are structurally similar to their previously 
synthesized dmise and dmit analogs, with a tetrahedral coordination environment around 
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the zinc center. When dmit and dmise bind to zinc, both show a slight increase in 
zwitterionic character typical of thione and selone coordination to first-row d-block metal 
ions with  and π donation as their primary metal-coordination mode. Treatment of 
Zn(dmit)2Cl2 and Zn(dmise)2Cl2 with H2O2 shows that the dmit ligands are less readily 
oxidizable than dmise ligands and form dmit-OH species. Both dmit and dmise undergo 
sacrificial oxidation to cleave the C=S/Se bond, however dmise undergoes C=Se bond 
cleavage alone, whereasthe C=S bond is cleaved to form a mixture of imidazolium cation 
as well as oxidized dmit (dmit-OH) species. Electrochemical studies indicate that when 
bound to zinc, dmit and dmise ligands become less readily oxidizable compared to free 
dmit and dmise, opposite the trend observed for similar Cu(I) and Fe(II) complexes.
16,19
  
Although dmit oxidation is metal-dependent, dmise oxidation is unaltered whether bound 
to redox-active metals such as copper and iron or the non-redox active zinc.  
 
4.5 Experimental Methods 
General procedures. The synthesis of complexes 3 and 4 were carried out under 
an inert atmosphere of argon using standard Schlenk techniques. The following reagents 
were used as received: acetonitrile (Acros), diethyl ether (Acros), zinc(II) chloride 
(Acros) and zinc(II) tetraflouroborate (Acros). Dmit and dmise were synthesized 
following reported procedures.
50
  All other reagents and solvents were used without 
further purification unless noted.  
Instrumentation.  
1
H and 
13
C NMR spectra were obtained on a Bruker-AVANCE 
300 MHz NMR spectrometer. 
1H NMR chemical shifts are reported in δ relative to 
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tetramethylsilane (δ 0) and referenced to solvent. Infrared spectra were obtained using 
Nujol mulls on KBr salt plates with a Magna 550 IR spectrometer. Abbreviations used in 
the description of vibrational data are as follows: vs, very strong; s, strong; m, medium; 
w, weak; b, broad. MALDI mass spectrometry experiments were performed using a 
Bruker Microflex MALDI-TOF mass spectrometer with trans-2-[3-(4-tert-butylphenyl)-
2-methyl-2-propenyldiene (m/z 250.3) as the matrix. Electrospray ionization mass 
spectrometry (ESI-MS) was conducted by Lynn Zang using a SYNAPT G2 LC/MS/MS 
System from Waters via direct injection of sample (0.10 mL/min flow rate) into a Turbo 
Ionspray ionization source. Samples were run under positive mode in acetonitrile, with an 
ionspray voltage of 2500 V and in QTOF scan mode.  All observed peak envelopes match 
theoretical calculations for their ions.  
Electrochemistry. A three-compartment cell was used with an Ag/AgCl reference 
electrode, a Pt counter-electrode, and a glassy carbon working electrode. 
Dimethylformamide (freshly distilled) was used as solvent with tetra-n-butyl ammonium 
phosphate as the supporting electrolyte. Solutions containing 0.1 M electrolyte were 
deaerated for 10 minutes by vigorous nitrogen purge. All E1/2 values were calculated from 
(Epa + Epc)/2 at a scan rate of 100 mV/s. The ferrocenium/ferrocene couple was 
measured under the same conditions to correct for junction potentials. The measured 
potentials were adjusted from Ag/AgCl to NHE (-0.197 V
51
) and then corrected with the 
measured ferrocenium/ferrocene couple vs. NHE (0.400 V
52
).  Cyclic voltammograms 
complexes 1 - 4 are provided in Figure 4.6.  
Synthesis of Zn(dmit)2Cl2  (1). Into a 25 mL Erlenmeyer flask, dmit (327 mg, 2.55 
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mmol) was dissolved in boiling acetonitrile (25 mL). ZnCl2 (174 mg, 1.28 mmol) was 
added with stirring, and the mixture was heated at a slow boil for approximately 20 min 
until the reaction volume was reduced to approximately 5 mL. Colorless crystals formed 
upon cooling to room temperature, and the flask was covered and refrigerated for 12 h. 
The solution was then filtered, and the crystals were washed with cold acetonitrile. Yield: 
430 mg, 86%. 
1
H NMR (DMSO-d6): δ 3.45 (s, 6H, CH3), 7.11 (s, 2H, CH). 
13
C{
1
H} 
NMR (DMSO-d6): δ 34.5 (CH3), 118.1 (CH), 161.6 (S=C). IR (cm
-1
): 3149 (m), 3099 
(m), 2920 (b), 2727 (w), 2671 (w), 1707 (w), 1606 (w), 1563 (s), 1463 (vs), 1378 (vs), 
1241 (w), 1227 (m), 1172 (m), 1085 (m), 865 (w), 751 (s), 740 (s), 678 (s), 630 (w), 501 
(m), 480 (w).MALDI-MS (m/z) = 228.0 [Zn(dmit)Cl]
+
, 357.0 [Zn(dmit)2Cl]
+
, 392.9 
[Zn(dmit)2Cl2]H
+
. Anal. Calcd. for C10H16Cl2N4S2Zn: C, 30.59; N, 14.27; H, 4.11. 
Found: C, 30.85; N, 14.30; H, 4.08. Melting point: 198-200 °C. 
Synthesis of Zn(dmise)2Cl2 (2). Complex 2 was prepared following the procedure 
for 1 except that ZnCl2 (140 mg, 1.03 mmol) was used and dmise (380 mg, 2.06 mmol) 
was used in place of dmit. After filtration, pale yellow crystals were obtained. Yield: 420 
mg, 84%. 
1
H NMR (DMSO-d6): δ 3.54 (s, 6H, CH3), 7.31 (s, 2H, CH). 
13
C{
1
H} NMR 
(DMSO-d6): δ 36.4 (CH3), 120.3 (CH), 154.8 (S=C). IR (cm
-1
): 3148 (w), 3095 (m), 2926 
(b), 2727 (w), 1711 (w), 1609 (w), 1562 (m), 1456 (vs), 1378 (vs), 1242 (w), 1225 (m), 
1149 (m), 1087 (m), 865 (w), 754 (s), 737 (s), 663 (m), 613 (w), 468 (m). MALDI-MS 
(m/z) = 276.0 [Zn(dmise)Cl]
+
, 450.8 [Zn(dmise)2Cl]
+
, 486.8 [Zn(dmise)2Cl2]H
+
. Anal. 
Calcd. for C10H16Cl2N4Se2Zn: C, 24.69; N, 11.52; H, 3.32. Found: C, 24.92; N, 11.56; H, 
3.21. Melting point: 208-210 °C (dec.). 
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Synthesis of [Zn(dmit)4][BF4]2  (3). Zn(BF4)2 (226 mg, 0.67 mmol) was dissolved 
in acetonitrile (5 mL) and added to a solution of dmit (170 mg, 1.3 mmol) in acetonitrile 
(10 mL). The solution stirred for 12 h, and the solvent volume was then reduced to 5 mL. 
The product was precipitated with diethyl ether and dried under vacuum, yielding a light 
yellow powder. Crystals were grown by slow vapor diffusion of ether into acetonitrile. 
Yield: 370 mg, 74%. 
1
H NMR (DMSO-d6): δ 3.45 (s, 12H, CH3), 7.10 (s, 4H, CH). 
13
C{
1
H} NMR (DMSO-d6): δ 34.4 (CH3), 118.0 (CH), 161.9 (S=C). IR (cm
-1
): 3168 (w), 
3140 (w), 3115 (w), 2925 (vs, b), 2727 (w), 1570 (m), 1490 (w), 1459 (s), 1398 (w), 1377 
(m), 1288 (w), 1180 (m), 1054 (s), 861 (w), 745 (m), 679 (m), 521 (w), 502 (w). MALDI-
MS (m/z) = 288.1 [Zn(dmit)4]
2+
, 663.2 [Zn(dmit)4][BF4]
+
. Anal. Calcd. for 
C20H32B2F8N8S4Zn: C, 31.95; N, 14.91; H, 4.29. Found: C, 31.98; N, 14.91; H, 4.29. 
Melting point: <260 °C. 
Synthesis of [Zn(dmise)4][BF4]2   (4). Complex 4 was prepared using the same 
procedure as complex 3 except Zn(BF4)2 (180 mg, 0.53 mmol) was used and dmise (187 
mg, 1.06 mmol) was used instead of dmit. Yellow crystals were grown by slow vapor 
diffusion of ether into acetonitrile. Yield: 400 mg, 80%. 
1
H NMR (DMSO-d6): δ 3.54 (s, 
12H, CH3), 7.32 (s, 4H, CH). 
13
C{
1
H} NMR (DMSO-d6): δ 36.3 (CH3), 120.1 (CH), 
155.1 (S=C). IR (cm
-1
): 3165 (w), 3139 (w), 3106 (w), 2972 (s), 2853 (s), 1569 (w), 1459 
(s), 1378 (m), 1260 (w), 1237 (m), 1146 (w), 1055 (s), 800 (w), 740 (m), 652 (w), 521 
(w). MALDI-MS (m/z) = 383.0 [Zn(dmise)4]
2+
, 854.9 [Zn(dmise)4][BF4]
+
 Anal. Calcd. 
for C20H32B2F8N8Se4Zn: C, 25.57; N, 11.93; H, 3.43. Found: C, 25.46; N, 11.71; H, 3.40. 
Melting point: <260 °C. 
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Reactivity of Zn(dmit)2Cl2 with H2O2. Zn(dmit)2Cl2 (20 mg, 0.041 mmol) was 
dissolved in dimethylsulfoxide-d6 (0.5 mL) and to this was added 1.0, 2.0, 3.0 or 4.0 
equiv of H2O2 (0.041 , 0.082, 0.123, or 0.164 mmol; 1.45, 2.90, 4.35, or 5.80 μL). The 
reaction mixtures were stirred for 10 min. Yield of oxidized product using 4 equiv H2O2: 
53% by 
1
H NMR spectroscopy. 
1
H NMR (DMSO-d6): δ 3.83 (s, 6H, 2CH3), 7.67 (s, 2H, 
2CH), 9.01 (s, 1H, CH). MALDI-MS: m/z positive ionization: 97.1 [C5H9N2]
+
, 100.0 
[ZnCl]
+
; negative ionization: 81.0 [SO3H]
-
. 
Reactivity of Zn(dmise)2Cl2 with H2O2. Zn(dmise)2Cl2 (20 mg, 0.051 mmol) was 
dissolved in dimethylsulfoxide-d6 (0.5 mL) and to this was added 1.0, 2.0, 3.0, or 4.0 
equivalents of H2O2 (0.051, 0.102, 0.153, or 0.204 mmol; 1.20, 2.40, 3.60, or 4.80 μL). 
The reaction mixtures were stirred for 10 min. Yield of oxidized product using 4 
equivalents of H2O2: 85% by 
1
H NMR spectroscopy. 
1
H NMR (DMSO-d6): δ 3.84 (s, 6H, 
2CH3), 7.67 (s, 2H, 2CH), 9.07 (s, 1H, CH). MALDI-MS: m/z positive ionization: 97.1 
[C5H9N2]
+
, 100.0 [ZnCl]
+
; negative ionization: 113.0 [SeO2H]
-
. 
 Single crystal X-ray data collection. Single crystals of Zn(dmit)2Cl2 (1), 
crystallized as colorless rods, were grown from cooling the reaction mixture of 
acetonitrile solution. [Zn(dmise)4][BF4]2 (4), crystallized as light yellow prisms, were 
grown from vapor diffusion of diethyl ether into an acetonitrile solution. Both crystals 
were mounted on a glass filament with epoxy glue, and immediately placed on the 
diffractometer in a room-temperature nitrogen gas stream. Intensity data were collected 
using a Rigaku Mercury CCD detector and an AFC8S diffractometer. The space groups 
P21/n and Pbcn were determined from the systematic absences for complexes 1 and 4 
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respectively (Table 4.4). The structures were solved by direct methods and subsequent 
Fourier difference techniques, and refined anisotropically, by full-matrix least squares, on 
F
2
 using SHELXTL 6.10.
53
 The quantity minimized by the least squares program was 
Σw = (Fo
2
 - Fc
2
)
2
 where w ={[σ2(Fo
2
)]+(0.0307P)
2
 + 1.57P} where P = (Fo
2
)+2Fc
2
)/3. In 
the final cycle of least squares, independent anisotropic displacement factors were refined 
for the non-hydrogen atoms, and hydrogen atoms were fixed in idealized positions with 
C—H = 0.96 A. Isotropic hydrogen atom displacement parameters were set equal to 1.5 
times Ueq of the attached carbon atom. For 1, the largest peak in the final Fourier 
difference map (0.45 e·A
-3
) was located 0.81 Å from H8 and the lowest peak (-0.40 e·A-
3) was located at a distance of 0.82 A from Zn1. For 4 the largest peak in the final 
Fourier difference map (0.84 e·A
-3
) was located 0.92 Å from F1 and the lowest peak (-
0.84 e·A
-3
) was located at a distance of 0.45 Å from F5. 
 
 
Figure 4.5. Crystal packing diagram for Zn(dmit)2Cl2 (1) showing short Cl-H interactions as viewed along 
the a-axis. 
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Figure 4.6. Crystal packing diagram for [Zn(dmise)4][BF4]2 (4) showing short F-H interactions as viewed 
along the c-axis. 
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Table 4.4. Summary of crystallographic data for complexes 1 and 4. 
  1 4 
Chemical formula C10H16Cl2N4S2Zn C20H32B2F8N8Se4Zn 
F.W. (g/mol
-1
) 392.66 939.37 
Space group P21/n Pbcn 
Crystal system Monoclinic Orthorhombic 
a, Å 9.364(1) 11.960(2) 
b, Å 13.590(1) 21.373(4) 
c, Å 13.202(2) 13.163(3) 
α, deg 90 90 
β, deg 108.736 90 
γ, deg 90 90 
V, Å
-3
 1591.4(4) 3364(1) 
Z 4 4 
Dcal, mg/m
3
 1.639 1.854 
indices (min) [-11, -16, -15] [-14, -25, -15] 
indices (max) [10, 15, 15] [14, 25, 15] 
parameters 176 223 
F(000) 800 1824 
μ, mm-1 2.13 5.13 
2θ range, deg 2.7-26.4 2.5-26.7 
collected reflections 11422 25454 
unique reflections 2859 2445 
Final R (obs. data)
a
, R1 0.0371 0.0563 
wR2 0.0829 0.1452 
final R (all data), R1 0.0445 0.0682 
wR2 0.0895 0.1593 
goodness of fit (S) 1.147 1.11 
largest diff. peak 0.45 0.84 
largest diff. hole -0.40 -0.82 
a
 R1 = Σ ǁ F0| - |Fcǁ/Σ|F0|; wR2 = {Σw(F0
2
 - Fc
2
)
2
}
1/2
. 
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CHAPTER FIVE 
SYNTHESIS AND CHARACTERIZATION OF IMIDAZOLE THIONES 
AND SELONES AND THEIR DERIVATIVES 
 
5.1 Introduction 
Thione and selone compounds feature a sulfur- or selenium-carbon double bond 
(S/Se=C), respectively, and they have been studied in a variety of applications, including 
zinc selenide synthons for electronics,
1-3
 biological antioxidants,
4-8
 and as antithyroid 
drugs.
9-16
 Initial interest in antioxidant thiones, selones, and their derivatives arose from 
the discovery of ergothioneine (Figure 5.1).
17-23
 More recently, ergothioneine’s selenium 
analog, selenoneine (Figure 5.1), was discovered in the blood of bluefin tuna and has 
been reported in human blood in concentrations up to 9 nM.
23
  Both ergothioneine and 
selenoneine have been studied for their ability to act as antioxidants through radical 
scavenging and metal coordination.
24,25
 Ergothioneine prevents Cu(I)-mediated  
  
Figure 5.1. Ergothioneine, selenoneine, methimazole, dmit, dmise and their novel sulfur and selenium 
containing compounds. 
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deoxyribose damage in concentrations up to 1 mM.
25
 Although little is known about 
selenoneine, it scavenges 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical and protects Fe
2+
 
from oxidation in hemoglobin and myoglobin in vitro.
23
  
Methimazole, a derivative of ergothioneine and a widely-prescribed anti-thyroid 
drug, is a potent ROS-scavenging antioxidant and prevents oxidative DNA damage.
14,26
 
Recently, the selenium analog of methimazole (MSeI; Figure 5.1) has attracted 
considerable attention, since MSeI is expected to be more nucleophilic than 
methimazole.
27,28
 Interestingly, methimazole, MSeI, and their derivatives do not exist in 
true selone or thione form (Figure 5.2A), but rather they exist primarily in the 
zwitterionic resonance structure (Figure 5.2B).
8,11-14,28
  
N,N’-Dimethylimidazole thione (dmit) and selone (dmise; Figure 5.1), thione and 
selone analogs of ergothioneine and selenoneine, prevent copper- and iron-mediated 
DNA damage at micromolar concentrations.
29
 Interestingly, dmit and dmise are 
multifunctional antioxidants, preventing oxidative DNA damage through both radical-
scavenging and metal-binding mechanisms.
29
 Altering the N-substituted functional groups, 
(R =  H, CH3, and Py) and potential denticity for metal chelation significantly alters the 
antioxidant activity of these thiones and selones.
29
  
To expand upon studies of the well-investigated dmit and dmise compounds as  
 
Figure 5.2. Thione and selone A) non-zwitterionic and B) zwitterionic resonance structures.  
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well as commercially available methimazole, we have synthesized novel sulfur- and 
selenium-containing compounds 1 - 4. Adding electron-withdrawing or -donating 
substituents to these imidazole thiones and selones may alter the resonance in these 
molecules to favor either the zwitterionic or non-zwitterionic structures, affecting their 
metal binding and antioxidant abilities. 
 
5.2 Results and Discussion 
Synthesis. The sulfur and selenium compounds 1, 2, 5, and 6 were synthesized 
either by nucleophilic sulfur and selenium addition, utilizing a carbene reaction of the 
imidazolium salt, or through electrophilic sulfur or selenium addition, utilizing low-
temperature metalation. Compounds 1 and 2 were synthesized by methyl iodide 
methylation of 4,5-dichloroimidazole to yield 4,5-dichloro-1,3-dimethylimidazolium 
iodide, followed by nucleophilic addition of elemental sulfur or selenium resulting in the 
corresponding dichloro-substituted thione (1) and selone (2) compounds (Scheme 5.1A).  
The trityl-substituted compound (3) was synthesized by deprotonation of the 
secondary amine, followed by trityl protection of the sulfur (Scheme 5.1B). This trityl-
protected thiol (3) blocks metal coordination to the sulfur atom, allowing for sole 
coordination through the nitrogen atom of the imidazole ring, a binding mode that is not 
observed for methimazole-metal coordination.
30
 Although trityl protection of sulfur 
atoms is not novel, trityl-protection of the sulfur is a novel synthetic route for addition of 
substituents to the nitrogen atom of thiones. Similar trityl-protection of the selone analog 
was also attempted; however under these conditions, the selone compound  
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 Scheme 5.1 
 decomposes, as observed by NMR spectroscopy. 
Treatment of 3 with chloroacetone, followed by acidic deprotection of the trityl 
group and purification yields the keto-substituted thione (4; Scheme 5.1B). Adding a keto 
group onto the imidazole nitrogen not only alters the electronics within the imidazole 
ring, but also may increase denticity by adding the keto oxygen as a possible metal-
binding site.  
 The novel compound 5 and the reported compound 6
10
 were synthesized using a 
new synthetic route by methylation of 1-methylimidazole, resulting in an imidazolium 
salt, followed by lithiation by n-butyllithium and subsequent electrophilic addition of 
elemental sulfur or selenium. Utilizing an acid workup yields the oxidized disulfide (5) or 
diselenide (6) salts (Scheme 5.1C). Rather than adding dmise to a solution of 
lactoperoxidase (LPO), H2O2, and KI in aqueous phosphate buffer,
10
 this method allows 
for a cheaper and more reliable synthetic route for good yields of 5 and 6. 
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Structural analysis of thione and selone compounds. Crystals of 
4,5-dichloro-1.3-dimethylimidazole thione (1) and 4,5-dichloro-1.3-dimethylimidazole 
selone (2) were grown by recrystallization from methanol solutions, and trityl-
methimazole (3) as a 1:1 adduct with trityl-alcohol were grown by recrystallization from 
acetonitrile solutions at -20 ˚C. Single crystal X-ray diffraction data were collected by Dr. 
Collin McMillen (Department of Chemistry, Clemson University) for 1 and 2, which 
crystallized as colorless columns, and 3, which crystallized as colorless blocks. The 
resulting molecular structures are shown in Figure 5.3, and selected bond distances are 
summarized in Table 5.1.  
The C=S bond length of 1.664(3) Å for the dichloro-thione (1) is significantly 
shorter than those in methimazole (1.699(5) Å
31
) and dmit (1.692(1) Å
32
), suggesting that 
1 favors a resonance structure with more double bond character than methimazole and 
dmit.  The C=Se bond length in 2 (1.829(6) Å) is also slightly shorter than those in MSeI 
(1.849(3) Å
28
) and dmise (1.843(9) Å
33
), again suggesting less zwitterionic character in 
the structure of the cloro-substituted selone. This decrease in C=S/Se bond lengths and  
 
Figure 5.3. Crystal structure diagrams with 50% probability density ellipsoids for A) 1,3-dimethyl-4,5-
dichloroimidazole thione (1), B) 1,3-dimethyl-4,5-dichloroimidazole selone (2), and C) trityl-methimazole 
(3). Hydrogen atoms are omitted for clarity. 
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Table 5.1. Selected average interatomic distances (Å) for methimazole, dmit, dmise, 1, 2, and 3. 
Compound C-N S/Se=C References 
dmit 1.349(1) 1.692(1) 32 
methimazole 1.356(2) 1.696(5) 31 
1 1.365(4) 1.664(3) this work 
3 1.35(1) 1.74(1) this work 
dmise 1.343(9) 1.843(9) 33 
MSeI 1.347(3) 1.849(3) 28 
2 1.361(9) 1.829(6) this work 
 
zwitterionic character compared to methimazole, MSeI, dmit, and dmise, likely results in 
decreased metal-binding affinity for 1 and 2 if the negative charge on the sulfur or 
selenium atom is reduced.  
Interestingly, the dichloro-thione (1) and dichloro-selone (2) crystallize in 
different space groups (P6522 and P21/n, respectively; Table 3).  Since this is not the case 
for isostructural dmise and dmit,
32,33
 we speculate that the interactions involving the 
chlorine atoms are integral in directing different packing arrangements for 1 and 2. In 
particular, differences in crystal packing may be due to additional stabilization from 
interaction of the chlorine atoms with π electron density from the imidazole ring enabled 
by the screw axis in the hexagonal packing (Figures 5.4 and 5.5) of 1. Furthermore, for 1, 
Cl-S interactions of 3.383(2) Å with C-Cl---S of 170.5(2)° are observed to occur in the ab 
plane.  This shorter, highly directional contact (~5% shorter than the sum of the van der 
Waals radii) is suggestive of Cl---S halogen bonding as a contributor to the unique 
packing of 1.  In the case of 2, similar C-Cl---Se interactions are observed (Cl---Se = 
3.52(4) Å, C-Cl---Se = 171.9(1)°), but the interaction of Cl with the imidazole π electron 
density appears absent. 
The aromaticity of methimazole, MSeI, dmit, dmise, and compounds 1 - 4 were 
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also considered based on the average imidazole C-N bond length (Table 5.1). As 
previously reported, methimazole has an average C-N bond length of 1.356(2) Å.
31
 For 
dmit, addition of a methyl group onto the imidazole nitrogen decreases the average C-N 
bond length within the ring (1.349(1) Å32) by 0.007 Å, indicating slightly more 
aromaticity of the imidazole ring in dmit. The dichloro-thione 1 has an average imidazole 
C-N bond length of 1.365(4) Å, 0.016 Å longer than that in dmit.
32
 The increase in 
average C-N bond length for 1 as compared to methimazole and dmit indicates an 
increase in C-N single bond character, and slightly less aromatic character than 
methimazole and dmit. Similar trends in aromaticity are also observed for the selones 2, 
MSeI,
28
 and dmise.
33
 MSeI has an average C-N bond length of 1.347(3) Å, whereas 
dmise has an average C-N bond length of 1.343(9) Å.
33
 The dichloro selone 2 has an 
average C-N bond length of 1.361(9) Å, 0.018 Å longer than that of dmise
33
 and 0.014 Å 
longer than MSeI. Both the lengthening of the C-N bonds and the shortening of the 
C=S/Se bonds relative to unsubstituted methimazole and MSeI are consistent with a 
decrease in the aromatic imidazole resonance structure the dichloro-thione (1) and 
-selone (2; Figure 5.2). 
Trityl-methimazole (3) has a C-S bond length of 1.74(1) Å, confirming single 
bond character fairly typical for thiol compounds (1.806(6) Å
34
). The average C-N bond 
length of 1.350(5) Å is very similar to the C-N bond length of methimazole and dmit 
(1.356(2) Å
31
 and 1.349(1) Å
32
; respectively).  Compound 3 presents an interesting case 
for future study, since as a ligand it will only bind metal ions through the non-methylated 
nitrogen site on the imidazole ring. This may permit a comparison study of the 
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requirement for metal-sulfur binding in metal-mediated DNA damage prevention. 
 NMR and IR spectroscopies. The 
1
H NMR resonances of the methyl and olefinic 
protons for complexes 1 – 4 are listed in Table 5.2. For the dichloro-thione 1, the methyl 
proton resonances (δ 3.59) are slightly shifted upfield compared to the methyl resonances 
of dmit (δ 3.6111) due to the induction effect of the Cl atoms into the imidazole ring. This 
effect is also observed for the selone analog 2 when comparing its methyl resonance (δ 
3.65) to the methyl resonance of dmise (δ 3.7111). These 1H NMR shifts corroborate the 
X-ray data, indicating a shift to the non-zwitterionic resonance form for 1 and 2 
compared to dmit and dmise (Figure 5.2). The opposite trend is observed for the methyl-
keto-thione (4), since the electron withdrawing methyl-keto substituent increases the 
induction effect of the opposite nitrogen-bound methyl, as supported by the slight 
downfield resonance shift of the methyl protons 4 (δ 3.68) compared to 1 and dmit.11 The 
increase in zwitterionic character of 4 is further confirmed by the downfield shift of the 
imidazole protons (δ 6.95 and 7.04) compared to dmit (δ 6.72). This increase in 
zwitterionic character of 4 as well as a possible chelate effect of the methyl-keto 
substituent may increase its metal binding affinity. 
The methyl proton
 
resonance of the trityl-protected thiol 3 (δ 2.92) is significantly 
shifted upfield compared to the thiones 1, 3, and dmit (δ 3.59 - 3.68), whereas the 
imidazole proton resonances of 1 and 3 (δ 6.79 and 7.05) are shifted downfield compared 
to those of dmit (δ 6.72).  This resonance shifting indicates a greater aromatic character 
compared to dmit. Because the trityl-protected thiol 3 is not a thione and should solely 
bind metals through the available nitrogen within the imidazole ring, the increase in 
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Table 5.2. Selected 
1
H NMR resonances (in CDCl3) and IR stretches for compounds 2 - 4, dmit, dmise, and 
methimazole. 
Compound 
1H NMR shifts (δ) 
Reference 
IR (cm
-1
)  
CH3 Imidazole C-H S/Se=C Reference 
1 3.59 n/a This work 1164 This work 
2 3.65 n/a This work 1144 This work 
3 2.92 6.79, 7.05 This work - - 
4 3.68 6.95, 7.04 This work 1152 This work 
dmit 3.61 6.72 11 1181 34 
dmise 3.71 6.88 11 1147 28 
methimazole 3.60 6.68, 6.72 35 1150 36 
 
imidazole aromatic character compared to 1, 3, and dmit may afford an increase in metal 
binding affinity due to an increase in zwitterionic character. The increase in zwitterionic 
character increases the partial negative charge on the S atom, potentially increasing metal 
binding affinity. 
The S/Se=C bond IR stretching frequencies of the thione and selone complexes 1, 
2, 4, dmit, dmise, and methimazole are listed in Tables 5.2. For the dichloro-thione 1, the 
observed S=C stretching vibration (1164 cm
-1
) is significantly shifted to lower energy 
compared dmit (1181 cm
-1 34). The same shift to lower energy is observed for the methyl-
keto thione 4 (1152 cm
-1
) compared to dmit, however the S=C bond energy is similar to 
methimazole (1150 cm
-136). The decrease in S=C bond energy of the dichloro-thione 1 
indicates an increase in single bond character compared to dmit similar to the observed 
effect in 
1
H NMR spectroscopy, however it is an opposite effect observed in X-ray 
possibly due to π-stacking with the imidazole ring and chloride atoms as observed in 
Figure 5.3 as well as possible solid vs. solution state interactions.  
Although large changes are observed in the S=C stretching vibration for the 
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thiones 1, 4, dmit, and methimazole, the same is not true for their selone counterparts. 
The observed Se=C stretching vibration for the dichloro-selone 2 (1144 cm
-1
) is similar to 
that observed for dmise (1147 cm
-1
 28), indicating little change in Se=C bond strength 
upon chloro substitution. This is not surprising, since unbound dmise has increased 
zwitterionic character compared to dmit as reported using DFT calculations.
8
 
Syntheses of these imidazole thione and selone compounds and their derivatives 
have required development of novel synthetic strategies. In particular, trityl protection of 
the sulfur atom allows for direct addition of aliphatic substituents onto the imidazolium 
nitrogen. The ability to synthesize novel thione and selone compounds under atmospheric 
conditions enables facile synthesis of new thiones and selones not achievable through 
reported methods.  
  
5.3 Conclusions  
We have synthesized novel sulfur and selenium compounds 1 - 4 and synthesized 
compounds 5 and 6 using new experimental methods. In addition, we have introduced a 
novel synthetic route for addition of aliphatic substituents to the nitrogen of the imidazole 
thione ring of by trityl protection of the sulfur, as observed in 3; however, the same 
synthetic procedures do not work for their selenium analogs. Synthesis of these novel 
thione and selone compounds 1 - 4 can be easily carried out under non-oxygen sensitive 
conditions. X-ray diffraction studies indicate that the addition of chloride atoms onto the 
imidazole ring decreases the zwitterionic character of thiones, however the selone analog 
shows no significant difference in zwitterionic character. 
1
H NMR and IR spectroscopies 
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indicate an increase in zwitterionic character for the dichloro-thione (1) and -selone (2) 
compounds, possibly increasing their metal binding affinities. The 
1
H NMR and IR data 
for the methyl-keto thione (4) indicates an increase in the increase in zwitterionic 
character compared to dmit and methimazole, possibly increasing its metal binding 
affinity. The keto-substituent also may afford an increase in metal binding affinity via 
increase in denticity though the available O and S atoms. Introduction of the trityl 
protection of the sulfur atom may be worth exploring as a method to easily synthesize 
novel thione derivatives. 
 
 5.4 Experimental Methods 
 All reagents were used as received with no purification; 1,3-dimethylimidazolium 
iodide was synthesized following published procedures.
11
  
Instrumentation. 
1
H and 
13
C{
1
H} NMR spectra were obtained on a Bruker-
AVANCE 300 MHz NMR spectrometer. 
1H NMR chemical shifts are reported in δ 
relative to tetramethylsilane (δ 0) and referenced to solvent. Infrared spectra were 
obtained using on KBr salt plates with a Magna 550 IR spectrometer. Abbreviations used 
in the description of vibrational data are as follows: vs, very strong; s, strong; m, 
medium; w, weak; b, broad. MALDI mass spectrometry experiments were performed 
using a Bruker Microflex MALDI-TOF mass spectrometer with trans-2-[3-(4-tert-
butylphenyl)-2-methyl-2-propenyldiene (m/z 250.3) as the matrix. In all cases, observed 
isotopic patterns matched their calculated values. 
Synthesis of 4,5-dichloro-1,3-dimethy-imidazole thione (1). A mixture of 
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4,5-dichloroimidazole (0.25 g, 1.83 mmol), iodomethane (0.115 g, 1.83 mmol), and 
potassium carbonate (0.375 g, 2.75 mmol) in acetonitrile (10 mL) was stirred at room 
temperature for 48 h. The mixture was filtered, and the filtrate was dried under vacuum to 
give a yellowish-white solid. The solid was dissolved in CH2Cl2 (25 mL) and washed 
with water (8 mL × 2) to remove potassium carbonate. The organic layer was separated 
and dried over MgSO4, and the resulting solution was evaporated to dryness under 
vacuum to afford a white solid. This white solid was dissolved in acetonitrile (0.5 mL), 
and iodomethane (0.5 mL, 8 mmol) was then added. The resulting solution was heated at 
55 °C for 18 h in a pressure tube, yielding white crystals that were then filtered, washed 
with diethyl ether (30 mL × 2), and dried under vacuum. Analysis of the white crystals of 
4,5-dichloro-1,3-dimethylimidazolium iodide (246 mg; 0.702 mmol) matches reported 
1
H 
NMR values.
11
 To a solution of 4,5-dichloro-1,3-dimethylimidazolium iodide (246 mg; 
0.702 mmol) dissolved in methanol (10 mL), sulfur powder (28 mg; 0.772 mmol) and 
potassium carbonate (97.0 mg; 0.900 mmol) were added and the solution was heated to 
reflux for 36 h. The hot yellow-brown mixture was filtered through a pad of celite to 
remove potassium carbonate and excess sulfur. The filtrate was dried under vacuum, and 
the resulting solid was dissolved in methanol (2 mL). The methanolic solution was cooled 
to -20 °C, yielding 4,5-dichloro-1,3-dimethy-imidazole thione (1) as colorless needles. 
Yield: 116 mg, 46%. 
1
H NMR (300 MHz, CDCl3): δ 3.59 (s, 6H). 
13
C{
1
H}NMR 
(CDCl3): δ 36.2 (s, CH3), 117.3 (s, C-Cl), 162.1 (s, C=S). IR (cm
-1
): 2914 (s, br), 2866 (s, 
b) 1592 (m), 1462 (s), 1378 (s), 1338 (m), 1222 (w), 1164 (m), 1132 9 (w), 1066 (m), 970 
(w), 951 (w), 854 (m), 665 (w), 616 (w), 565 (m), 416 (m). MALDI-MS (m/z): 197.2 
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[C4H6Cl2N2S]H
+
. Anal. Calcd. for C4H6Cl2N2S: C, 30.47; H, 3.07; N, 14.21. Found: C, 
30.23; H, 3.02; N, 14.16. m.p.: 180 – 182 ˚C. 
Synthesis of 4,5-dichloro-1,3-dimethylimidazole selone (2). To a solution of 
4,5-dichloro-1,3-dimethylimidazolium iodide (426 mg; 1.45 mmol) dissolved in 
methanol (10 mL), Se powder (126 mg; 1.60 mmol), and K2CO3 (169 mg; 1.22 mmol) 
were added, and the mixture was heated to reflux for 36 h. The resulting black solution 
was filtered through a pad of celite to remove potassium carbonate and excess selenium. 
The filtrate was dried under vacuum, and the resulting solid was dissolved in methanol (2 
mL). The methanolic solution was cooled to -20 °C, yielding 4,5-dichloro-1,3-dimethy-
imidazole selone (2) as colorless needles. Yield: 187 mg, 44%. 
1
H NMR (300 MHz, 
CDCl3): δ 3.65 (s, 6H). 
13
C{
1
H}NMR (CDCl3): δ 35.2 (s, CH3), 114.4 (s, C-Cl), 156.8 (s, 
C=Se). IR (cm
-1
): 3434 (s, b), 2082 (m, b), 1636 (s), 1438 (w), 1372 (m), 1337 (w), 1144 
(m), 1134 (m), 851 (w), 602 (w), 540 (w), 432 (w), 420 (w). MALDI-MS (m/z): 244.8 
[C4H6Cl2N2S]H
+
. Anal. Calcd. for C4H6Cl2N2Se: C, 24.61; H, 2.48; N, 11.48. Found: C, 
24.59; H, 2.51; N, 11.50. m.p.: 185 – 187 ˚C. 
Synthesis of trityl-methimazole (3). To a solution of methimazole (250 mg, 2.19 
mmol) dissolved in dry acetonitrile (50 mL), Cs2CO3 (856 mg, 2.62 mmol) and trityl 
chloride (610 mg, 2.19 mmol) were added, and the reaction mixture was stirred for 12 h. 
The solvent was removed under vacuum, and the resulting solid was washed with 
distilled H2O (30 mL × 2) and filtered leaving a peach colored solid of trityl-
methimazole. Yield: 333 mg, 43%. 
1
H NMR (CDCl3): δ 2.92 (s, CH3),  6.79 (JHH = 0.6, 
d, CH), 7.05 (JHH = 0.6, d, CH), δ 7.23 - 7.38 (m, trityl CH). 
13
C{
1
H} NMR (CDCl3):  δ 
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33.0 (s, CH3), 72.9 (s, S-C trityl), 122.9 (s, CH), 127.2 (s, CH), 127.3 (m, CH), 130.0 (s, 
CH), 130.5 (s, CH), 144.0 (s, C), 146.9 (s, C-Ph). IR (cm
-1
): 3407 (s, br), 3082 (m), 3055 
(m), 3029 (m), 2367 (w), 2334 (w), 1956 (w), 1594 (w), 1490 (s), 1445 (s), 1407, (w), 
1340 (w), 1280 (m), 1183 (w), 1158 (w), 1118 (w), 1061 (w), 1033 (m), 914 (w), 892 
(w), 846 (w), 735 (s), 699 (s), 669 (w), 620 (w), 502 (w).  MALDI-MS (m/z): 157.1 
[C23H20N2S]H
+
. Anal. Calcd. for C23H20N2S: C, 77.49; H, 5.66; N, 7.86. Found: C, 77.47; 
H, 5.68; N, 7.88. m.p.: 164 – 167 ˚C. 
Synthesis of 1-keto-3-methylimidazole thione (4). Trityl-methimazole (4) (367.5 
mg, 1.03 mmol) was dissolved in acetonitrile (80 mL) and cooled to 0 °C. Once cooled, 
chloroacetone (0.1 mL, 1.14 mmol) was added and the reaction mixture was solution was 
stirred for 6 h at 0 ˚C. The solution was treated with 10 mL of 1% TFA in water and the 
reaction mixture was stirred for 30 min producing a white precipitate. The white 
precipitate was removed via vacuum filtration and the filtrate was dried under vacuum to 
yielding 1-keto-3-methylimidazole thione (4) as a dark brown oil.  Yield: 180 mg; 50%. 
1
H NMR (CDCl3): δ 2.29 (s, CH3), 3.68 (s, CH3), 4.07 (s, CH2), 6.95 (s, CH), 7.04 (s, 
CH). 
13
C{
1
H} NMR (CDCl3):  δ 30.2 (s, CH3), 42.6 (CH3), 67.4 (s, CH2), 117.9 (s, CH), 
118.3 (s, CH), 162.3 (s, C=S), 201.9 (C=O). IR (cm
-1
):3431 (s, br), 2370 (w), 2343 (w), 
1734 (w), 1654 (m, br), 1637 (m, br), 1577 (w), 1458 (w), 1281 (w), 1034 (w), 1152 (w), 
1064 (w), 1035 (w), 688 (m, br).   MALDI-MS (m/z): 114.0 [C4H5N2S]H
+
 and 171.1 
[C7H10N2OS]H
+
. Anal. Calcd. for C7H10N2OS: C, 49.39; H, 5.92; N, 16.46. Found: C, 
49.28; H, 5.90; N, 16.40. 
Synthesis of 2,2'-disulfanediylbis(1,3-dimethyl-2,5-dihydro-1H-imidazol-3-ium) 
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(5). 1,3-dimethylimidazolium iodide (1.36 g, 6.09 mmol) was dissolved in dry 
tetrahydrofuran (50 mL), and the solution was cooled to -78 °C. Once cooled, 
n-butyllithium (2.2 mL, 2.5 M in hexanes) was added and the reaction mixture was 
allowed to stir for 35 min. The reaction mixture was warmed to room temperature, and 
then sulfur powder (292 mg, 9.12 mmol) was added, the reaction mixture was stirred for 
12 h, quenched with water (10 mL), and neutralized with 1 N HCl (10 mL). From the 
resulting solution, the desired product was extracted with dichloromethane (25 mL × 3), 
and the organic layer was washed with brine (20 mL) and then dried over sodium sulfate. 
The dichloromethane was removed under vacuum, affording 2,2'-disulfanediylbis(1,3-
dimethyl-2,5-dihydro-1H-imidazol-3-ium) (5) as a brown solid. Yield: 1.30 g, 73%. 
1
H 
NMR (CDCl3): δ 3.62 (s, 6H), 6.68 (s, 2H). 
13
C{
1
H} (CDCl3): δ 35.2 (s, CH3), 117.5 (s, 
CH), 162.8 (C=S). IR (cm
-1
): 3434 (s, b), 3157 (w), 3116 (w), 1637 (m), 1574 (w), 1493 
(m), 1466 (m), 1438 (m), 1394 (w), 1240 (m), 1182 (w), 1085 (w), 731 (m), 663 (m), 515 
(w). MALDI-MS (m/z): 389.0 [C10H22N4S2I]
+
. Anal. Calcd. for C10H22N4S2I2; C, 30.85; 
H, 5.70; N, 14.39. Found: C, 30.83; H, 5.69; N, 14.35. m.p.: 148 – 150 ˚C. 
Synthesis of 2,2'-diselanediylbis(1,3-dimethyl-2,5-dihydro-1H-imidazol-3-ium) 
(6). Compound 6 was synthesized similarly to 5, except selenium powder (4.10 g, 51.9 
mmol) was used instead of sulfur powder. The resulting orange solid was dried under 
vacuum, affording 2,2'-diselanediylbis(1,3-dimethyl-2,5-dihydro-1H-imidazol-3-ium). 
Yield 8.02 g, 76%. 
1
H NMR (CDCl3): δ 3.71 (s, 6H), 6.86 (s, 2H). 
13
C{
1
H} NMR 
(CDCl3): δ 35.6 (s, CH3), 117.7 (s, CH), 171.6 (C=Se). IR (cm
-1
): 3434 (s, b), 2088 (w, 
b), 1635 (s), 1486 (w), 1433 (w), 1384 (m), 1238 (w), 1148 (m), 737 (w), 652 (w). 
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MALDI-MS (m/z): 485.9 [C10H22N4Se2I]
+
. Anal. Calcd. for C10H22N4Se2I2; C, 19.69; H, 
3.64; N, 9.18. Found: C, 19.60; H, 3.60; N, 9.12. m.p.: 153 – 156 ˚C. 
X-ray data collection and structural determination. Single crystals grown from 
vapor diffusion were mounted on a glass filament with epoxy. The crystals were grown 
by recrystallization from methanol for 4,5-dichloro-1,3-dimethy-imidazole thione (1) and 
4,5-dichloro-1,3-dimethy-imidazole selone (2) and acetonitrile for trityl-methimazole (3). 
Intensity data were collected using a Rigaku Mercury CCD detector and an AFC8S 
diffractometer. The space groups P6522 for 1 and P21/n for 2 and 3 were determined from 
the observed systematic absences. Data reduction including the application of Lorentz 
and polarization (Lp) effects and absorption corrections used the CrystalClear program.
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The structures were solved by direct methods and subsequent Fourier difference 
techniques, and refined anisotropically, by full-matrix least-squares, on F
2
 using 
SHELXTL 6.10.
38
 The quantity minimized by the lest squares program was Σw(Fo
2
 - 
Fc
2
)
2
 where w = 1/[σ2(Fo
2
) + (0.0646P)
2
 + 1.0966P] for 1, w = 1/[σ2(Fo
2
) + (0.0537P)
2
 + 
3.3289P] for 2, w = 1/[σ2(Fo
2
) + (0.0768P)
2
 + 3.2106P] for 3, and P = (Fo
2
 + 2Fc
2
)/3. In 
the final cycle of least squares, independent anisotropic displacement factors were refined 
for the non-hydrogen atoms, and the methyl hydrogen atoms were fixed in idealized 
positions with C-H = 0.96 Å. Their isotropic displacement parameters were set equal to 
1.5 times Ueq of the attached carbon atom. 
For complex 1, the largest peak in the final Fourier difference map (0.26 eÅ
-3
) 
was located 1.20 A ° from Cl1, and the lowest peak (-0.28 eÅ
-3
) was located at a distance 
of 0.86 Å from Cl1. For complex 2, the largest peak in the final Fourier difference map 
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(0.66 eÅ
-3
) was located 0.77 A from Se1, and the lowest peak (-0.61 eÅ
-3
) was located at 
a distance of 0.81 A from Se2. For 3, the largest peak in the final Fourier difference map 
(0.22 eÅ
-3
) was located 1.41 Å from O1, and the lowest peak (-0.26 eÅ
-3
) was located at a 
distance of 0.87 Å from S1. Final refinement parameters for the structures of 1, 2, and 3 
are given in Table 5.3, and selected bond distances are summarized in Table 5.1.  
 
Figure 5.4. Crystal packing diagram for 4,5-dichloro-1,3-dimethylimidazole thione (1) showing π-overlap 
of the imidazole rings and Cl atoms.  
 
Figure 5.5. Crystal packing diagram for 4,5-dichloro-1,3-dimethylimidazole selone (2). 
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Table 5.3. Summary of crystallographic data for compounds 1, 2, and 3. 
 
1 2 3 
Chemical formula C5H6Cl2N2S C5H6Cl2N2Se  [C29H20N2S][C19H16O] 
F.W. (g/mol
-1
) 197.08 243.98 616.79 
Space group P6522 P21/n P21/n 
Crystal system hexagonal monoclinic Monoclinic 
a,Å 8.5087(12) 11.872 (2) 16.574(3) 
b,Å 8.5087(12) 14.261 (3) 8.6031(17) 
c,Å 20.583(4) 15.506 (3) 23.214(5) 
α, deg 90 90 90 
β, deg 90 103.76(3) 92.89 
γ, deg 90 90 90 
V,Å
-3
 1290.5(4) 2549.8(9) 3305.8(11) 
Z 6 12 4 
Dcal, Mg/m
3
 1.522 1.907 1.239 
indices (min) [-10, -10, -19] [-14, -17, -18] [-19, -9, -27] 
indices (max) [10, 10, 24] [11, 17, 18] [19, 10, 27] 
parameters 49 278 416 
F(000) 600 1416 1304 
μ, mm-1 0.924 4.973 0.134 
2θ  range, deg 2.76-25.14 1.97-25.25 2.46-25.25 
collected reflections 8247 21802 27561 
unique reflections 758 4607 5990 
Final R (obs. Data)
a
, R1 0.0499 0.0447 0.0691 
wR
2
 0.1329 0.113 0.1624 
final R (all Data), R1 0.0525 0.054 0.0978 
wR
2
 0.1351 0.121 0.1912 
goodness of fit (S) 1.087 1.087 1.039 
Absolute structure param. (Flack) 0.08 (31) - - 
largest diff. Peak 0.259 0.656 0.216 
largest diff. Hole -0.283 -0.609 -0.259 
a
 R1 = Σ ǁ F0| - |Fcǁ/Σ|F0|; wR
2
 = {Σw(F0
2
 - Fc
2
)
2
}
1/2
. 
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CHAPTER SIX 
SYNTHESIS AND CHARACTERIZATION OF IRON(II) AND ZINC(II) 
COMPLEXES OF METHIMAZOLE AND ITS DERIVATIVES  
 
 
6.1 Introduction 
Methimazole, 2-mercaptoimidazole, and their substituted derivatives are of 
interest due to their various biological and metal coordination properties.
1-17
 
Ergothioneine (Figure 6.1) is a potent antioxidant, preventing oxidative damage to lipids, 
proteins, and DNA.
18-20
 DFT and gel electrophoresis studies have shown that 
ergothioneine-copper coordination prevents copper-mediated oxidative DNA damage by 
inhibition of copper redox cycling.
21,22
 Methimazole (Figure 6.1) is a widely-prescribed 
antithyroid drug that inhibits thyroid hormone synthesis.
23
 Imidazole-2-thione derivatives 
have additional biological properties, including as a potentially new class of potent CCR2 
antagonists for the treatment of thyroid disorders,
24
 inhibition of peroxidase-catalyzed 
iodination reactions,
1
 and potent antioxidants for oxidative DNA damage prevention.
17,25 
Although imidazole-2-thione derivatization chemistry is well-explored, only recently 
 
Figure 6.1. Representative thione and selone compounds and their oxidized dimers. 
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have selenium analogs of these molecules been investigated.26-28 The selenium analog of 
ergothioneine, selenoneine (Figure 6.1), was recently discovered in the blood of bluefin 
tuna and humans with heavy tuna consumption in 5-10 nM concentrations.
29
 Selenoneine 
binds iron(II) in hemoglobin and myoglobin, preventing iron(II) auto-oxidation.
29
 The 
selenium analog of methimazole (MSeI; Figure 6.1) and its derivatives have also 
attracted attention because of the greater nucleophilicity of selone-containing compounds 
compared to their sulfur analogs,
30-32
 and these selones may inhibit thyroid peroxidase 
(TPO) and lactoperoxidase (LPO) enzymes by a different mechanism than their sulfur 
counterparts.
7
 Other investigations utilizing DNA gel electrophoresis have shown that 
imidazole-2-thione and –selone derivatives are potent antioxidants, preventing metal-
mediated DNA by radical scavenging as well as iron and copper coordination.
17
  
We have investigated the Fe(II) and Zn(II) coordination of methimazole and 2-
mercpatoimidazole because iron and zinc are the two most abundant d-block metal ions 
in biological systems,
33
 and metal binding may contribute to their biological effects.  In 
addition, comparing the properties of these iron and zinc complexes will allow us to 
determine the effect of redox activity of the metal ion on the ability of these metal-bound 
thione complexes to generate and/or scavenge radical species.  Methimazole and its 
selenium analog (MSeI) oxidize to their respective disulfide and diselenide 
compounds,
4,7-9,34
 but unlike their parent thiones and selones, the biological and 
antioxidant effects of these disulfide (mim
Me
)2 and diselenide (seim
Me
)2 (Figure 6.1) 
compounds have not been examined. We have investigated the coordination modes of 
(mim
H
)2, (mim
Me
)2, and (seim
Me
)2 with Fe(II) and Zn(II) to investigate their  potential 
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antioxidant mechanisms and their metal binding properties.
 
  
 
6.2 Results and Discussion 
Synthesis of Fe(II)- and Zn(II)-thione and -selone complexes. The syntheses of 
iron and zinc thione and selone complexes 1, 2, and 3 are shown in Scheme 1. Treating 
FeCl2·4H2O with two equivalents of methimazole (Scheme 6.1A) in a mixture of 
dichloromethane and triethylorthoformate (to remove water from the Fe(II) starting 
material) forms four-coordinate Fe(methimazole)2Cl2 (1) complexes in good yield (70%). 
Complex 1 decomposes in air within 20 min in the solid state and within 2-5 min in 
solution.  
Scheme 6.1 
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To compare the properties of analogous Fe
2+
 and Zn
2+
 complexes, Zn
2+
-
methimazole and 2-mercaptoimidazole complexes were also synthesized. Treating ZnCl2 
with two equivalents of methimazole or 2-mercaptoimidazole in acetonitrile for 4 h forms  
four-coordinate ZnL2Cl2 (L = methimazole (2) or 2-mercaptoimidazole (3) complexes in 
83% yields (Scheme 6.1A). Unlike the iron methimazole complex 1, the zinc thione 
complexes 2 and 3 are air-stable in the solid state and in solution.  
 Since methimazole and MSeI oxidize to form (mim
R
)2 and (seim
R
)2 (Figure 6.1), 
Fe(II) and Zn(II) complexes of these oxidized disulfide and diselenide ligands were 
synthesized. Treating FeCl2·4H2O with 1 equivalent of (mim
H
)2 in a mixture of methanol 
and triethylorthoformate forms four-coordinate [(κ2-mimH)2]FeCl2 (4) in reasonable yield 
(60%, Scheme 6.1B). Similar to the Fe(II) complex 1, complex 4 decomposes in air 
within 20 min in the solid state and 2-5 min in solution. Complex 5 was similarly 
synthesized in 53% yield (Scheme 6.1B) and is also air sensitive, decomposing within 30 
min in the solid state and within 10 min in solution.  
 The analogous Fe(II) diselenide complex 6 was also synthesized by treating 
FeCl2·4H2O with 1 equivalent of (κ
2
-seim
Me
)2 in a mixture of methanol and 
triethylorthoformate (51%, Scheme 6.1B). Likely due to the greater oxophilicity of 
selenium compared to sulfur, complex 6 is the most air-sensitive of the three iron(II) 
compounds, decomposing in air within 2 min in the solid state and 60 s in solution.  
 Treating ZnCl2 with 1 equivalent of (mim
Me
)2 in a mixture of methanol and 
triethylorthoformate yields [(κ2-mimMe)2]ZnCl2 (7, 53% Scheme 6.1B), analogous to the 
Fe(II) complex 5.  Zn(II) complex 7 is air-stable in the solid state and in solution. 
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NMR spectroscopy. The paramagnetic 
1
H NMR spectrum of Fe(methimazole)2Cl2 
(1) acquired in deuterated acetonitrile shows a large downfield shift of the methyl proton 
resonance (δ 13.16) and large upfield shifts of the olefinic resonances (δ 0.87 and 5.42) 
and the N-H resonance (δ 3.69) compared to unbound methimazole (Table 6.1). The large 
shifts observed and broadening for all proton resonances upon iron coordination are 
attributed to the paramagnetic effects of Fe
2+
.  
In contrast, the diamagnetic 
1
H NMR spectrum of Zn(methimazole)2Cl2 (2) 
acquired in deuterated dimethylsulfoxide shows no significant shifts of the methyl, two 
olefinic, and N-H proton resonances (δ 3.42, 6.87, 7.06, and 12.07, respectively) 
compared to unbound methimazole (Table 6.1).  The 
1
H NMR spectrum of 
Zn(2-mercaptoimidazole)2Cl2 (3) shows slight downfield shifts for both imidazole and N-
H proton resonances (δ 6.83 and 11.97, respectively) compared to unbound 
2-mercaptoimidazole (δ 6.81 and 11.92, respectively).  The slight downfield shift for all 
proton resonances of Zn-thione complexes 2 and 3 demonstrate that bound methimazole 
and 2-mercaptoinidazole slightly favor their zwitterionic resonance structures compared 
to the unbound thiones.  
The 
13
C{
1
H} NMR spectrum of iron complex 1 could not be obtained due to the 
large paramagnetic effects of Fe
2+
. The 
13
C{
1
H} NMR spectrum of the analogous zinc 
complex 2 shows slight upfield resonance shifts for the methyl carbon (δ 33.6), the 
olefinic carbons (δ 114.2 and 119.6), and the C=S carbon (δ 160.9) compared to unbound 
methimazole (δ 33.9, 114.4, 119.8, and 191.5, respectively). The 13C{1H} NMR spectrum 
of 3 shows no significant shifts of the olefinic carbon resonances (δ 116.0), and the C=S 
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carbon (δ 160.8) compared to unbound 2-mercaptoimidazole.  
The paramagnetic 
1
H NMR spectrum of [(κ2-mimH)2]FeCl2 (4) shows broad N-H 
and imidazole proton resonances with significant shifting (δ 2.57, 1.99, and 2.10, 
respectively) compared to the unbound disulfide (Table 6.1). Similar upfield shifts are 
observed for the 
1
H NMR methyl and imidazole proton resonances of [(κ2-mimMe)2]FeCl2 
(5) compared to unbound methimazole (Table 6.1). The 
1H NMR spectrum of [(κ2-
seim
Me
)2]FeCl2 (6) is similar to its sulfur analog 5, in that both the methyl and imidazole 
proton resonances are broadened and shifted upfield (δ 2.58, 1.26, and 1.25, respectively) 
compared to that of unbound (seim
Me
)2 (δ 3.66, 7.05, and 7.15, respectively).  
The 
1H NMR spectrum for [(κ2-mimMe)2]ZnCl2 (7) is similar of that of the zinc-
imidazole complex 2 in that the methyl and imidazole proton resonances are slightly 
shifted downfield (δ 3.42, 6.87, and 7.06, respectively) compared to unbound (mimMe)2 
Table 6.1. 
1
H NMR resonances for iron and zinc complexes 1 - 7. 
Compound δ CH3 δ CH δ NH 
Methimazole* 3.42 6.87, 7.05 12.06 
Fe(methimazole)2Cl2  (1)* 13.16 0.87, 5.42 3.69 
methimazole** 3.41 6.59, 7.05 12.05 
Zn(methimazole)2Cl2  (2)** 3.42 6.87, 7.06 12.07 
2-mercaptoimidazole** - 6.81 11.92 
Zn(2-mercaptoimidazole)2Cl2  (3)** - 6.83 11.95 
(mim
H
)2 * - 6.81  
[(κ2-mimH)2]FeCl2 (4)* - 1.99, 2.10 2.57 
(mim
Me
)2* 3.42 6.87, 7.05  
[(κ2-mimMe)2]FeCl2 (5)* 2.26 0.87, 1.25 - 
(seimMe)2* 3.66 7.05, 7.15 
 
[(κ2-seimMe)2]FeCl2 (6)* 1.13 3.43,8.00 - 
(mim
Me
)2** 3.42 6.87, 7.05 - 
[κ2-mimMe)2]ZnCl2 (7)** 3.42 6.87, 7.06 - 
* 
1
H NMR spectrum acquired in CD3CN 
** 
1
H NMR spectrum acquired in DMSO-d6 
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 (Table 6.1). 
13
C{
1
H} NMR for Fe(II) complexes 1, 4, 5, and 6  could not be obtained due to 
the paramagnetic effects of the Fe(II) center. However, the 
13
C{
1
H} NMR spectrum of 
the zinc complex 7 shows very slight downfield shifts for the methyl (δ 34.0), imidazole 
(δ 114.35 and 120.0), and quaternary (δ 161.4) carbon resonances compared to unbound 
(mim
Me
)2 (δ 33.8, 114.1,  119.8 and 160.3, respectively).  
Because NMR spectra of Fe(II)-thione complexes 1, 4, 5, and 6 show 
paramagnetic contributions from the iron(II) center, it is not possible to evaluate thione or 
selone ligand binding using this method. However, the 
1
H NMR and {
1
H}
13
C NMR 
spectra of zinc complexes 2, 3, and 7 display little to no significant differences in the 
resonance shifts of the bound thione ligands compared to the free thiones, indicating that 
the zinc-bound thiones, while favoring their zwitterionic forms, do not significantly 
increase in zwitterionic resonance character compared to the unbound thiones. 
Infrared spectroscopy. Infrared spectroscopy was performed on iron and zinc 
complexes 1-3 to determine the effects of metal binding on the C=S/Se bond strength. 
The IR spectrum of Fe(methimazole)2Cl2 (1) shows a S=C stretching vibration at 1155 
cm
-1
, slightly shifted to higher energy from unbound methimazole (1150 cm
-1 35
). Similar 
to complex 1, the IR spectrum of Zn(methimazole)2Cl2 (2) also shows a slight shift of the 
C=S stretching vibration to higher energy (1156 cm
-1
).  In contrast, no significant shift is 
observed for the C=S stretch of Zn(2-mercaptoimidazole)2Cl2 (3, 1153 cm
-1
) compared to 
unbound 2-mercaptoimidazole (1151 cm
-1
).  For the diselenide and disulfide complexes 4 
– 7 the S-S stretching vibrations occur at 512 cm-1, typical for S-S bond vibrations 
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(500-540 cm
-1
). 
The slight increase in C=S stretching vibrations for complexes 1 and 2 is opposite 
to that observed previously for Fe(dmit)2Cl2, [Fe(dmit)2(NCCH3)]
2+
, and [Fe(dmit)4]
2+
 
complexes
16
 that have C=S stretching vibrations that shift to lower energy (1176 – 1178 
cm
-1
) compared to unbound dmit (1181 cm
-136
).  The IR data for complexes 1 - 3 suggest 
that the thiones bind through primarily σ and π donation as previously observed for iron 
(Chapter 2) and zinc (Chapter 4) binding. 
Structural analysis of thione,disulfide, and diselenide complexes with iron and 
zinc. Crystals of Fe(methimazole)2Cl2 (1),  Zn(methimazole)2Cl2 (2) were grown via slow 
diffusion of ether into acetonitrile solution, and crystals of [(κ2-mimH)2]FeCl2 (4), 
[(κ2-mimMe)2]FeCl2 (5), and [(κ
2
-seim
Me
)2]FeCl2 (6) were grown via diffusion of ether 
into methanolic solution. Single-crystal X-ray diffraction data were collected by Dr. 
Collin McMillen (Department of Chemistry, Clemson University).  Selected bond 
distances and angles for 1, 2, 4, 5, and 6 are summarized in Tables 6.2 and 6.3, and their 
structures are shown in Figures 6.2 and 6.3.  
The Fe(II) center in complex 1 adopts a distorted tetrahedral coordination 
geometry with bond angles ranging from 112.89(3)° to 110.50(4)°. The Fe(II) center is 
bound through the sulfur atoms of the thione, rather than through the available nitrogen 
atom of the imidazole ring. The Fe-S bond distances of 2.344(2) Å, are similar to those of 
reported Fe(II)-thione complexes (2.298(1) – 2.474(1) Å).15 Although 1 is similar in iron 
coordination environment to Fe(dmit)2Cl2 (Chapter 2), the imidazole ring orientations are 
different. The Fe(methimazole)2Cl2 (1) complex, when looking down the FeCl2 plane 
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Figure 6.2. Crystal structure diagrams with 50% probability density ellipsoids for Fe(methimazole)2Cl2 (1) 
A) looking down the S-Fe-S plane and B) looking down the Fe-Cl plane and Zn(methimazole)2Cl2 (2) C) 
looking down S-Zn-S plane and D) looking down Zn-Cl plane. Hydrogen atoms are omitted for clarity. 
 
Table 6.2. Selected bond lengths and angles for complexes 1 and 2. 
1 2 
Fe1—S1 2.3442 (8) Zn1—S1 2.3353 (13) 
Fe1—S1i 2.3442 (8) Zn1—S2 2.3450 (14) 
Fe1—Cl1 2.2856 (8) Zn1—Cl2 2.2530 (13) 
Fe1—Cl1i 2.2856 (8) Zn1—Cl1 2.2602 (14) 
S1—C1 1.718 (3) S1—C1 1.709 (5) 
S1
i—C1i 1.718 (3) S2—C5 1.714 (5) 
  
  
Cl1—Fe1—Cl1i 110.50 (4) Cl2—Zn1—Cl1 109.89 (5) 
Cl1—Fe1—S1 112.89 (3) Cl2—Zn1—S1 102.63 (5) 
Cl1
i—Fe1—S1 111.19 (3) Cl1—Zn1—S1 115.24 (5) 
Cl1—Fe1—S1i 111.19 (3) Cl2—Zn1—S2 118.47 (5) 
Cl1
i—Fe1—S1i 112.89 (3) Cl1—Zn1—S2 106.92 (5) 
S1—Fe1—S1i 97.65 (4) S1—Zn1—S2 103.90 (5) 
i symmetry operator for symmetrically equivalent atoms: -x, y, -z+2/3 
 
 (Figure 6.2B), is in the shape a “w” with the imidazole rings cis to one another, while 
Fe(dmit)2Cl2 complex is in the shape of a “hook” with the imidazole rings trans to each 
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other. For 1, the imidazole ring planes are inclined at 76.07°, and the ring centroids are 
twisted at 12.79° to one another (measuring the centroid-S-S-centroid torsion angle). 
Both rings are inclined at 53.54° relative to the FeCl2 group (the rings are related by 
symmetry, so the angle is the same). For Fe(dmit)2Cl2 the ring planes are inclined at 
65.59° to one another, and the ring centroids are twisted at 97.95° to one another.  
Similarly to complex 1, its zinc counterpart 2 also crystallizes in a distorted 
tetrahedral coordination geometry with bond angles ranging from 102.63(5)° to 
118.47(5)°. The Zn-S bond distances of 2.335(1) Å and 2.345(1) Å are slightly shorter 
compared to the previously synthesized Zn-thione complex Zn(dmit)2Cl2 (2.354(1) Å and 
2.377(1) Å (Chapter 4) but similar to [Zn(dmit)4]
2+
 (2.339(1) Å and 2.357(1) Å.
37
 
 Changing the metal center from iron to zinc changes the solid state packing of the 
complexes. Complex 1 packs in space group P2n which contains an inversion center, 
whereas complex 2 packs in space group P212121 that does not contain an inversion 
center. Unlike complex 1, complex 2 is in the shape of a “lightning bolt” with the 
imidazole rings trans to each other when viewed down the FeCl2 plane, a packing effect 
possibly caused by the methyl groups on the imidazole rings being cis to one another 
(Figure 6.2C). In contrast, its iron counterpart 1 has the methyl groups trans to one 
another (Figure 6.2A). This difference in the orientation of the imidazole rings when 
compared to Zn(dmit)2Cl2 (Chapter 4) is the result of the absent methyl group on the 
nitrogen atoms of the imidazole ring. 
X-ray diffraction structures of the iron and zinc complexes with oxidized 
methimazole and seleno-methimazole ligands (4 - 6) were also obtained (Figure 6.3), and 
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selected bond lengths and angles are provided in Table 6.2. The iron(II) metal center in 
[(κ2-mimMe)2]FeCl2 (4; Figure 6.3A) adopts a distorted tetrahedral geometry, with bond 
angles ranging from 104.6(1)° to 123.96(6)° and is bound by two chloride atoms and two 
nitrogen atoms within the imidazole rings of the [(κ2-mimMe)2] ligand. The Fe-N bond 
distances are 2.074(4) Å and 2.075(4) Å, similar to the M-N bond lengths of 
[(κ2-mimBut)2]MCl2 (M = Fe(II), Co(II), Zn(II), and Ni(II)) complexes (1.980(3) to 
2.060(4) Å
26
) [(κ2-seimMes)2]MCl2 (M = Fe, Co, and Ni) complexes (2.004(4) to 
2.0985(3) Å
26
). The S-S bond length of 2.066(2) Å is similar to the previously reported 
[(κ2-mimMe)2]ZnCl2 complex and the unbound (κ
2
-mim
Me
)2 compound (2.069(1) Å
38
 and 
2.085(2) Å,
39
 respectively).  
The iron(II) center of [(κ2-mimH)2]FeCl2 (5; Figure 6.3B) also adopts a distorted 
tetrahedral geometry with bond angles ranging from 104.00(9)° to 115.87(4)°. The S-S 
bond length of 2.069(1) Å is similar to 4, previously reported [(κ2-mimBut)2]MCl2 (M =  
 
Figure 6.3. Crystal structure diagrams with 50% probability density ellipsoids for A) [(κ2-
mim
H
)2]FeCl2 (4), B) [(κ
2
-mim
Me
)2]FeCl2 (5), and C) [(κ
2
-seim
Me
)2]FeCl2 (6). Hydrogen atoms are 
omitted for clarity.  
A B
C
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Table 6.3. Selected bond lengths and angles for complexes 4, 5, and 6. 
4 5 6 
Fe1—N3 2.076 (3) Fe1—N3 2.074 (4) Fe1—N1 2.073 (4) 
Fe1—N1 2.082 (3) Fe1—N1 2.075 (4) Fe1—N3 2.075 (4) 
Fe1—Cl1 2.2764 (11) Fe1—Cl1 2.2647 (15) Fe1—Cl1 2.2720 (16) 
Fe1—Cl2 2.2809 (10) Fe1—Cl2 2.2829 (15) Fe1—Cl2 2.2922 (16) 
S1—C1 1.755 (4) S1—C1 1.756 (5) Se1—C1 1.893 (5) 
S2—C4 1.748 (4) S2—C5 1.741 (5) Se2—C5 1.887 (5) 
S1—S2 2.0699 (14) S1—S2 2.066 (2) Se1—Se2 2.3433 (9) 
  
    N3—Fe1—N1 114.47 (12) N3—Fe1—N1 109.87 (17) N1—Fe1—N3 114.12 (16) 
N3—Fe1—Cl1 108.42 (9) N3—Fe1—Cl1 106.50 (13) N1—Fe1—Cl1 104.10 (12) 
N1—Fe1—Cl1 104.00 (9) N1—Fe1—Cl1 104.64 (12) N3—Fe1—Cl1 104.82 (13) 
N3—Fe1—Cl2 105.24 (8) N3—Fe1—Cl2 106.21 (12) N1—Fe1—Cl2 104.15 (13) 
N1—Fe1—Cl2 109.17 (9) N1—Fe1—Cl2 105.26 (12) N3—Fe1—Cl2 106.42 (13) 
Cl1—Fe1—Cl2 115.87 (4) Cl1—Fe1—Cl2 123.96 (6) Cl1—Fe1—Cl2 123.65 (7) 
C1—S1—S2 101.48 (12) C1—S1—S2 101.59 (16) C1—Se1—Se2 97.80 (14) 
C4—S2—S1 102.33 (12) C5—S2—S1 100.83 (18) C5—Se2—Se1 97.70 (16) 
 
Fe(II), Co(II), Zn(II), and Ni(II)) complexes (1.980(3) - 2.060(4) Å
26
), and the free 
disulfide (mim
Me
)2 (2.085 (2) Å
39
). Although complexes 4 and 5 are similar in structure, 
their space groups are different (Pbca and P21/c, respectively) due to the methylated 
nitrogen within the imidazole rings of 4 altering the packing in the crystal system. 
For the iron-selenide complex [(κ2-seimMe)2]FeCl2 (6; Figure 6.3C), the iron(II) 
center also adopts a distorted tetrahedral geometry with bond angles ranging from 
104.10(13)° to 123.64(6)°. The average Fe-N bond length of 2.074(4) Å is similar to the 
average M-N bond lengths of [(κ2-seimMes)2]MCl2 (M = Fe(II), Co(II), and Ni(II)) 
complexes (2.004(4) to 2.0985(3) Å
26
).  In addition, the Se-Se bond length of 2.343(1) Å 
is similar to reported [(κ2-seimMes)2]MCl2 (M = Fe(II), Co(II), and Ni(II)) complexes 
averaging Se-Se bond lengths of 2.312(1) to 2.3284(6) Å.
26
 
Complexes 4 - 6 are isomorphous with each other and published [(κ2-
196 
 
mim
But
)2]MCl2 complexes (M = Fe(II), Co(II), Ni(II), Zn(II)) and [(κ
2
-seim
Mes
)2]MCl2 (M 
= Fe(II), Co(II), Ni(II)) where (κ2-mimBut)2 and (κ
2
-seim
Mes
)2 are bis(1-R-imidazol-2-
yl)disulfides (R = butyl) and diselenides (R = Mes). For complexes 4, 5, and 6, the [(κ2-
mim
Me
)2], [(κ
2
-mim
H
)2], and [(κ
2
-seim
Me
)2] ligands bind iron through the nitrogen atoms, 
creating a seven-membered chelate ring. The disulfide or diselenide bond twists from one 
imidazole ring to the other, intersecting the FeCl2 or ZnCl2 plane. 
It is interesting to note that methimazole and 2-mercaptoimidazole bind to iron 
and zinc through the sulfur atom rather than through the nitrogen atom in the imidazole 
ring; this exclusive sulfur binding is also observed for other metal complexes.
15
 It is not 
until the thiones become oxidized to the disulfide dimers that they bind to iron and zinc 
through the imidazole nitrogens. This may be attributed to the tendency of the thiones to 
exist in their zwitterionic resonance structures rather than their thione resonance 
structures,
16
 increasing the partial negative charge on the sulfur atom and increasing their 
metal binding affinity. 
 
6.3 Conclusions 
We have synthesized several novel Fe
2+
 and Zn
2+
-methimazole and 2-
mercaptoimidazole complexes to examine the metal binding properties of the current 
thyroid drug methimazole and its derivatives. When bound to Zn
2+
, the thiones 
methimazole and 2-meraptoimidazole show no significant increase or decrease intheir 
zwitterionic character using 
1
H NMR spectroscopy. These thiones readily oxidize to form 
their disulfide and diselenide dimers that coordinate readily through the available 
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imidazole nitrogens to form seven-atom ring systems. However, Fe(II) and Zn(II) 
complexes of methimazole and 2-mercaptoimidazole ligands bind solely through the 
sulfur atoms rather than through these imidazole nitrogen atoms. Infrared spectroscopy of 
the iron- and zinc-thione complexes 1 – 3 suggest metal coordination of the thiones is 
primarily through σ and π donation as observed for M(dmit/dmise)2Cl2 and 
[M(dmit/dmise)4]
2+
 (M = Fe(II) or Zn(II)) complexes (Chapters 2 and 4). Further 
characterizationand reactivity studies of these complexes including electrochemical 
studies and oxidation by H2O2, will aid in understanding the mechanisms by which 
methimazole and its derivatives prevent metal-mediated oxidative DNA damage. 
 
6.4 Experimental Methods  
General procedures. The synthesis and handling of all iron complexes were 
carried out under an inert atmosphere of nitrogen or argon using standard glove-box and 
Schlenk techniques. The following reagents were used as received: diethyl ether (Acros), 
hydrated iron(II) chloride (Acros), zinc(II) chloride (Alfa Aesar), methimazole (Acros), 
and 2-mercaptoimidazole (Acros).  
Instrumentation. 
1
H and 
13
C{
1
H} NMR spectra were obtained on Bruker-
AVANCE 300 MHz and 500 MHz NMR spectrometers. 
1
H and 
13
C{
1
H} NMR chemical 
shifts are reported in δ relative to tetramethylsilane (δ 0) and referenced to solvent. 
Infrared spectra were obtained using Nujol mulls on KBr salt plates with a Magna 550 IR 
spectrometer. Abbreviations used in the description of vibrational data are as follows: vs, 
very strong; s, strong; m, medium; w, weak; b, broad. MALDI mass spectrometry 
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experiments were performed using a Bruker Microflex MALDI-TOF mass spectrometer 
with trans-2-3-(4-tert-butylphenyl)-2-methyl-2-propenyldiene (m/z 250.3) as the matrix. 
Synthesis of Fe(methimazole)2Cl2 (1). FeCl2·4H2O (168 mg, 0.845 mmol) was 
dissolved in triethylorthoformate/dichloromethane 1:1 (10 mL), and to this solution was 
added a solution of methimazole (192 mg, 1.68 mmol) in dichloromethane (10 mL) via 
cannula. The reaction mixture was stirred for 2 h, the solvent was reduced to ~5 mL, and 
diethyl ether (20 mL) was added to precipitate Fe(methimazole)2Cl2 (1) from solution. 
The mixture was filtered, washed with diethyl ether (10 mL × 3), and dried under 
vacuum to afford Fe(methimazole)2Cl2 (1) as a beige solid. Crystals for X-ray analysis 
were grown via slow vapor diffusion of ether into acetonitrile yielding colorless crystals. 
Yield: 225 mg, 75%. 
1
H NMR (CD3CN): δ 13.16 (s, 3H, CH3), 5.42 (s, 1H, CH) 0.87 (s, 
1H, CH), and 3.69 (s, 1H, NH). IR (cm
-1
): 3338 (b), 3156 (s), 3128 (s), 2926 (b), 1707 
(w), 1611 (w), 1506 (s), 1456 (s,b), 1377 (s), 1346 (s), 1279 (s), 1243 (w), 1154 (s), 1096 
(s), 1081 (s), 1017 (w), 919 (m), 859 (w), 750 (s), 687 (w), 668 (s), 605 (w), 512 (s). 
MALDI-MS (m/z): [Fe(C4H6N2)Cl2]H
+
 239.9, [Fe(C4H6N2)2Cl2]H
+
 354.8. Anal. Calcd. 
For C8H12Cl2FeN4S2: C, 27.06; N, 15.78; H, 3.41. Found: C, 27.12; N, 15.74; H, 3.39. 
Melting point: 160 ˚C (dec). 
Synthesis of Zn(methimazole)2Cl2 (2). ZnCl2 (112 mg, 0.823 mmol) was dissolved 
in acetonitrile (20 mL), and to this solution was added a solution of methimazole (186 
mg, 1.64 mmol) in acetonitrile (10 mL) via cannula. The reaction mixture was stirred for 
2 h, the solvent was reduced to ~5 mL, and diethyl ether (20 mL) was added to 
precipitate Zn(methimazole)2Cl2 (2) from solution. The mixture was filtered, washed with 
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diethyl ether (10 mL × 3), and dried under vacuum to afford Zn(methimazole)2Cl2 (2) as 
a white solid. Crystals for X-ray analysis were grown via diffusion of ether into 
acetonitrile. Yield: 249 mg, 83%. 
1
H NMR ((CD3)2SO): δ 3.42 (s, 3H, CH3), 6.87 (d, J HH 
= 2.4 MHz, 1H, CH), 7.06 (d, J HH = 2.4 MHz, 1H, CH), 12.09 (s, 1H, NH). 
13
C{
1
H} 
NMR ((CD3)2SO): δ 33.5 (CH3), 114.2 (CH), 119.6 (CH), 160.9 (C=S). IR (cm
-1
): 3233 
(b), 3136 (w), 2926 (s,b), 2855 (s), 1675 (w), 1575 (s), 1463 (s), 1405 (w), 1377 (m), 
1282 (w), 1254 (w), 1156 (m), 1086 (m), 1017 (w), 920 (w), 839 (w), 750 (w), 730 (s), 
685 (w), 669 (w), 517 (w). MALDI-MS (m/z) = [Zn(C4H6N2S)Cl2]H
+
 249.9, 
[Zn(C4H6N2S)2Cl2]H
+
 364.1. Anal. Calcd. For C8H12Cl2N4S2Zn: C, 26.35; N, 15.37; H, 
3.32. Found: C, 26.23; N, 15.42; H, 3.28. Melting point: 160-163°C.  
Synthesis of Zn(2-mercaptoimidazole)2Cl2 (3). ZnCl2 (112 mg, 0.823 mmol) was 
dissolved in acetonitrile (20 mL) and to this solution was added a solution of 2-
mercaptoimidazole (186 mg, 1.64 mmol) in acetonitrile (10 mL) via cannula. The 
reaction mixture was stirred for 12 h, and the volume was reduced to ~5 ml in vacuo. 
Zn(2-mercaptoimidazole)2Cl2 (3) was precipitated from solution by addition of diethyl 
ether (20 mL). The mixture was filtered, washed with diethyl ether (10 mL × 2), and 
dried under vacuum to afford Zn(2-mercaptoimidazole)2Cl2 (3) as a beige solid.  Crystals 
for X-ray analysis were grown via diffusion of ether into acetonitrile. Yield: 83%. 
1
H 
NMR ((CD3)2SO): δ 6.83 (s, 2H, CH), 11.95 (s, 1H, NH). 
13
C{
1
H} NMR ((CD3)2SO): 
116.0 (CH), 160.8 (C=S). IR (cm
-1
): 3233 (b), 3136 (w), 2926 (s,b), 2855 (s), 1675 (w), 
1575 (s), 1463 (s), 1405 (w), 1377 (m), 1282 (w), 1254 (w), 1156 (m), 1086 (m), 1017 
(w), 920 (w), 839 (w), 750 (w), 730 (s), 685 (w), 669 (w), 517 (w). MALDI-MS (m/z): 
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[Zn(C3H4N2S)2Cl]H
+
 299.9, [Zn(C3H4N2S)2Cl2]H
+
 334.9. Anal. Calcd. For 
C6H8Cl2N4S2Zn: C, 21.41; N, 16.65; H, 2.40. Found: C, 21.38; N, 16.58; H, 2.37. 
Melting point: 156-158°C. 
Synthesis of [(κ2-mimH)2]FeCl2 (4). FeCl2·4H2O (182 mg, 0.845 mmol) was 
dissolved in triethylorthoformate/methanol 1:1 (10 mL) and to this was added a solution 
of (mim
H
)2 (192 mg, 0.845 mmol) in methanol (10 mL) via cannula. The reaction mixture 
was stirred for 2 h, the solvent was evaporated under vacuum to ~5 mL, and the product 
was precipitated from solution by addition of diethyl ether (20 mL). The mixture was 
filtered, washed with diethyl ether (10 mL x 3), and dried under vacuum to afford [(κ2-
mim
H
)2]FeCl2 (4) as a beige solid. Crystals for X-ray analysis were grown via slow vapor 
diffusion of dichloromethane into acetonitrile solution. Yield: 60%. 
1
H NMR (CD3CN): δ 
6.83 (s, 2H, CH), 11.95 (s, 1H, NH). IR (cm
-1
): 3306 (m), 3197 (s), 3171 (w), 3137 (w), 
2926 (b), 2361 (w), 2342 (w), 1710 (w), 1691 (w), 1580 (s), 1466 (s), 1407 (s), 1377 (s), 
1276 (w), 1220 (m), 1155 (w), 1116 (w), 1066 (m), 954 (w), 913 (w), 844 (w), 759 (s), 
736 (s), 688 (w), 671 (s), 512 (w), 492 (m). MALDI-MS (m/z) = [Fe(C6H6N4S2)Cl2]H
+
 
324.9. Anal. Calcd. For C6H6Cl2FeN4S2: C, 22.17; N, 17.24; H, 1.86. Found: C, 22.09; N, 
17.17; H, 1.92. Melting point: 168 °C (dec.). 
Synthesis of [(κ2-mimMe)2]FeCl2 (5).  FeCl2·4H2O (168 mg, 0.845 mmol) was 
dissolved in triethylorthoformate/methanol 1:1 (10 mL) and to this was added (mim
Me
)2 
(191 mg, 0.845 mmol) in methanol (10 mL) via cannula. The reaction mixture was stirred 
for 12 h, the solvent was evaporated under vacuum to ~5 mL, and the product was 
precipitated from solution by addition of diethyl ether (20 mL). The mixture was filtered, 
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washed with diethyl ether (10 mL × 2), and dried under vacuum to afford [(κ2-
mim
Me
)2]FeCl2 (5) as  a beige solid. Crystals for X-ray analysis were grown via slow 
vapor diffusion of ether into methanol yielding yellow/olive green crystals. Yield: 56% 
1
H NMR (CD3CN): δ 2.26 (s, 3H, CH3), 1.25 (s, 1H, CH), 0.87 (s, 1H, CH). IR (cm
-1
): 
3338 (b), 3156 (s), 3128 (s), 2926 (b), 1707 (w), 1611 (w), 1506 (s), 1456 (s,b), 1377 (s), 
1346 (s), 1279 (s), 1243 (w), 1154 (s), 1096 (s), 1081 (s), 1017 (w), 919 (m), 859 (w), 
750 (s), 687 (w), 668 (s), 605 (w), 512 (s). MALDI-MS (m/z): [Fe(C8H11N4S2)Cl]
+
 317.1 
and [Fe(C8H11N4S2)Cl2]H
+
 352.0. Anal. Calcd. For C8H10Cl2FeN4S2: C, 27.21; N, 15.87; 
H, 2.85. Found: C, 27.19; N, 15.92; H, 2.91. Melting point: 170°C (dec). 
Synthesis of [(κ2-seimMe)2]FeCl2 (6). FeCl2·4H2O (168 mg, 0.845 mmol) was 
dissolved in triethylorthoformate/methanol 1:1 (10 mL) and to this was added (seim
Me
)2 
(270 mg, 0.845 mmol) in methanol (10 mL) via cannula. The reaction mixture was stirred 
for 2 h, the solvent was reduced under vacuum to ~5 mL, and the product was 
precipitated from solution by addition of diethyl ether (20 mL). The mixture was filtered, 
washed with diethyl ether (10 mL × 2), and dried under vacuum to afford [(κ2-
seim
Me
)2]FeCl2 (6) as a beige solid. Crystals for X-ray analysis were grown via slow 
vapor diffusion of ether into methanol yielding yellow-green crystals. Yield: 51% 
1
H 
NMR (CD3CN): δ 1.13 (s, 3H, CH3), 3.43 (s, 1H, CH), 8.00 (s, 1H, CH). IR (cm
-1
): 3338 
(b), 3156 (s), 3128 (s), 2926 (b), 1707 (w), 1611 (w), 1506 (s), 1456 (s,b), 1377 (s), 1346 
(s), 1279 (s), 1243 (w), 1154 (s), 1096 (s), 1081 (s), 1017 (w), 919 (m), 859 (w), 750 (s), 
687 (w), 668 (s), 605 (w), 512 (s). MALDI-MS (m/z): [Fe(C8H11N4Se2)Cl]
+ 
412.9 and 
[Fe(C8H11N4Se2)Cl2]H
+
 448.6. Anal. Calcd. For C8H10Cl2FeN4S2: C, 27.21; N, 15.87; H, 
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2.85. Found: C, 27.19; N, 15.92; H, 2.91. Melting point: 162°C (dec). 
Synthesis of [(κ2-mimMe)2]ZnCl2 (7). ZnCl2 (168 mg, 0.845 mmol) was dissolved 
in triethylorthoformate/methanol 1:1 (10 mL) and to this was added (κ2-mimMe)2 (191 
mg, 0.845 mmol) in methanol (10 mL) via cannula. The reaction mixture was stirred for 2 
h, the solvent was reduced under vaccum to ~5 mL, and [(κ2-mimMe)2]ZnCl2 (7) was 
precipitated from solution by addition of diethyl ether (20 mL). The mixture was filtered, 
washed with diethyl ether (10 mL x 2), and dried under vacuum to afford [(κ2-
mim
Me
)2]ZnCl2 (7) as a beige solid (52%). Crystals for X-ray analysis were grown via 
slow vapor diffusion of ether into ethanol yielding yellow/olive green crystals. 
1
H NMR 
((CD3)2SO): δ 3.17 (s, 3H, CH3), 6.86 (s, 1H, CH), 7.05 (s, 1H, CH). IR (cm
-1
): 3338 (b), 
3156 (s), 3128 (s), 2926 (b), 1707 (w), 1611 (w), 1506 (s), 1456 (s,b), 1377 (s), 1346 (s), 
1279 (s), 1243 (w), 1154 (s), 1096 (s), 1081 (s), 1017 (w), 919 (m), 859 (w), 750 (s), 687 
(w), 668 (s), 605 (w), 512 (s). MALDI-MS (m/z): [Zn(C8H11N4S2)Cl2]H
+
 360.1. Anal. 
Calcd. For C8H10Cl2ZnN4S2: C, 27.21; N, 15.87; H, 2.85. Found: C, 27.19; N, 15.92; H, 
2.91. Melting point: 160°C. 
Single crystal X-ray data collection. Crystals of Fe(methimazole)2Cl2 (1),  
Zn(methimazole)2Cl2 (2) were grown via slow diffusion of ether into acetonitrile 
solution, and [(κ2-mimH)2]FeCl2 (4), [(κ
2
-mim
Me
)2]FeCl2 (5), and [(κ
2
-seim
Me
)2]FeCl2 (6) 
were grown via diffusion of ether into methanol solution. Single crystal X-ray diffraction 
data were collected for Fe(methimazole)2Cl2 (1), which crystallized as colorless plates 
Zn(methimazole)2Cl2 (2), which crystallized as colorless prisms, [(κ
2
-mim
H
)2]FeCl2 (4), 
which crystallized as yellow plates, [(κ2-mimMe)2]FeCl2 (5), which crystallized as yellow 
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plates, and [(κ2-seimMe)2]FeCl2 (6), which crystallizes as orange plates. The crystals were 
mounted on a glass filament with epoxy glue, and immediately placed on the 
diffractometer in a room-temperature nitrogen gas stream. Intensity data were collected 
using a Rigaku Mercury CCD detector and an AFC8S diffractometer. The space groups 
P2n, P212121, and Pbca were determined from the systematic absences for complexes 1,  
2, and 4 respectively (Table 6.4). The space groups Pbca and Pbca were determined from 
the systematic absences for complexes 5 and 6 (Table 6.5). Data reduction including the 
application of Lorentz and polarization effects and absorption corrections was performed 
using the CrystalClear program. The structures were solved by direct methods and 
subsequent Fourier difference techniques, and refined anisotropically, by full-matrix least 
squares, on F2 using SHELXTL 6.10.
40
 The quantity minimized by the least squares 
program was Σw = (Fo
2
 - Fc
2
)
2
 where w = {[σ2(Fo
2
)] + (0.0307P)
2
 + 1.57P} where P = 
(Fo
2
)+2Fc
2
)/3. In the final cycle of least squares, independent anisotropic displacement 
factors were refined for the non-hydrogen atoms, and hydrogen atoms were fixed in 
idealized positions with C—H = 0.96 Å. Isotropic hydrogen atom displacement 
parameters were set equal to 1.5 times Ueq of the attached carbon atom.  
For 1 the largest peak in the final Fourier difference map (0.46 e A
-3
) was located 
1.85 Å from H4C and the lowest peak (-0.33 e∙A-3) was located at a distance of 1.11 Å 
from N1. For 2 the largest peak in the final Fourier difference map (0.44 e∙A-3) was 
located 1.47 Å from Zn1 and the lowest peak (-0.39 e∙A-3) was located at a distance of 
0.94 Å from Zn1. For 3 the largest peak in the final Fourier difference map (0.51 e A
-3
) 
was located 0.92 Å from Cl1 and the lowest peak (-0.42 e∙A-3) was located at a distance 
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of 0.85 Å from Zn1. For 4 the largest peak in the final Fourier difference map (0.51 e∙A-3) 
was located 0.92 Å from Cl1 and the lowest peak (-0.42 e∙A-3) was located at a distance 
of 0.85 Å from Fe1. For 5 the largest peak in the final Fourier difference map (0.51 e∙A-3) 
was located 0.92 Å from Cl1 and the lowest peak (-0.42 e∙A-3) was located at a distance 
of 0.85 Å from Fe1. For 6 the largest peak in the final Fourier difference map (0.51 e∙A-3) 
was located 0.92 Å from Cl1 and the lowest peak (-0.42 e∙A-3) was located at a distance 
of 0.85 Å from Fe1. 
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Table 6.4. Summary of crystallographic data for complexes 1, 2, and 4. 
  1 2 4 
Chemical formula C8H12Cl2FeN4S2 C8H12Cl2N4S2Zn C6H6N4S2Cl2Fe 
F.W. (g/mol
-1
) 355.09 364.61 325.02 
Space group 
 
P21/n P21/c Pbca 
Crystal system Monoclinic Orthorhombic Monoclinic 
a,Å 6.6906 (13) 7.7787 (16) 6.8467 (14) 
b,Å 8.5246 (17) 13.415 (3) 12.133 (2) 
c,Å 12.896 (3) 13.649 (3) 15.242 (4) 
α, deg 90 90 90 
β, deg 95.42(3) 90 116.68 (2) 
γ, deg 90 90 90 
V,Å
-3
 732.2 (3) 1424.3 (5) 1131.4 (4) 
Z 2 4 4 
Dcal, mg/m
3
 1.611 1.7 1.908 
indices (min) [-6, -10, -15] [-9, -16, -16] [-7, -14, -18] 
indices (max) [8, 10, 15] [9, 16, 16] [8, 14, 18] 
parameters 79 156 137 
F(000) 360 736 648 
μ, mm-1 1.663 2.375 2.143 
2θ range, deg 2.39 - 25.24 2.13 - 25.25 2.25 - 25.23 
collected reflections 5665 11529 9306 
unique reflections 1320 2579 2044 
Final R(obs. data)
a
, R1 0.0316 0.036 0.0289 
wR
2
 0.0786 0.0846 0.0777 
final R(all data), R1 0.0355 0.0421 0.0308 
wR
2
 0.0827 0.0888 0.0799 
goodness of fit (S) 1.108 1.162 1.157 
largest diff. peak 0.459 0.438 0.506 
largest diff. hole -0.334 -0.39 -0.401 
a
 R1 = Σ ǁ F0| - |Fcǁ/Σ|F0|; wR2 = {Σw(F0
2
 - Fc
2
)
2
}
1/2
. 
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Table 6.5. Summary of crystallographic data for complexes 5 and 6. 
 
5 6 
Chemical formula C8H10Cl2FeN4S2 C8H10Cl2FeN4Se2 
F.W. (g/mol
-1
) 353.04 446.87 
Space group Pbca Pbca 
Crystal system Orthorhombic Orthorhombic 
a,Å 8.5009 (17) 8.2950 (17) 
b,Å 13.183 (3) 13.646 (3) 
c,Å 24.812 (5) 25.385 (5) 
α, deg 90 90 
β, deg 90 90 
γ, deg 90 90 
V,Å
-3
 2778.5 (10) 2873.5 (10) 
Z 8 8 
Dcal, mg/m
3
 1.688 2.066 
indices (min) [-10, -15, -29] [-9, -16, -28] 
indices (max) [10, 15, 29] [9, 16, 30] 
parameters 156 157 
F(000) 1424 1712 
μ, mm-1 1.752 6.471 
2θ range, deg 2.90 - 25.15 2.93 - 25.25 
collected reflections 20889 20137 
unique reflections 2485 2583 
Final R(obs. data)
a
, R1 0.0524 0.03394 
wR2 0.1225 0.0964 
final R(all data), R1 0.0681 0.0431 
wR2 0.1338 0.0997 
goodness of fit (S) 1.113 1.124 
largest diff. peak 0.577 0.513 
largest diff. hole -0.463 -0.558 
a
 R1 = Σ ǁ F0| - |Fcǁ/Σ|F0|; wR2 = {Σw(F0
2
 - Fc
2
)
2
}
1/2
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CHAPTER SEVEN 
SYNTHESIS, CHARACTERIZATION, AND REACTIVITY OF IRON(II)- 
AND ZINC(II) COMPLEXES OF IMIDAZOLE THIONE AND SELONE 
LIGANDS: INVESTIGATIONS INTO OXIDATION MECHANISMS 
 
7.1 Conclusions 
 Metal-mediated oxidative DNA damage is an underlying cause of many diseases 
and becomes very prevalent under oxidative stress conditions.
1-5
 During oxidative stress, 
reactive oxygen species (ROS) production increases such that cellular antioxidants cannot 
scavenge them effectively, leading to increased oxidative DNA damage.
1-5
 To protect 
cells from increased ROS production, multifunctional antioxidants have become a topic 
of particular interest. Studies have determined that sulfur- and selenium-containing amino 
acids and their derivatives effectively prevent Fe(II)- and Cu(I)-mediated oxidative DNA 
damage primarily by metal coordination rather than hydroxyl radical scavenging.
6-10
 
Initial interest in antioxidant thiones and selones and their derivatives has arisen from the 
discovery of the antioxidant properties of naturally occurring ergothioneine and 
selenoneine.
11-17
 ROS scavenging as well as iron and copper coordination by thione and 
selone compounds are responsible for their prevention of DNA damage, but 
understanding this novel multifunctional antioxidant activity is lacking, since few iron(II) 
complexes with thione and selone ligands are reported.
18
 
  N,N’-dimethylimidazole thione (dmit), N,N’-dimethylimidazole selone (dmise), 
ethyl-bis(imidazole) thione (ebit), and ethyl-bis(imidazole) selone (ebis) readily bind 
Fe(II) in a variety of coordination environments (Chapter 2).
19
 DFT calculations and 
1
H 
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and 
13
C{
1
H} NMR results demonstrate an increase in zwitterionic character when these 
thione and selone ligands are bound to Fe(II). Electrochemical studies revealed that 
although Fe(III/II) redox potentials of these iron-thione and -selone complexes fall within 
the ability of biological reductants to reduce Fe(III) to Fe(II) (-0.32 V vs. NHE)
20
 the 
thione and selone ligands in these Fe(II) complexes have significantly higher oxidation 
potentials than the corresponding Fe(II/II)-derived potentials as well as their unbound 
thione and selone compounds.
19
 These higher ligand-based oxidation potentials suggest 
that the bound thiones and selones should undergo sacrificial oxidation and protect Fe(II) 
from oxidation to Fe(III). 
 Since these electrochemical studies of Fe(II)-dmit and –dmise complexes suggest 
the ligands would undergo sacrificial oxidation prior to Fe(II) oxidation to Fe(III) 
(Chapter 2),
19
 Fe(dmit)2Cl2 and Fe(dmise)2Cl2 complexes were treated with multiple 
equivalents of H2O2 (Chapter 3). 
1
H NMR specteroscopic examination of Fe(dmit)2Cl2 
and Fe(dmise)2Cl2 after H2O2 oxidation identified sacrificial oxidation of dmit and dmise 
ligands to afford the imidazolium cation. Similar reactivity of dmit and dmise and 
formation of imidazolium was also observed upon treating [Tpm*Cu(dmit/dmise)]
+
 with 
H2O2, demonstrating similar metal-coordination antioxidant mechanisms for dmit and 
dmise. Mass spectrometry examination of the oxidized products indicate formation of the 
imidazolium cation and oxidized sulfur or selenium species. The major iron-containing 
products of Fe(dmit)2Cl2 oxidation by H2O2 is the Fe(III) species [FeCl4]
-
 (m/z 197.91),  
demonstrating that dmit does not protect Fe(II) from oxidation. However, when 
Fe(dmise)2Cl2 is treated with H2O2, the Fe
2+
 is protected from oxidation by sacrificial 
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oxidation of the selone ligand. Thus, dmit and dmise undergo facile oxidation when 
bound to iron(II), but presence of  dmise ligands protects Fe(II) from oxidation more than 
dmit coordination. 
 Since zinc does not participate in production of metal-mediated ROS, 
Zn(dmit/dmise)2Cl2 and [Zn(dmit/dmise)4]
2+
 complexes were synthesized and 
characterized. Zn(dmit/dmise)2Cl2 complexes were also treated with H2O2 and these 
results compared to oxidation of the analogous Fe(II) complexes to investigate the role of 
redox-active metal centers in metal-binding thione and selone antioxidant activity 
(Chapter 4). The 
1
H and 
13
C{
1
H} NMR spectra of zinc(II)-dmit and -dmise complexes 
show very slight downfield shifts for both methyl and olefinic proton resonances 
compared to unbound dmit and dmise, indicating a very slight increase in zwitterionic 
character when bound to Zn(II), similar to that observed for analogous Fe(II)complexes.
19
 
Electrochemical studies of Zn(II)-thione and –selone complexes demonstrate that when 
bound to Zn(II), the dmit- and dmise-based oxidation potentials become more negative 
by an average of 0.06 V compared to free dmit and dmise. This decrease in ligand 
oxidation potential indicates that dmit and dmise are less readily oxidizable when bound 
to Zn(II), a trend opposite to that observed for analogous Fe(II)-dmit and dmise 
complexes.
19
 The 
1
H NMR spectrum of Zn(dmise)2Cl2 upon treatment with H2O2 
indicates imidazolium formation similar to that observed for oxidation of Fe(II)-dmise 
complexes (Chapter 3). However, after treatment of Zn(dmit)2Cl2 with H2O2, 
imidazolium is observed in addition to oxidized [dmit(OH)]H
+
 and [dmit(OH)3]
- 
species 
and sulfur oxide species as determined by mass spectrometry. Mass spectrometry also 
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indicates formation of the Zn(II)-containing species, [ZnCl3]
-
, for both Zn(dmit)2Cl2 and 
Zn(dmise)2Cl2 oxidation by H2O2. These results indicate that C-S cleavage does not 
always occur upon zinc-bound dmit oxidation, in contrast to the results observed upon 
hydrogen peroxide oxidation of the analogous Fe(II) complex. 
 Since dmit, dmise, methimazole, and 2-mercaptoimidazole are potent antioxidants 
that prevent iron- and copper-mediated DNA damage,
10
 we have synthesized novel 
thione- and selone-containing derivatives (Chapter 5). The newly synthesized 
4,5-dichloro-1,3-dimethylimidazole thione and selone compounds have S/Se=C bond 
lengths on average 0.021 Å shorter than the C=S/Se bonds of dmit and dmise,  indicating 
a decrease in zwitterionic character as compared to dmit and dmise. This decrease in 
zwitterionic character may decrease their metal-binding affinity. We have also discovered 
a novel synthetic route for the addition of substituents onto the protonated nitrogen of 
methimazole to affording novel thione compounds. Use of trityl as a thione protecting 
group enables non-air sensitive synthetic techniques to be utilized as well as a simple 
purification route for the synthesis of novel thione derivatives. In addition, 
trityl-protected methimazole allows addition of aliphatic substituents not previously 
achievable by nucleophilic methods and also blocks metal coordination to the sulfur 
atom, forcing coordination through the nitrogen atom of the imidazole ring, a binding 
mode not observed for methimazole. The novel synthetic route utilizing trityl protection 
of thiones as well as the synthesis of novel thione and selone derivatives has allow us to 
expand our catalog of imidazaole thione and selone compounds and future derivatives 
that previous synthetic methods would not afford. 
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 Methimazole, a current drug for treating hyperthyroidism,
22
 is a potent antioxidant 
that prevents iron- and copper-mediated oxidative DNA damage.
10,23,24
 We have 
synthesized Fe(II) and Zn(II) complexes of methimazole and and its derivatives to 
understand how metal coordination may affect their potential biological activity (Chapter 
6).  X-ray crystallographic structures show that methimazole coordinates Fe(II) and 
Zn(II) through its S atom rather than through the N atom of the imidazole ring. NMR and 
IR results indicate that metal coordination of these ligands primarily occurs through 
sigma- and pi-donor interactions and results in an increase in zwitterionic ligand 
character, as reported for dmit (Chapter 2). Since methimazole and its selenium analog 
oxidize to their respective disulfide and diselenide compounds, Fe(II) complexes of these 
oxidized (mim
H
)2, (mim
Me
)2, and (seim
Me
)2 ligands and Zn(II) complexes of (mim
Me
)2 
were synthesized. Upon zinc coordination, these oxidized disulfide and diselenide ligands 
bind through their N atoms, forming seven membered ring systems. Studies of these iron 
and zinc complexes of methimazole and related ligands provide insight into the possible 
metal coordination of these biologically relevant thione and selone antioxidants.  
 Thiones and selones coordinate solely through the sulfur or selenium atoms via σ 
and π bond donation and favor their zwitterionic resonance forms when coordinated to 
Fe(II) and Zn(II). The mechanism of dmit oxidation is dependent upon metal 
coordination; however, the mechanism of dmise oxidation is not, and dmise undergoes 
sacrificial oxidation with cleavage of the C=Se bond when bound to Cu(I), Fe(II), and 
Zn(II). A new synthetic route utilizing trityl protection of thiones may enable synthesis of 
novel thione derivatives unachievable using previous methods. This work has expanded 
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our understanding of thione and selone antioxidant mechanisms and their ability to 
coordinate the biologically relevant metals iron and zinc. 
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APPENDIX A 
 
